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Abstract 
Methodology studies for cyclic boronate ester synthesis 
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Figure i: Target molecules. 
 
Structures i,ii,iii represent a general depiction of cyclic boron-containing heterocyles 
targeted in this methodology study. These molecules will be made using a range of 
new organic pathways. A 1,3 nitrogen-boron relationship in selected structures will 
also be investigated due to its importance in pharmaceutical chemistry. 
 
In the pursuit of cyclic boranes a new method for the preparation of unsaturated 
ketones has been discovered, which utilises the boron chemistry outlined below. 
 
O
O
TMS
Br
+
(a)
iv v vi  
Figure ii: Reagents and Conditions: (a) 
t
BuLi, B(O
I
Pr)3, Et2O, -79 °C, 20 %. 
 
Novel aspects of furan chemistry 
It was found that the furan derivative vii, when treated with palladium salts, gave the 
bis-annulated benzene structure viii. This sequence gave rise to a novel method for 
the construction of aromatic rings. This reaction was tested on a range of substituted 
furans in order to examine the scope of this reaction. 
 
O
OTBS
O
Br
O
O
TBSO
(a)
vii viii  
Figure iii: Reagents and Conditions: (a) Pd(OAc)2, K2CO3, MeCN, 80 °C, 25%. 
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Ac   acetyl  
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borax               sodium borate     
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t
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n
Bu   butyl 
ºC   degrees celsius 
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Cp                    cyclopentadiene 
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E
+
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HPLC   high performance liquid chromatography 
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PTSA   para-toluenesulfonic acid 
i
Pr   iso-propyl 
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sat                    saturated 
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1.1 Boron 
Boronate esters and borinic acids are trivalent boron containing organic compounds. 
Boronate esters consist of one alkyl constituent and two ester groups and generally 
have the molecular formula RB(OR)2 but can also exist as RB(OR)(OH) whereas 
borinic acids consist of two alkyl groups, one hydroxyl group and have the molecular 
formula R2BOH (Figure 1.1). Boron has three valence electrons and when in the 
aforementioned structures has a total of 6 valence electrons with an empty p-orbital. 
This gives a trigonal planar conformation and sp
2
-hybridization. The empty p-orbital 
lies orthogonal to these three groups and it is this empty p-orbital that allows boron 
to act as a strong Lewis acid and gives it the ability to form an ate complex. The ate 
complex is boron in its tetra-bonded form which has sp
3
-hybridisation. 
 
B B B B
R
RR
R
RHO
OH
RHO
OH
OHHO
B
R
ORRO
Borane Borinic acid Boronic acid Boric acid Boronate ester  
Figure 1.1 
 
Borinic acids are the product of oxidation of boranes and boronate esters are the 
oxidation product of borinic acids. The toxicity of these compounds is considered 
low and hence makes them a useful tool for the organic chemist. These compounds 
are oxidised and degrade to boric acid which is of low toxicity in man.  
  
The boron oxygen bond is incredibly strong at around ~ 519 kJ mol
-1
 compared to 
that of C-O ~384 kJ mol
-1(1)
. This is due to the conjugation between the lone pairs on 
oxygen and boron’s vacant p orbital, allowing partial double bonding character (2). 
Boron’s strong affinity for oxygen and its relatively strong bond with carbon, 
coupled with the ability to switch from sp
2
 to sp
3
 has meant it is of great importance 
in organic synthesis and is often featured in stereodirected synthesis. 
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1.2 Brief introduction into the use of boron derivatives in 
pharmaceuticals 
1.2.1 Diabetes 
A key area of interest and use of boronic acids is as an enzyme inhibitor. This 
inhibition of enzymes is mostly based on the ability of boron to convert between 
trigonal and tetrahedral forms by accepting lone pairs, mainly hydroxyl groups. This 
interaction with hydroxyl groups also extends to the diols of sugars. This effects 
glucose concentration variation with permeability changes
(3,4,5)
. These changes could 
therefore be used to control the release of insulin from polymer encapsulation. 
 
Recent work with regard to boronic acid’s ability to covalently bind 1,2 and 1,3 with 
diols concerns the monitoring of blood glucose level in real time
(6)
. This has been 
proposed utilising fluorescence which is triggered by photoelectron transmission 
(PET) following boron binding to the diol. 
 
N
(HO)2B
N
B
OO
R2R1
HO OH
R1 R2
hv
hv hv
1.1 1.2  
Figure 1.2 
 
Figure 1.2 represents work done by Shinkai
(7)
 who utilised a 1,5 relationship between 
boron and nitrogen due to its known ability to form B-N dative covalent bonds. This 
anchimeric B-N interaction was found to increase the binding affinity to glucose and 
fructose. The increase in binding affinity to 1,2 and 1,4-diols is thought to be 
favourable due to a significant release of angle strain, and rehybridization of boron 
from sp
2
 to sp
3(8)
. A difference in fluorescence intensity is observed which could be 
due to the nitrogen lone pair quenching the anthracene moiety through PET. The 
exact mechanism is not known however, and Fang et al. think the change in the bond 
strength between nitrogen and boron is not responsible and are leaning towards a 
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hydrolysis mechanism
(9)
. This system demonstrates a useful reporter and possible 
sensor for sugars and could help in the development of monitoring devices for 
diabetes sufferers. 
1.2.2 Serine protease inhibitors 
Boronic acids can also be used to inhibit serine protease, and the boronic acid 1.3 in 
particular was found to be a very potent thrombin inhibitor, the final serine protease 
in the blood coagulation cascade resulting in the transformation of fibrogen to 
fibrin
(10)
. Naturally thrombin is a good target for the development of anticoagulant 
agents of which boropeptides are potent inhibitors 
(12)
. 
O
N
O
NH
B
HCl H2N
HO
OH
CF3
1.3
.
 
Figure 1.3 
 
Alternatively the boropeptide 1.4 on screening for its thrombin inhibition qualities 
was found to inhibit factor Xa. Factor Xa like thrombin plays an important role in the 
coagulation cascade and has the physiological role for proteolytic cleavage of 
prothrombin to thrombin and is therefore considered an attractive method for 
thrombosis prevention
(11)
.  
S
CN
O
N
O NH
BHCl H2N
OH
OH
1.4
.
 
Figure 1.4 
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1.2.3 Proteosome inhibitors 
Dipeptidyl boronic acids have been found to be potent and selective inhibitors of 
proteosomes
(13)
. Proteosomes are eukaryotic cytoplasmic proteinase complexes that 
play a major role in cellular pathways for the rapid breakdown and processing of 
proteins to peptides and amino acids
(13)
. Due to there function and role they have 
been implicated in many disease states including, muscular dystrophy, the cachexia 
accompanying cancer and malnutrition, emphysema, leprosy and acute leukemia as 
well as multiple myeloma
(14)
. The proteosome 26S is the multi-catalytic protease 
responsible for intracellular protein turnover in eukaryotic cells. This includes the 
degradation of damaged, oxidised or misfolded proteins and is key to cell life cycle. 
It should be noted however that this is also responsible for accelerated protein 
degradation that occurs with cancer
(15)
. Degradation is done by a tagging process 
whereby a small protein, ubiquitin; labels the cell for destruction. Adams and 
Behnke
(16)
 found that tripetidyl boronic acids show a high selectivity for proteasome 
26S inhibition along with leucine at p1, with generally large throphobic residues at 
p2 and p3.  
N
N
O
HN
O
H
N B
OH
OH
1.5  
Figure 1.5 
 
Following this on the 13
th
 May 2003, Bortezomib
(17)
 or Velcade 1.5 as it is marketed 
by millennium pharmaceuticals was cleared for public use. It is the first proteosome 
inhibitor to be approved by the US FDA and the first boron containing 
pharmaceutical. It was approved for multiple myeloma (MM), a type of blood cancer 
that affects 2-3 people in every 100,000. MM is a malignant B-cell tumour 
characterised by osteolytic bone lesions. In vitro it has been found that myeloma 
cells were 1000 times more sensitive to apoptosis than normal plasma cells
 
when 
exposed to Bortezomib
(18)
. The dipeptidyl boronic acid forms a complex with the 
threonine hydroxyl group in the ‘‘chymotrypsin-like’’ active site, situated in the 20S 
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protesome sub-unit.  Here it forms a reversible inhibitor and it is this ‘’chymotryptic-
like’’ activity of the proteosome which inhibits proteolysis. 
1.2.4 Enoyl Reductase 
Diazaborines of general structure 1.6 contain a 1,2-diazine ring and boron as a third 
heteroatom and have been found to inhibit cell growth by preventing 
lipopolysaccharide synthesis. This is the biosynthesis of fatty acids and is carried out 
by enoyl reductase (ENR) and this process plays an integral role in the synthesis of 
the bacterial cell wall in gram-negative strains
 (19)
.  
 
N
N
B
R OH
R
1.6
R
 
Figure 1.5 
 
Diazaborines have been shown to bind alongside nicotinamide adenine dinucleotide 
(NAD
+
)
 
in order to affect ENR
(20)
. X-ray studies have shown that a covalent bond is 
formed between 2’ hydroxy of the nicotinamide ribose and boron. The inhibition is 
brought about via a tight but noncovalent binding of the bisubstrate analogue of the 
enzyme
(21)
. An already marketed drug, isoniazid 1.7 also targets ENR, and is used in 
the front line treatment of tuberculosis.  
 
N
H2NHN
O
1.7  
Figure 1.6 
 
However some strains of Mycobacterium tuberculosis emerging are resistant
(22)
 to 
isoniazid and so demonstrates the importance of developing new boron containing 
pharmaceuticals that could perhaps provide more effective alternatives for the future. 
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1.2.5 Beta Lactam inhibitors 
Bacterial β-lactamases catalyse the destruction of β-lactam antibiotics via hydrolysis 
of the amide bond. This results in the resistance of some types of antibiotics and so 
the search for new β-lactamase inhibitors are essential in the fight against bacterial 
infections. It has been shown that boronic acids bind well to β-lactamases(23) and are 
therefore potent β-lactamase inhibitors, again due to their ability to undergo 
hydrolysis and form an ate complex stopping the hydrolysis of the β-lactam ring; see 
figure 1.7. The more the boronic acid resembles the β-lactamases natural inhibitors, 
the better the inhibition
(24)
. 
 
S
H
N
B
HO OH
O O
OH
S
H
N
B
HO
OH
O O
OH
O
ser-betaL
betaL-ser-OH
1.8
1.9  
 
Figure 1.7 
 
Bacterial resistance to β-lactam antibiotics continues to increase and identification of  
a novel class of β-lactamase inhibitors is of vital importance in the pursuit of more 
effective antibiotics
(25)
. It is therefore not surprising the vastly growing attention 
boronic acids are gaining within the field of pharmaceutically important molecules 
and it is therefore our intention to develop new methods in the construction of cyclic 
boronate esters with an hydroxyl moiety and nitrogen present in the α-position. 
 
 
 
Novel strategies for the construction of cyclic boronate esters & acids                                    Introduction 
 
20 
1.3 The construction of α-aminoboronic acids and their 
derivatives. 
1.3.1 Research conducted by Matteson et al. 
Matteson’s group has been the most active in creating synthetic pathways to the 
construction of α-aminoboronic acids. In order to access this range of compounds 
Matteson employed halide displacement to introduce nitrogen.
(26)
  
 
I B
OnBu
OnBu
(a) B
OH
OH
N
1.10 1.11  
 
Scheme 1.1: Reagents and Conditions (a) Piperidine, 1-butanol, 0 °C. 
 
 
The α-haloalkaneboronic ester 1.10 was synthesised by treating iodomethylmercuric 
iodide with boron tribromide and sodium iodide, followed by esterification of the 
resulting product to give the iodomethaneboronate 1.10 in moderate yield (35-40 %). 
The iodide of 1.10 was then displaced on treatment with piperidine to give the the α-
aminoboronic acid 1.11 which could not be purified
(27)
. 
B
OH
OH
N B
O
O
N
HO
(a)
1.11 1.12  
 
Scheme 1.2: Reagents and Conditions (a) Catechol, MeCN, H2O, methyl iodide, DMSO. 
 
 
Matteson further reacted the piperdinomethaneboronic acid 1.11 esterifying with 
catechol and methylating nitrogen to give a stable quarternary ammonium derivative 
1.12 (~50 %). Ammonia and its derivatives were also used in the displacement 
reaction but routes were capricious. When dimethylamine was used as the 
nucleophile, the product 1.13 was obtained, however, proved difficult to purify and 
was categorised as its catechol ester 1.14.  
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N B
OH
OH
N
B
O
O
I B
OnBu
OnBu
(a) (b)
1.10 1.13 1.14  
Scheme 1.3: Reagents and Conditions (a) Dimethylamine, 1-butanol, 0 °C; 
(b) catechol, MeCN, H2O,  0 
°
C. 
 
Phthalimidomethane boronic acid was also prepared but attempted hydrolyses failed 
to give the free amine. The iodomethaneboronic acid 1.10 reacted with morpholine to 
give the aminomethane boronic ester 1.15 which was esterified with pinacol to give 
the ester 1.16. 
I B
OnBu
OnBu
(a) B
OnBu
OnBuO
N B
O
OO
N
(b)
1.10 1.15 1.16  
Scheme 1.4: Reagents and Conditions (a) Morpholine, Et2O, 0 °C; (b) pinacol, Et2O, 97%. 
 
This showed that the B-C-N bond was stable to hydroxyl groups. Unfortunately the 
attempted deprotonation of 1.16 between boron and nitrogen failed in Matteson’s 
hands. 
I
B
O
O
NH2(a)
1.17 1.18  
Scheme 1.5: Reagents and Conditions (a) liquid NH3, bomb, 25 °C. 
 
Matteson found that the α-iodoboronate 1.17 yielded the 2-phenylethylamine 1.18 on 
treatment with liquid ammonia under pressure. It was discovered that α-amino 
boronic acids are unstable if nitrogen is protonated. The boronic ester group and the 
proton on nitrogen are said to trade places. In another example the silylated α-
aminoboronate 1.19 gave the amine derivative 1.21 when treated with methanol. The 
free amine 1.20 resulting in desilylation could not be purified and was found with 
heat or hydroxylic solvents to rearrange to the 2-phenylamine-N-boronic ester 
1.21
(28)
. 
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(SiMe3)2N
B
O
O
(a)
H2N
B
O
O N
H
B
O
O
1.19 1.20 1.21  
Scheme 1.6: Reagents and Conditions (a) MeOH, Et2O, 0 °C.  
 
The boronic acid 1.22 made in the Matteson laboratory was found to be a potent 
inhibitor of the serine protease, chymotrypsin
(29)
. Homologation of the 
benzylboronate 1.22 was achieved with dichloromethyllithium to give 1-chloro-2-
phenylethaneboronate 1.24. This is thought to proceed by benzyl migration from the 
initially formed ate complex with boron 1.23 (scheme 1.6). 
B
O
O
B
O
O
Cl
Cl
B
O O
Cl
LiCHCl2
1.22 1.23 1.24  
Scheme 1.7 
 
Treatment of 1.24 with lithiohexamethyldisilazane gave the silyated amino boronic 
ester 1.25 in 85 % yield. The amine 1.25 was de-silylated using acetic anhydride in 
the presence of glacial acetic acid to give the pinanediol acetamido boronate 1.26  
(56 %); then removal of pinanediol gave the acetamido boronic acid 1.27 (71 %)
(30)
. 
 
(a)
B
O
O
B
O
OCl
B
O
O(Me3Si)2N
(b)
B
O
OH3COCHN
(c)
(d)
B
H3COCHN
OH
OH
1.22 1.24
1.25 1.26
1.27  
 
Scheme 1.8: Reagents and Conditions (a) LiCH2Cl2, THF, -100 °C; (b) LiN(SiMe3)2, THF,    
-78 °C; (c) acetic anhydride, acetic acid, THF, -78 °C; (d) BCl3, DCM, 20 °C. 
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Starting with allyl borate 1.28 homologation and halide installation alpha to boron 
was achieved by the analogous sequence shown in scheme 1.9. Desilylation and 
acetylation to give (s)-pinanediol (r)-(1-acetamidoallyl)boronate 1.30 followed 
without difficulty. Radical addition of methyl mercaptan to the olefin gave the 
boronic ester 1.31 which was a crystalline solid. Subsequent treatment of 1.31 with 
boron tribromide gave the acid 1.32. Esterification with ethylene glycol, gave again a 
crystalline solid 1.33. This time an interesting X-ray structure could be deduced and 
was consistent with a, dative bond from the oxygen of the amide moiety
(31)
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1.28 1.29
1.30 1.31
1.32 1.33  
 
 
Scheme 1.9: Reagents and Conditions (a) LiCH2Cl2, THF, -100 °C; (b) LiN(SiMe3)2, acetic 
anhydride, acetic acid, THF, -78 °C, 71%; (c) methanethiol, irradiated (100W) mercury 
vapour lamp, 81%; (d) BCl3, DCM, 20 °C; (e) ethylene glycol, methanol, (83% two steps). 
 
Matteson has reported that many of these compounds have been extremely difficult 
to synthesise and are particularly capricious in nature. It appears the main route for 
installation of nitrogen has been through alpha halide displacement. 
 
 
 
 
 
 
 
Novel strategies for the construction of cyclic boronate esters & acids                                    Introduction 
 
24 
1.3.2 The work of Kettner in nitrogen installation. 
Kettner developed a range of α-aminoboronic acids in the hope of targeting hepatitis 
C protease inhibition
(32)
. Processing by this viral protease is achieved almost 
exclusively at the cysteine residue
(33)
. It was then an observation that the moiety 
CHF2 is an isotere for a sulfhydryl group and so Kettner set about developing a 
synthesis to α-aminoboronic acids with a difluoroethyl side chain.  
 
Cl I Cl B
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O S
B
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O
F
F
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O
F
F
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B
O
O
F
F
H3N
B
O
O
F
F
(c)
(d) (e)
(f)
Pz-CO-Val-Val-Hyp(Bzl)-NH
(g)
1.34 1.35 1.36
1.37 1.38 1.39
1.40
Cl
 
 
Scheme 1.10: Reagents and Conditions (a) 
n
BuLi, B(OiPr)3, pinacol; (b) thiophenol, 
diisopropylethylamine; (c) 
n
BuLi, diisopropylamine, 2-bromo-1,1-difluoroethane, THF, 0 °C, 
56%; (d) MeI, NaI, MeCN, rt, 49%; (e) LiN(SiMe3)2, THF, -78 °C, HCl, 52%; (f) Pz-CO-Val-
Val-Hyp(Bzl)-OH, N-methylmorpholine, isobutyl chloroformate, THF, -20 °C; (g) (+)-
pinanediol, MeOH, (67% two steps).  
 
Kettner starts his synthesis with chloroiodomethane 1.34 which is treated with 
n
BuLi 
to give chloromethyl lithium which in the presence of triisopropyl borate adds in a 
SN2 fashion. Pinacol was added to the reaction mixture containing the acid which 
gave the transesterification product 1.35. The α-chloride 1.35 is then reacted with 
thiophenol in the presence of diisopropylamine to give the thioether 1.36. The S-
CH2-B moiety can be deprotonated and hence easily alkylated at this point. Kettner 
then treated the thioether 1.36 with LDA in the presence of 2-bromo-1,1-
difluoroethane to give the alkylated product 1.37. The thiophenol moiety was 
methylated using methyl iodide and the resulting sulfonium salt displaced with 
sodium iodide to give the α-iodoboronate 1.38. By analogy to the work of Matteson 
shown in scheme 1.8, lithium bistrimethylsilylamine is used to displace iodide and 
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install nitrogen. This group is subsequently desilylated and turned into the amine 
hydrochloride salt for stability 1.39. From here the peptide chain was incorporated 
onto nitrogen and the pinacol removed with the resulting boronic acid, esterified with 
pinanediol to give the boronate ester 1.40 which was found to demonstrate good 
inhibition of the hepatitis C protease.  
 
 
 
 
Scheme 1.11: Reagents and Conditions (a) H2, Pd/C; (b) HCl/dioxane. 
 
 
Kettner was also able to alkylate following the same procedure as Scheme 1.10 but 
with 
t
butyl bromoacetate and methyl acrylate as electrophiles. He then followed this 
with iodide displacement using sodium azide 1.41 and reduction to the amine salt 
1.42 by catalytic hydrogenation in the presence of anhydrous hydrochloric acid. 
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2. Results and 
Discussion 
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Aim 
The aim of this project was to develop novel synthetic routes toward the construction 
of heterocycles containing boron as an ester or borinic acid, configuring nitrogen 
functionality alpha to boron as well as to synthesise novel compounds in this class. 
With the main focus on establishing the boron-nitrogen 1,3 proximity. Synthetic 
routes were then designed which utilised the 1,3-nitrogen-boron relationship and 
would allow a range of compounds to be effected. 
 
2.1 Formation of methyl isocyano-pinacol borane 
The readily available PINBOP 2.1 was treated with thioanisole which was metallated 
with 
n
BuLi and TMEDA according to the procedure developed by Corey using 
DABCO
(34) 
but later modified by Matteson
(27)
. This gave the thiophenylboronic ester 
1.36 in reasonable yield (75 %). 
 
B
O
S
B
OO
(a)
O
O
2.1 1.36  
Scheme 2.1: Reagents and Conditions (a) Thioanisole, 
n
BuLi, TMEDA, THF, isopropyl-
pinacol borate, 0 °C. 
 
The known iodomethaneboronic ester 2.2 was then synthesised according to 
Matteson
(27)
 by stirring the phenylthioboronic ester 1.36 with methyl iodide and 
sodium iodide at room temperature in acetonitrile for 48 hr to give the iodide 2.2 in 
moderate yield (57 %).  
 
S
B
OO
(a) B
O
O
I
1.36 2.2  
 
Scheme 2.2: Reagents and Conditions (a) NaI, MeI, MeCN, 48 hr. 
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It was thought the iodide could then be displaced using a SN2 reaction with silver 
cyanide to give the isocyanide 2.3 and the required 1,3-boron-nitrogen framework. 
 
B
O
O
I B
O
O
N
2.2 2.3
 
Scheme 2.3: Reagents and Conditions (a) AgCN, MeCN, heat. 
 
However the reaction failed to proceed at room temperature and in refluxing 
acetonitrile for 12 hrs; starting material was recovered. Utilising the synthesised 
iodomethane 2.2 carbanion formation alpha to boron was investigated using LDA at  
-78 °C. To a solution of 2.2 and LDA was added the electrophile allyl bromide in an 
attempt at alkylation to give the homoallylic iodoborate 2.4. 
I B
O
O
I B
O
O
2.2 2.4  
 
Scheme 2.4: Reagents and Conditions (a) 
n
BuLi, diisopropylamine, allyl bromide, THF. 
 
The reaction failed and decomposed. It is most likely 2.2 underwent lithium-halogen 
exchange before attacking itself and decomposing. Before taking a slightly different 
synthetic route the remaining iodide was used in attempts to displace iodide with 
LiHMDS followed by carbanion formation and alkylation using allyl bromide. All 
attempts to form the desired amine 2.5 failed. 
 
O
B
O
N(TMS)2
2.5  
Figure 2.1 
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2.2 Proposed amino-oxaborolan (route 1) 
The known oxaborolan 2.6 
(35,36) 
was a good starting point for a synthesis of the 
amino-oxaborolan 2.9 and it was hypothesised that 2.6 could be converted to the 
iodo-oxaborolan 2.7 using sodium iodide and methyl iodide. This iodide could in 
turn be displaced using sodium azide to give the α-azide 2.8 which could then be 
reduced for example with dichloroindium hydride under mild conditions
(37)
 to give 
the desired amino-oxaborolan 2.9.  
 
S B
O
OH
B
O
OH
B O
HO
N
N
N
(a) (b)I
(c)
B
O
OH
H2N
2.6 2.7 2.8
2.9  
Scheme 2.5: Reagents and Conditions (a) MeI, NaI, MeCN; (b) NaN3, MeCN; (c) InCl3, 
Et3SiH, MeCN. 
 
2.2.1 Synthesis of known phenylthio-oxaborolan 2.7 
The borate 1.36 was added according to Matteson
(38)
 to a solution of 
n
BuLi and 
diisopropylamine in THF generating a carbanion alpha to boron. 
S
B
OO
S B
O
OH
S B
OH
O
O
(a) +
1.36 2.6 2.10  
Scheme 2.6: Reagents and Conditions (a) 
n
BuLi, diisopropylamine, ethylene oxide, -78 °C, 
THF. 
 
To the in situ generated salt was added ethylene oxide at -78 °C which underwent 
nucleophilic attack to ring open and then cyclise onto boron with subsequent 
hydrolytic loss of pinacol to yield the cyclic boronate ester 2.6 as a white crystalline 
solid with the structure then confirmed by crystallography. The uncyclised product 
2.10 is also formed which can be separated and further cyclised to 2.6 using borax or 
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BCl3, however BCl3 gave a slightly improved yield of 20 %. This was repeated 
several times due to the low original yield of 2.6 of between 5-10 %. 
2.2.2 Halogenation of oxaborolan 2.6 
S B
O
OH
B
O
OH
(a) I
2.6 2.7   
Scheme 2.7: Reagents and Conditions (a) NaI, MeI, MeCN, heat. 
 
When 2.6 was treated with NaI and MeI in MeCN at room temperature followed by 
boiling in acetonitrile for six hours the desired product 2.7 was not obtained. Instead 
thioanisole was recovered along with decomposition products.  
2.3 Proposed target amino-oxaborolan (route 2) 
Using 2.6 as a starting material it was hypothesised that treatment with the trimethyl 
variant of Meerwein’s salt could give the unstable compound 2.11 and on treatment 
of 2.6 with sodium azide, displacement of thioanisole could occur to give the boronic 
acid 2.7 with azide alpha to boron. 
S
O
B
OH
S
O
B
OMe
N3
O
B
OH
(a) (b)
2.6 2.11 2.7  
Scheme 2.8: Reagents and Conditions (a) [(CH3)3O]BF4 2 eq, Et2O (b) NaN3, MeCN. 
 
Trimethyloxonium tetrafluoroborate was added to 2.6 in diethyl ether and stirred for 
two hours. After all the starting material had disappeared according to tlc, the solvent 
was removed and the salt taken up in acetonitrile whereupon it was heated under 
reflux with sodium azide for 6 hours in the hope that azide would displace 
thioanisole to give the desired product 2.7. On work-up a white crystalline solid was 
isolated which resembled the borate salt 2.11 according to 
1
H-NMR, after mass 
spectrometry it was then thought to be the ate complex 2.12. Waiting on further mass 
spectrometry evidence the white crystalline solid was dissolved in DMSO and heated 
to 140 °C in a further attempt to obtain 2.7, this time the idea was to induce 
migration of the azide into the alpha position by a 1,2-anionic shift; see scheme 2.9. 
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2.11
2.8
2.6
S B
O
N3
OMe
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Scheme 2.9 
 
The desired boric acid 2.7 was not formed and after flash column chromatography a 
decomposition product was isolated and characterised as 2.13 (87 % yield).  
 
S B
O
OMe
N3
S OMe
2.12 2.13
(a)
 
Scheme 2.10: Reagents and Conditions (a) DMSO, 140 °C. 
 
The resulting pale straw coloured oil was in fact that of the methoxy phenyl thio 
ether 2.13. Extrapolating back to the starting material it is now thought that 2.12 was 
in fact the ring open methoxy compound 2.14 and on heating, the di-methylated 
species 2.14 decomposed with loss of boron to yield the ether 2.13 shown in scheme 
2.11. 
S B
O
MeO
N3
S OMe
2.14 2.13  
Scheme 2.11 
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2.4 Retrosynthetic approach to amino-oxaborolan (route 3) 
By utilising alkene metathesis it was hypothesised the unsaturated oxaborolan 2.15 
could be made from its metathesis precursor 2.17. The precursor 2.17 could be 
generated from the pinacol protected boron-acetamide 2.18 and allyl alcohol. A key 
step to this synthesis will be the generation of the acetamide from its imidate 
precursor 2.19 which relies on a [3,3]-sigmatropic shift using Overman conditions to 
install nitrogen alpha to boron. 
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O
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B
OHO
H2N
2.15 2.16
2.17
2.18 2.19
2.20 2.21
2.22 2.242.23
2.25  
Scheme 2.11: Retrosynthesis of 2.15. 
 
The imidate precursor 2.19 is simply constructed from the allylic alcohol 2.20, a base 
and trichloroacetonitrile. The alkenyl alcohol 2.20 is a product of hydroboration 
between the alkyne 2.22 and pinacol borane followed by TBDMS removal. The 
starting alkynyl alcohol 2.23 is formed from the aldehyde 2.25 using routine steps. 
The long chain aldehyde heptanal 2.25 was chosen purely for its ability to add mass 
and create a less volatile set of compounds. 
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2.5 Oxaborolan synthetic approach (route 3) 
2.5.1 Generation of the hydroboration precursor 
Heptaldehyde 2.25 was reacted with the anion of TMS-acetylene created with 
butyllithium to give the secondary alcohol 2.24 in good yield (96 %). The TMS 
group was removed using a catalytic amount of sodium methoxide in methanol to 
give the secondary alkynyl alcohol 2.23 (92 %) which was then protected with 
TBDMSCl in the presence of imidazole and a catalytic amount of DMAP to give 
2.22 (72 %). This was carried out in preparation for the hydroboration of the 
acetylene moiety 2.22 with pinacol borane.  
O
OH
TMS
OHOTBS
(a)
(b)
(c)
2.25 2.24
2.232.22
 
Scheme 2.12: Reagents and Conditions (a) 
n
BuLi, TMS-acetylene, THF; (b) NaOMe, 
MeOH, DCM; (c) TBDMSCl, Et3N, DMAP, DCM. 
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2.5.2 Hydroboration of alkyne 2.22 
Pinacolborane was added across the acetylenic triple bond which was activated using 
Schwartz reagent (Cp2ZrHCl). This transition metal complex has been reported to 
catalyse hydroboration with alkynes and pinacolborane at room temperature by 
Pereira and Srebnik
(38)
.  Y. D. Wang & G. Kimball
(39)
 have reported a method for the 
hydroboration of alkynes that give excellent yields as well as stereoselectivity and 
regioselectivity (E)-vinylboronic esters. 
OTBS
C6H13
TBSO B
O
O
C6H13
HO B
O
O
(a) (b)
2.22 2.21 2.20
 
Scheme 2.13: Reagents and Conditions (a) Pinacolborane, Schwartz reagent; 
(b) Ni(Cl)2
.
(H2O)6, 1,2-ethanedithiol, DCM/methanol. 
 
This method uses a base and slightly elevated temperatures to increase E 
stereochemistry. This is achieved by reducing the formation of an intermediate 
zirconocene complex that has pseudo-Z conformation with the oxygen on the 
TBDMS-ether group. Under this intermediate conformation hydroboration would 
achieve the Z-stereoisomer. The resulting (E)-vinylboronic ester 2.21 was achieved 
in good yield (92%). 
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Scheme 2.14: Mechanistic pathway for hydroboration with Schwartz reagent. 
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2.5.3 TBDMS removal 
Removal of the tert-butyldimethylsilyl protecting group using a fluoride source was 
not achieved and after failure of this with TBAF and HF another non-fluoride 
method was sort. The failure of deprotection using a fluoride source is not known 
and due to the reported success of such methods was peculiar. Removal of the 
TBDMS ether also failed using a method developed by Khan
(40)
, using catalytic 
acetyl chloride in dry methanol. In the end the (E)-alkenylboronic ester 2.21 was 
deprotected using a catalytic amount of nickel (II) chloride hexahydrate and 1,2-
ethanedithiol
(41)
. 
 
O B
O
O
Si
NiCl2
.6H2O HSCH2CH2SH [ Ni (SCH2CH2S)]n + HCl
HO
B
O
O
SiClO
SiMe
MeOH HCl
+
2.21
2.20
 
 
Scheme 2.15: Mechanistic pathway for TBDMS deprotection of 2.21. 
 
These two compounds react to form a polymeric nickel complex that is black in 
solution and can release hydrochloric acid. It is hydrochloric acid which is thought to 
catalyse the deprotection of TBDMS ethers and is highlighted in scheme 2.15. The 
reaction was carried out in methanol/DCM (2:5), which is said to be the best ratio 
and gave the resulting allylic alcohol 2.20 in good yield (82 %). The alcohol was 
purified using flash column chromatography. 
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2.5.4 Imidate formation and 3,3-sigmatropic rearrangemnet  
C6H13
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ONH
Cl3C
(b)
2.20 2.19 2.18
 
Scheme 2.16: Reagents and Conditions (a) DBU, trichloroacetonitrile, THF; (b) Heat, 
xylene. 
 
Conversion of the secondary allylic alcohol 2.20 to an imidate was achieved using 
DBU to deprotonate the alcohol and then the addition of trichloroacetonitrile at 0 °C. 
The reaction worked well using a slight excess of trichloroacetonitrile and gave the 
crude imidate 2.19 in good yield (97 %). It is well known that on heating, allylic 
trichloroacetimidates undergo a facile [3,3]-sigmatropic rearrangement which was 
first reported by L. Overman
(42)
. On heating the imidate 2.19 in xylene no reaction 
occurred and so a number of different conditions and reagents were used in order to 
facilitate the desired [3,3]-shift. Overman has also looked at catalysts to assist the 
rearrangement of imidates and this is well documented in other [3,3]-sigmatropic 
reactions such as the Cope and Claisen varients. These reactions can need heat in 
excess of 180 C. Palladium (II) and mercury (II) catalysts were looked at including 
palladium chloride, palladium bis(benzonitrile) dichloride and mercury 
trifluoroacetate
(43,44,45)
.  
  
 
Reagents and conditions 
    
Reagent Yield % Temperature 
2.19 toluene 0 reflux 
2.19 toluene, K2CO3 0 reflux 
2.19 xylene 0 reflux 
2.19 xylene,  K2CO3 0 reflux 
2.19 1,4 dioxane 0 reflux 
2.19 THF, 5% Pd bis(benzonitrile) dichloride 0 reflux 
2.19 THF, 5% Pd Cl2 0 reflux 
2.19 THF, 20% Hg trifluroacetate 0 reflux 
2.19 THF, microwave 125 °C, 4 bar 0 85 °C 
2.19 Xylene, microwave 180 °C, 6 bar decomp 180 °C 
2.19 xylene, 10% Pd bis(benzonitrile) dichloride 0 reflux 
 
Table 2.1: Results for attempts on the rearrangement of imidate 2.19. 
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Table 2.1 lists numerous attempts to carry out this reaction. It is also reported that 
the Overman reaction works well and in good yield with inductively electron 
donating groups alpha
(46)
 to the double bond. As boron occupies this position and has 
an empty p orbital it can behave as a Lewis acid accepting electron density and it 
could be this effect that has stopped the electron rich double bond from undergoing a 
[3,3]-sigmatropic shift. It has been reported by Hall
(47) 
that the alkenyl boronates 
could generate mesomeric resonance forms. As the electron rich double bond donates 
into the empty boron p orbital it generates a degree of carbon-boron π-bonding; see 
figure 2.2. 
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Figure 2.2: Polarising effects on alkenyl boronates. 
 
A 
13
C-NMR study carried out by Yamamoto and Moritani
(48)
 concurs that there is 
significant evidence that points towards π-bonding in alkenylboranes. 
 
It could be this effect that has prevented the alkenyl imidate from undergoing a [3,3]-
sigmatropic shift. Another possibility is intermolecular interactions from the lone pair 
on nitrogen donating into the Lewis acidic boron centre forming an ate complex, 
although this could not be verified.   
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2.6 Boron mediated Mitsunobu SN2  
Utilising the allylic secondary alcohol 2.20, a new scheme was then proposed. 
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Scheme 2.17: Reagents and Conditions (a) NaN3, PPh3, DTBAD, THF. 
 
According to a new publication entitled SN2' boron-mediated Mitsunobu reactions
(49)
, 
an interesting method for installing nucleophiles alpha to boron on allylic alcohol 
boronate esters was discovered. In this paper it is reported that in a one pot synthesis, 
an alkenic boronate secondary alcohol can be converted to an α-substituted 
allylboronate. This is done by treating the alcohol with triphenylphosphine and 
DTBAD as in a Mitsunobu reaction to form the phosphonium intermediate 2.26. It 
was then postulated by analogy to Berreé's reaction that benzoate forms an ate 
complex with boron, if an azide could be substituted for benzoate this would then 
undergo an anionic 1,2-shift 2.27 displacing the phosphonium as phophine oxide to 
afford the alkenyl azide 2.28. However the reaction did not proceed and the allyl 
alcohol 2.20 was recovered. This could be due to sodium azide not being a strong 
enough nucleophile or the postulated ate complex 2.27 could be stable to migration. 
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2.7 Nitrogen installation using allylic acetate 
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Scheme 2.18: Reagents and Conditions (a) DBU, DCM, trichloroacetoacetate; (b)  
Pd(PPh3)4, NaN3, THF, heat;  (c) allyl alcohol, NH3, THF, NH4Cl; (d) Grubbs (II), DCM; 
(e) PPh3. 
 
A new route was proposed; again starting from the secondary alcohol 2.20 then by 
conversion to an allylic acetate 2.29. Allylic acetates interact with tetrakis 
triphenylphosphine palladium (0) which activates the allyl-O bond of allyl acetate to 
afford η3-allyl(acetate)palladium species(50,51). It was hoped that this species could be 
formed on the current system and the acetate ultimately displaced by azide either by 
a 1,2-shift from the ate complex or by a direct SN2 displacement of acetate. If the 
latter worked it would be possible to detect isomers as this would allow the azide to 
approach from either end of the π-allyl bond. Pd(PPh3)4 was freshly prepared 
according to the method of Hegedus
(51)
 and was isolated as a bright yellow solid 
which was kept at -20 °C under argon. 
 
The boronate allyl acetate 2.29 was heated in refluxing acetonitrile with catalytic 
Pd(PPh3)4 and sodium azide for two hours, a UV active spot was observed using thin 
layer chromatography however after work-up only decomposition products were 
isolated. The reaction was tried again this time without the palladium, resulting in 
recovery of starting material.  
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The nucleophile was changed from sodium azide to sodium cyanide and then to TMS 
cyanide respectively and adopting the previous palladium conditions; again the 
starting material remained unchanged. 
 
Looking back to scheme 2.16; it seemed worth changing the properties of the boron 
moiety to see if this would have any bearing on the [3,3]-sigmatropic shift to give the 
acetamide. One possible reason for this failed reaction was due to boron’s empty p 
orbital. It is known that if the group alpha to the electron rich double bond has a 
positive inductive effect this speeds up the reaction
(46)
 . Looking at the work reported 
by Vedejs and more recently by Molander involving alkenyl-potassium 
trifluoroborate salts
(52,53)
, it was thought that by changing the pinacolborate moiety to 
potassium trifluoroborate the inductive qualities could be beneficial to the [3,3]-
sigmatropic shift reaction in this system. The potassium trifluoroborate protecting 
group is also much more stable and less sensitive to air than pinacol borate. It would 
hopefully allow ease of purification for further steps and could provide help in 
removing the difficulties in purifying compound 2.19 which was decomposed by 
both column chromatography and distillation.
 
 
2.8 Potassium trifluoride protection of boron 
 
C6H13
O B
O
O
C6H13
O BF3K
O
2.29 2.31
(a)
C6H13 BF3K
(b) N3
2.32
O
X
 
Scheme 2.19: Reagents and Conditions (a) KHF2, DCM, H2O; (b) Pd(PPh3)4, NaN3, 
MeCN, reflux. 
 
The alkenyl acetate 2.29 was easily converted to its alkenyl-trifluoroborate salt 2.31 
using potassium hydrogen fluoride and water
(54)
 in good yield (98 %). The resulting 
allyl acetate trifluoroborate salt 2.31 was then reacted with 
tetrakis(triphenylphosphine)palladium (0) and sodium azide and heated to reflux in 
acetonitrile and again in methanol. However only starting material was obtained after 
24 hr in each medium respectively. 
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2.8.1 Potassium trifluoroborate imidate formation 
HO
B
O
O
HO
BF3K
BF3K
NH
O
Cl3C
(a)
(b) (c)
2.20 2.33
2.35
O
BF3K
Cl3C
NH
2.34  
 
Scheme 2.20: Reagents and Conditions (a) KHF2, DCM, water; (b) DBU, 
trifluoroacetonnitrile, DCM, 0° C; (c) DMSO heat 140 0 °C.  
 
The alkenyl alcohol 2.20 was easily converted to its boron trifluoroborate potassium 
salt 2.33 (98 %) using KHF2 and water. The salt 2.33 was then dissolved in hot 
acetonitrile and cooled to room temperature whereupon DBU was added. The 
reaction mixture was then cooled further to 0 °C whereupon trichloroacetonitrile was 
added dropwise, left for an hour and worked up with water to afford the crude 
trichloroacetimidate 2.34 as an off white solid, the structure of which was tentatively 
confirmed at the time with proton NMR. The product from the previous reaction was 
heated in deuterated DMSO in a sealed NMR tube at 140 °C for 36 hours in an 
attempt to rearrange the little product retrieved. The trichloroacetimidate was thought 
to have undergone a [3,3]-sigmatropic shift to afford the trichloroacetamide 2.35 
according to 
1
H-NMR. This was only done on a small amount of the crude and hence 
in a sealed NMR tube. The 
1
H-NMR spectrum depicted a loss of starting material 
and in favour of the imidate. The 
1
H-NMR was taken every twelve hours and loss of 
the alkene peaks in the starting material was observed. The new peaks were thought 
to be associated with the acetamide and consisted of two doublet of doublets and a 
multiplet. Figure 2.3 depicts the 
1
H-NMR study and shows spectra taken after 
twelve hour intervals. 
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Figure 2.3: Shows 
1
H-NMR taken every 12 hours for 2.34 heated at 140° C in DMSO. 
 
Further characterization of 2.35 using mass spectrometry was not possible, the parent 
ion was not found and 
13
C-NMR analysis gave inconclusive results partly due to the 
small amount of material recovered (~10 mg). Sadly resynthesis of the potassium 
trifluoroborate salt 2.34 and hence the Overman reaction to give 2.35 was not 
possible. Due to the encouraging initial findings, attempts to remake the precursor 
were tried repeatedly; altering many variables slightly and drastically to try and 
repeat the previous findings. Table 2.2 lists the numerous attempts to remake 2.34. 
The reason for the inability to remake the imidate 2.34 is still unknown and clearly 
represents how capricious this chemistry is. Alas no more time could be justified on 
this one reaction and so an alternative route was sought. 
 
Reagents and conditions 
    
Reagent Yield % Temperature 
2.33 CCl3CN (1.2 eq), DBU, MeCN 0  25 °C 
2.33 CCl3CN, DBU, MeCN, NH4Cl 0 25 °C 
2.19 KHF2, MeCN, H2O decomp 0 °C 
2.33 CCl3CN, DIPEA, MeCN 0 25 °C 
2.33 CCl3CN, DBU, DCM 0 25 °C 
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2.33 CCl3CN, DBU, DME 0 25 °C 
2.33 CCl3CN, DBU, MeOH 0 25 °C 
2.33 CCl3CN (1.2 eq), DBU, MeCN 0 40 °C 
2.33 CCl3CN, NaH, MeCN 0 70 °C 
2.33 CCl3CN, DBU decomp 25 °C 
2.33 CCl3CN (5 eq), DBU, NH4Cl 0 25 °C 
 
Table 2.2: Results for resynthesis of 2.34. 
 
2.9 N-Methyliminodiacetic acid boron protection 
An alternative protecting group for boron was then found, one that had greater 
solubility but also retained the similarity to potassium trifluoroborate in that it could 
attenuate reactivity by rehybridization from sp
2
 to sp
3
. Work recently done on just 
this by Gillis and Burke
(55)
 looked at prevention of transmetalation by reduced 
attenuation in the Suzuki Miyaura coupling of protected haloboronic acids as 
building blocks. They found that N-methyliminodiacetic acid (MIDA) was a good 
trivalent ligand capable of reduced attenuation and easy protection and removal. 
Protection was achieved by heating a boronic acid in a benzene/DMSO solvent 
mixture to reflux with water removal using a Dean-Stark apparatus. Deprotection can 
then easily be achieved with sodium hydroxide or sodium hydrogen carbonate. 
Methyliminodiacetic acid was prepared according to G. J. Berchet
(56)
 from 
methylamine and chloroactic acid in a basic solution of sodium hydroxide. 
 
                
B
O
O
TBSO
B
OH
OH
TBSO
B
O
O
TBSO
O
O
N
(a)
(b)
2.21 2.36
2.37
 
Scheme 2.21: Reagents and Condition (a) NaIO4, NH4OAc, acetone, H2O, 48hr; (b) 
Benzene/DMSO, N-MIDA, Dean-Stark, 16 hr. 
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The stable tetracoordinated MIDA-protected boronates stem initially from work 
carried out by Rettig and Trotter
(57)
 who showed the stable nature of such compounds 
and confirmed with the use of crystallography the dative B-N bond is 1.67 Å long. 
Matteson found that when in these tetracoordinated states the B-O bond of boronic 
esters increases to somewhere in between 1.43-1.47 Å, 0.10 Å, longer than its 
tricoordinated analogues. This undoubtedly reduces the B-O bond strength, however 
due to the initial strength of such bonds even when in the tetrahedral conformation 
they are still comparable to that of C-O at about ~1.43 Å
(1)
. 
 
The TBDMS protected borate 2.21 was treated with sodium periodate and 
ammonium acetate in an acetone/water mixture to remove pinacol. The resulting 
boronic acid 2.36 (92 %) was then treated with methyliminodiacetic acid resulting in 
the MIDA boronate 2.37 (59.5 %) as an off white solid. 
B
O
O
TBSO
O
O
N B
O
O
HO
O
O
N
B
O
O
O
O
O
N
NH
Cl3C
(a)
(b)
2.37 2.38
2.39  
Scheme 2.22: Reagents and Conditions (a) HF (40%) Aq, MeCN, 8 hr; (b) DBU, CCl3CN, 
DCM, 2 hr.   
 
The TBDMS protected MIDA boronate 2.37 was desilylated using HF and purified 
using flash column chromatography to give the secondary alcohol 2.38 in good yield 
(98.8 %). To this alcohol was added trichloroacetonitrile and DBU dropwise at          
-78 °C giving the imidate 2.39 as a pale off white/green semi solid (32.4 %). 
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2.10 MIDA boronate Overman precursor 
The newly formed Overman precursor 2.39 did not undergo the required [3,3]-
sigmatropic rearrangement despite numerous attempts and given its greater solubility 
benefits. This was an impediment to the synthetic study which meant that a route not 
dependent on the [3,3]-sigmatropic rearrangement to install the alpha nitrogen 
moiety would be required. Table 2.3 lists the results of the rearrangement attempts. 
B
O
O
O
O
O
N
NH
Cl3C
BO
O
O
O
O
N
HN
Cl3C
2.39 2.40
 
Scheme 2.23: Reagents and Conditions; See table below. 
 
Reagents and conditions 
    
Reagent Yield % Temperature 
2.39 xylene 0  refluxing 
2.39 xylene, K2CO3 0 refluxing 
2.39 5% Pd(OAc)2, toluene 0 refluxing 
2.39 5% PdCl2, toluene decomp refluxing 
2.39 MeCN 0 refluxing 
2.39 Toluene, 5% Pd bis(benzonitrile) dichloride 0 refluxing 
2.39 K2CO3, MeCN 0 refluxing 
2.39 NBS, CDCl3 decomp rt 
2.39 K2CO3, MeCN 0 refluxing 
 
Table 2.3: Results for attempts on the rearrangement of imidate 2.39. 
 
When 2.39 was heated in boiling toluene with a catalytic amount of palladium 
chloride the allylic chloride 2.41 was formed in moderate yield (68.4 %). It is 
thought palladium (II) chloride formed a η3-allyl complex with the olefin of 2.39 and 
this resulted in the loss of imidate and capture of chloride by nucleophilic attack. 
B
O
O
Cl
O
O
N
2.41  
Figure 2.4 
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2.11 1-Trimethylsilyl-2-propenylzinc reagent 
 
Parsons and Eshelby
(58,59)
 found that the organozinc reagent 2.43 derived from 1-
trimethylsilyl-2-bromoprop-2-ene 2.42 when treatment with 
t
BuLi followed by the 
addition of zinc chloride reacts with aldehydes to give alkylated products with an 
apparent silicon shift 2.44. 
TMS
Br
TMS
ZnCl R
OH TMS(a) (b)
2.42 2.43 2.44  
Figure 2.5: Reagents and Conditions (a) 
t
BuLi, ZnCl; (b) aldehyde. 
 
Parsons was able to trap the organozinc reagent 2.43 with a range of electrophiles 
giving at times two differently alkylated products. This seemed dependent on the 
temperature that the organozinc reagent 2.43 was allowed to reach after it was made 
in situ. Parsons et al. reacted the organozinc reagent with a range of electrophiles 
including the aldehyde 2.45 which was being investigated for its use in the total 
synthesis of galbonalide b. It was found that reagent 2.43 attacked the aldehyde 2.45 
to give the alcohol 2.46 as expected; however it also formed the homo allyic alcohol 
2.47, which appeared to involve the migration of silicon. 
TMS
Br 1) tBuLi
2) ZnCl2
3) O
O
TMS
O
OH
O
OHTMS
2.42
2.45
2.46
2.47
 
Scheme 2.24: Reagents and Conditions. See table below 
Temp. (°C) for organozinc 
formation 
 
Yields of Isomers (%) 
   
 2.46a 2.46b 2.47a 2.47b 
 (anti) (syn)   
-70 to 0 0 0 48 17 
-70 to 20 to -70 0 0 58 19 
-70 to -50 25 13 7 5 
-100 10 50 10 6 
     
Table 2.4: Reaction of organozinc reagent 2.43 with aldehyde 2.45 
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The work stemmed initially from that carried out by Fleming and Pulido et al.
(60,61,62)
 
who were investigating the reaction of silyl-cuprate reagents with allenes giving allyl 
or vinylsilanes. Fleming found when treating the reagents, tert-butyl(diphenyl)silyl 
cuprate and phenyl(dimethyl)silyl cuprate with propa-1,2-diene cupration occured 
prop-1-en-2-yl and prop-2-enyl respectively.  
SiPh2Bu
t
SiPhMe2
(a) (b)
•
2.48
2.49
2.50
(b)(c)
 
Scheme 2.25: Reagents and Conditions (a) (
t
BuPh2Si)2CuLi, THF, -78 °C; (b) NH4Cl, 
MeOH, -78 °C; (c) (PhMe2Si)2CuLi, THF, -78 °C. 
 
It was therefore hypothesised that the mechanism of synthesis for the allylic alcohol 
2.47 could be from the organozinc reagent 2.43 transmetalating to that of its isomer 
2.51 through possible allene formation. 
ZnCl
TMS
TMS
ZnCl
2.43 2.51  
Figure 2.6: Proposed isomerisation of organozinc reagent 2.43 to its isomer 2.51. 
 
To test this theory the cyclic silane organozinc reagent 2.52 was treated with 
benzaldehyde which gave the homo allylic alcohol 2.53 solely. This example proved 
the migration of silicon cannot proceed through an allenyl intermediate and led to a 
revised mechanism being proposed.
  
 
ZnCl
TMS
TMS OH
R
(a)
2.52 2.53  
Scheme 2.26: Reagents and Conditions (a) RCHO. 
 
Therefore Parsons and Viseux
(63)
 proposed a new mechanism for this type of reaction 
whereby the organozinc reagent acts as a Lewis acid and a nucleophile. Zinc 
coordinates to the oxygen on the carbonyl group, chlorine then associates with the 
silicon atom to induce 1,2-nucleophilic attack on the aldehyde as the trimethysilyl 
group is lost and recaptured with the breaking of the carbon zinc bond. 
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ZnCl
TMS
Zn O
R
Zn
Me3Si
Cl
O
R Cl
Me3Si
Cl
TMS OH
R
(b)
2.52
2.53
2.54 2.55
 
Scheme 2.27: Proposed mechanistic pathway for the construction of 2.53. 
 
It is believed therefore that the organozinc reagent acts as both a Lewis acid in 
accepting the lone pair on oxygen and a nucleophile as it attacks silicon to recapture 
the trimethylsilyl group. The proposed mechanism of attack for the organozinc 
reagent 2.52 on an aldehyde is therefore thought to progress through chelation of the 
carbonyl group with zinc and in a concerted step forms a transitionary 5-membered 
ring 2.55 followed by the loss and recapture of TMS to give the alcohol 2.53 see 
scheme 2.27. If the reaction does proceed through a 5-membered heterocyclic 
intermediate then it may be possible to replicate this chemistry on a boron system. 
Replacing zinc chloride with an appropriate boron source would give the 
organoboron reagent 2.56. The addition of aldehydes to 2.56 could form stable 5-
membered heterocycles that could generate a new synthetic route in the construction 
of cyclic boronate esters like 2.57 providing an easy route into the construction of 
such compounds. 
TMS
B(OMe)2
(a) O B
OH
R
2.56 2.57
 
Scheme 2.28: Reagents and Conditions (a) RCHO. 
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2.12 Prop-2-enylzinc reagent and tiglic aldehyde 
The organozinc reagent 2.43 can be used in the generation of carbon-carbon bonds 
utilising electrophilic capture as outlined in chapter 2.10. Tiglic aldehyde was then 
used as the electrophile to generate a homoallylic alcohol when reacted with the 
organozinc reagent according to Eshelbys conditions
(64) 
to test the chemistry. 
 
(b)
TMS
Br
TMS
ZnCl
(a)
TMS OH
2.42 2.43 2.58  
Scheme 2.25: Reagents and Conditions (a) 
t
BuLi, Et2O, -78 °C; (b) Tiglic aldehyde,  
-78 °C. 
 
The organozinc reagent 2.43 was prepared in two steps from 2,3-dibromopropene 
2.59. 2,3-Dibromopropene 2.59 was reacted with trichlorosilane in the presence of 
triethylamine and copper (I) chloride followed by the reaction of the resulting 
trichloride with three equivalents of methylmagnesium bromide according to Itoh
(65)
 
to give the allylic silane 2.42. 2-Bromo-1-trimethylsilylprop-2-ene is then treated 
with 
t
BuLi followed by the addition of zinc chloride to give the organozinc reagent 
2.43 in situ. To this was added tiglic aldehyde and the allylic alcohol 2.58 was 
isolated as a colourless oil in a rather disappointing yield (12.6 %) owing to a 
suspected loss during purification. 
(a)Br
Br
TMS
Br
2.59 2.42
 
Scheme 2.26: Reagents and Conditions (a) HSiCl3, Et3N, CuCl, MeMgBr. 
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2.13 1-Trimethylsilyl-2-propenyl organoboron 
It was hypothesised that instead of zinc chloride, trimethyl borate could be used to 
generate the organoborate reagent 2.56. The resulting borate should react in a similar 
fashion, however hopefully trapping out as the cyclic boronate ester 2.60 after 
forming a five membered ring. This would therefore provide a promising method for 
the construction of cyclic organoborates that could be extended. 
 
TMS
Br
TMS
B(OMe)2
O B
O
(a) (b)
2.42 2.56 2.60
 
Scheme 2.27: Reagents and Conditions (a) 
n
BuLi, Et2O, -78 °C; (b) tiglic aldehyde, -78 °C. 
 
However after the suspected formation of the organoboron 2.56 reagent in situ with 
trimethylborate and then subsequent treatment with tiglic aldehyde the hypothesised 
cyclic organoborate 2.60 was not found and instead the unsaturated ketone 2.61 was 
isolated as a bright orange solid (7.5 %). 
O
2.61  
Figure 2.7 
 
The reaction was carried out again but this time with the slightly more stable 
triisopropyl borate in the hope this would generate a less reactive intermediate, 
however the unsaturated ketone 2.61 was obtained again. 
 
A proposed mechanism for such a reaction is set out in scheme 2.27 below. The 
bromo-trimethylsilyl reagent 2.42 on addition of 
t
BuLi undergoes lithium-halogen 
exchange. When treated with triisopropyl borate this lithiate forms the organo-boron 
reagent 2.63. On addition of tiglic aldehyde boron is thought to behave as a Lewis 
acid accepting a lone pair from the oxygen of the aldehyde coupled with loss of the 
trimethylsilyl group by nucleophilic attack of bromide on the silicon; this can allow 
nucleophilic addition of the alkene in a concerted step to give an intermediate 5-
membered cyclic boronate ester 2.64. It is then thought diradical oxygen inserts into 
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the boron oxygen bond giving the intermediate boronate ester 2.65. Once this ester 
2.65 has formed it can add to another equivalent of tiglic aldehyde by nucleophilic 
attack from the terminal alkene as oxygen leaves boron to form a ketone producing 
the alkoxide 2.66. With proton exchange the unstable intermediate 2.66 then 
undergoes dehydration to lose two molecules of water and give the unsaturated enone 
2.61. 
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O
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Scheme 2.28: Proposed mechanistic pathway for 2.61. 
 
Increasing the amount of tiglic aldehyde from 1 to 1.5 equivalents and carrying out 
the reaction under an atmosphere of oxygen increased the yield of enone isolated to 
26.3 %. 
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In order to determine the true mechanism for the synthesis of enone 2.61, it was our 
intention to react tiglic aldehyde in a similar manner as before but using degassed 
solvents in an inert atmosphere and in the dark to test the insertion of oxygen into the 
carbon-boron bond. 
  
Following the discovery that tiglic aldehyde when added to 2-bromoallyl-TMS 2.42 
in the presence of tri-isopropyl borate and 
t
BuLi afforded the enone 2.61, it was 
thought the same reaction could occur in the presence of other aldehydes. 
Benzaldehyde was chosen as it had been successfully alkylated using Parsons’ 
organozinc method
(63)
. Benzaldehyde was redistilled from zinc powder and reacted in 
the same manner as tiglic aldehyde adding 1.5 equivalents of aldehyde to the 
organoboron reagent followed by switching to an atmosphere of oxygen after 
addition. The reaction yielded a bright yellow solid that resembled the enone 2.67 by 
1
H-NMR in its crude state. However purification of the small quantity isolated 
proved difficult and the enone mixture seemed to be unstable and after purification 
using flash column chromatography nothing of significance could be identified.  
  
Br
Br
TMS
Br
O
(b)
O
2.59 2.42 2.61
(a)
O
O
2.67
(c)
 
 
Scheme 2.29: Reagents and Conditions (a) 
t
BuLi, TMSCl; (b) 
t
BuLi, B(O
i
Pr)3, O2, Et2O, 
-78 °C; (c) 
t
BuLi, B(O
i
Pr)3, O2, Et2O, -78 °C. 
 
Following the promising initial proton NMR of the reaction between benzaldehyde 
and the TMS reagent, it would be of benefit to try the reaction again and on differing 
aldehydes to establish the depth and scope of this new and interesting chemistry. 
However it appeared this chemistry would not be beneficial to the construction of 
cyclic boronate esters as previously thought and the chemistry was abandoned in 
favour of a new palladium cyclisation project outlined in chapter 5.  
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2.14 Effecting the Overman rearrangement 
In a final attempt to synthesise the imidate 2.19 and to allow further attempts at the 
Overman rearrangement, excess base (DBU, 1.5 eq) and excess trichloroacetonitrile 
(12 eq) were added to the free alcohol 2.20 at 0 °C and allowed to warm to rt, stirring 
in DCM. This unusually gave the acetamide 2.18 in 35 % yield as a colourless oil as 
well as the intended imidate 2.19 in an estimated 60 % yield. 
HO
B
O
O
O
B
O
O
NH
Cl3C
(a)
2.20 2.18  
 
Scheme 2.30: Reagents and Conditions (a) DBU (1.5 eq), trichloroacetonitrile (12 eq), 
DCM, 4 hr, rt. 
 
The acetamide 2.18 however is thought to be present in the ate complex, forming a 
five membered ring with oxygen 2.68. This is hypothesised due to the diastereotopic 
nature of the pinacol group which is seen as four separate singlet peaks on 
1
H-NMR 
indicating a change from sp
2
 to sp
3
 hybridisation of boron and so differing the 
conformation and therefore the environment of each methyl attributed to the pinacol 
moiety. 
 
O
B
OO
HN
CCl3
2.68
 
Figure 2.8 
 
It is not the first time a structure like this has been proposed and Matteson
(31)
 proved, 
using crystallography, that the oxygen in the acetamide 1.33 coordinated to boron 
proving the 5-membered 1,3,2-dioxaborolane ring was no longer planar as seen in its 
tricoordinated state. This resulted in longer B-O bond lengths reducing the ability of 
oxygen to partially π-bond with boron. 
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S
O
B
O
O
HN
1.33
 
Figure 2.9 
 
The formation of the acetamide 2.18 from its free alcohol 2.20 under excess 
conditions only, and at room temperature was a curious result and indicated that in 
these conditions the energy barrier to the [3,3]-sigmatropic rearrangement had been 
greatly reduced along with the perceived issue of boron polarising the double bond 
alpha to it. A mechanism for this reaction was then proposed. 
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Scheme 2.31: Possible mechanistic pathway for acetamide 2.68 formation. 
 
DBU is used to aid the formation of the intermediate imidate 2.70, which due to the 
excess base and trichloroacetonitrile in solution attacks a second equivalent of 
trichloroacetonitrile giving the double addition product 2.71. The second generated 
imine can then form an ate complex with boron and hence the nine membered ring 
2.71. Now with the double bond alpha to boron no longer polarised and the nitrogen 
associated with the first equivalent of trichloroacetonitrile in close proximity and in a 
facile position next to the double bond the 3,3-sigmatropic rearrangement can take 
place and at room temperature. The intermediate ate complexed heterocycle 2.72 
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then fragments to give the alkoxide acetamide 2.73 which forms the ate complexed 
acetamide 2.67 on work-up. 
 
The acetamide 2.67 is stable to purification using flash column chromatography but 
is however highly unstable to air and must be kept under nitrogen and in the freezer. 
As with all the boron imidates synthesised in this study the acetamide did not give a 
high resolution mass spectrum with the molecular ion. The data proved inconsistent 
and repeatedly gave differing mass spectra. A boron chemical test was carried out by 
dissolving the pure product in methanol and acidified with conc. sulphuric acid. The 
mixture was then heated until a gas evolved which burnt with a green flame on 
ignition with a lit splint indicating the presence of boron. This result is also backed 
up with an 
11
B-NMR. 
  
57 
 
 
 
 
 
3. Future Work 
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3.1 Dioxaborolan-2-yl(non-2-enyl)acetamide 
Following the discovery that the alcohol 2.18 when treated with excess DBU and 
trichloroacetonitrile rearranges to the acetamide 2.68, a continuation of this route has 
been proposed.  
O
B
OO
HN
CCl3
HO
B
O
O
2.18 2.68  
Scheme 3.1: Reagents and Conditions (a) DBU (1.5 eq), trichloroacetonitrile (12 eq), 
DCM, 4 hr, rt.  
 
Treatment of the acetamide 2.68 with the alkoxide of prop-2-en-1-ol would hopefully 
add to the boron centre displacing pinacol and on work up with water give the 
boronate ester 3.1. Cross metathesis of 3.1 using Grubbs (II) catalysts could then 
give the cyclic boronate acetamide 3.2. 
O
B
OO
HN
CCl3
O
B
OH
O
HN
CCl3
B
OH
O
HN
CCl3
O
(a)
(b)
2.68 3.1
3.2  
Scheme 3.2: Reagents and Conditions (a) propenyl alcohol, Et3N; (b) Grubbs (II).  
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3.2 Alkenylboron-trichloroacetamide 
There are so many compounds within this class that could be of interest, focus must 
really be about developing methods that give building blocks for further exploration. 
Following the work conducted with MIDA protected boronates the proposed 
alternative route to synthesising cyclic compounds with a 1,3-boron-nitrogen 
framework is shown in scheme 3.3. 
 
 
 
Scheme 3.3: Reagents and Conditions (a) K2CO3, DCM; (b) Et3N, Heat. 
 
The known chloromethyl acetate 3.3 can be synthesised from heating acetyl chloride, 
paraformaldehyde and zinc chloride together according to Tendler
(66)
. When treated 
with trichloroacetamide 3.4 this compound would undergo SN2 attack from the lone 
pair attributed to nitrogen to give the trichloroacetamide acetate 3.5. This when 
treated with the known butadiene boronate 3.6 which is in turn prepared by a Stille 
coupling between allyl-bromide, N-MIDA boronate and alkenyl stannane
(67)
 could 
give the unsaturated piperidine 3.7. Upon heating the imine and the diene in the 
presence of potassium carbonate the acetamide 3.5 could collapse to the dienophile 
3.8 whereupon it should undergo a [4+2] cycloaddition to give the unsaturated 
piperidine 3.7 with boron functionality alpha to nitrogen.  
Cl3C
O
N
AcO
Cl3C
O
N Cl3C
O
N
3.8 3.7
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O
O
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Scheme 3.4: Proposed mechanistic pathway for synthesis of 3.7.  
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This would be an effective method for the construction of a series of compounds 
with structure flexibility introduced by changing the groups attached to the 
dienophile. 
3.3 Five and six membered oxaborine synthesis 
The thioanisole boronate ester 1.36 can be deprotonated alpha to boron as shown in 
the construction of the oxaborolan 2.6 in chapter 2.2.1. When the carbanion of 1.36 is 
treated with oxetane the cyclised oxaborolane results as well as the ring open alcohol 
which when protected would give the boronate ester 3.8. Nitrogen functionality 
could then be installed by methylating sulfur with methyl iodide and displacing 
phenylthiol with iodide from sodium iodide as has been proven on a similar 
system
(32)
. 
S
B
O
O
S
BO
O
OTBDMS
BO
O
OTBDMS
I
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HN
O
Cl3C
B
OH
O
NH
O
Cl3C
(a) (b)
(c) (d)
1.36
3.8 3.9
3.10
3.11
 
Scheme 3.5: Reagents and Conditions (a) 
n
BuLi, Et2O, oxetane, TBDMSCl, -78 °C; (b) 
MeI, NaI, DCM; (c) acetamide, Et3N; (d) HF (40%), MeCN. 
 
The hope would then be that the trichloroacetamide could displace iodide to give the 
boro-acetamide 3.10. TBDMS-deprotection followed by heating in a boiling water 
methanol mixture with borax could then potentially bring about cyclisation to give 
the oxaborolane 3.11 with nitrogen functionality alpha to boron. 
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If successful this method could also be adapted to create the 5-membered oxaborolan 
3.13 and utilise the already synthesised open chain boronate ester 2.10 from the 
reaction of thio-phenyl pinacol borate 1.36 and 
t
BuLi followed by alkylation with 
ethylene oxide. 
S B
OH
O
O I B
OTBS
O
O B
O
OH
Cl3C
OHN
(a) (b)
2.10 3.12 3.13  
Scheme 3.6: Reagents and Conditions (a) TBDMSCL, imidazole, DMAP, Et2O; (b) 
acetamide, Et2N, DCM; (c) HF (40%), MeCN. 
 
Simple TBDMS protection of this open chain primary alcohol followed by halogen 
substitution of the thio-phenyl moiety and then amidation using trichloroacetamide 
would give a nice synthesis of the amino oxaborolan 3.13. If successful a range of 
compounds can be developed varying the alkylation substituents and to possibly 
include propylene oxide and 1,3-propylene oxide giving access to a 3-methyl 
substituted 5 membered or 6-membered variants respectively. 
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3.4 Modification of the synthesis of unsaturated ketones 
Following the discovery of the unusual method for preparing enones from aldehydes 
and the TMS-bromo reagent 2.42 it is proposed that a series of different enones could 
be synthesised from varying aldehydes. If this were to be successful it would also be 
of interest to investigate the possibility of using two different aldehydes added at 
varying times to produce asymmetric enones. The example in scheme 3.7 shows the 
formation of an unsaturated enone 3.14 using tiglic aldehyde and benzaldehyde. A 
possible method for the synthesis of 3.14 could be to ensure formation of the 
organoboron reagent 2.63 in situ is in excess comparatively to the addition of the first 
aldehyde. The reaction would then be held at -78 °C for an hour, followed by the 
addition of the second aldehyde.  
TMS
Br
O
3.142.42
(a)
 
Scheme 3.7: Reagents and Conditions (a) 
t
BuLi, B(O
I
Pr)3, tiglic aldehyde (0.75 eq). 
benzaldehyde (0.75 eq), O2, Et2O, -78 °C.  
 
Investigation into the possible mechanism would also be beneficial with emphasis on 
trapping out the proposed cycloboronate intermediate. This could be achieved by 
substituting triisopropyl borate with partially protected boron derivatives for 
example, isopropylpinacol borate and investigating the reaction on less reactive 
boronates. If so, this could still be a good novel method for the construction of cyclic 
boronate esters and is worth more attention. 
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4. Experimental 
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4.1 General Procedure 
All reactions were carried out under an atmosphere of nitrogen unless otherwise 
stated, using oven dried glassware. Commercially available chemicals and reagents 
were used as supplied unless otherwise stated. 
Tetrahydrofuran and diethyl ether were distilled from sodium using benzophenone as 
an indicator. Dichloromethane and acetonitrile were distilled from calcium hydride.  
Dry alcohol solvents were distilled from magnesium turnings and stored over 4 Å 
molecular sieves. Triethylamine and pyridine were distilled from calcium hydride 
and stored over potassium hydroxide. All solvents for high temperature reactions 
(>100 °C) were first deoxygenated by sparging for at least 1 hour with nitrogen or 
argon gas.  
Microwave reactions were carried out using a CEM Discover-S 300W microwave 
system with a pressure tolerance of up to 18bar. 
Reactions were monitored by crude NMR of the RM or by tlc using Merck glass 
backed tlc plates coated with a 0.25 mm layer of 60 F254 silica gel.  Visualisation was 
achieved using 254 nm UV radiation (where applicable) and potassium 
permanganate, phosphomolybdic acid or vanillin stains as deemed appropriate. 
Column chromatography was carried out using Merck Kieselgel 60. 
NMR spectroscopy was performed using either Varian NMR System-600 MHz (600 
MHz for 
1
H and 151 MHz for 
13
C), or Varian NMR System-500 MHz (500 MHz for 
1
H and 126 MHz for 
13
C). The solvent used for NMR samples was either deuterated 
chloroform or perdeuterated dimethylsulfoxide.  
Heteronuclear Single Quantum Coherence (HSQC), Heteronuclear Multiple Bond 
Coherence (HMBC), Correlation Spectroscopy (COSY) and Hydrogen-Deuterium 
exchange (H-D) experiments were also run where necessary to allow for the full 
elucidation of structures. 
Mass spectrometry was performed using a Fissons Instrument VG Autospec and a 
Bruker Daltonics Apex III.   
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Infrared spectra were recorded on a Perkin-Elmer 1710 Fourier transform instrument 
with an ATR attachment. 
Melting points were recorded using a Gallenkamp melting point apparatus and are 
uncorrected. 
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(1.36) 4,4,5,5-Tetramethyl-2-(phenylthiomethyl)-1,3,2-
dioxaborolane27 
S
B
O
O
1
2 3
4
567
8
9
 
 
To a solution of thioanisole (2.4 g, 2.27 ml 19.35 mmol) in THF (40 ml) was added 
TMEDA (1.97 g, 2.4 ml, 19.35 mmol) and treated with butyllithium (8.25 ml, 20.64 
mmol) at or below rt. The solution was then allowed to stir for 1 hour whereupon it 
was cooled to –78 °C and PINBOP (3.6 g, 3.95 ml, 19.35 mmol) was added dropwise 
over a period of 0.5 hr, then allowed to warm to rt overnight. The reaction mixture 
was quenched with saturated ammonium chloride solution (40 ml) and the organic 
phases separated, washed with brine (3 x 20 ml) and reduced in vacuo to give a crude 
pale yellow oil. This oil was purified using flash column chromatography and eluted 
with 95 % diethyl ether in hexane to give the title compound as a pale straw coloured 
oil (3.64 g, 75 %). 
 
1
H-NMR (500 MHz, CDCl3)  7.31 (2H, d, J=8.0, H-2 + H-4), 7.26 (2H, t, J=6.8, H-
1 + H-5), 7.12 (1H, t, J=7.2, H-3), 2.42 (2H, s, H-7), 1.24 (12H, s, H-9). 
 
13
C NMR (126 MHz, CDCl3)  138.74 (1-C), 128.61 (2+6-CH), 127.09 (3+5-CH), 
125.01 (4-CH), 84.18 (8-C x 2), 24.69 (9-CH3 x 4), 13.30 (7-CH2). 
 
HRMS (ESI+) calcd for C13H19BNaO2
+ 
m/z 273.1097 found 273.1111. 
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(2.2) 2-(Iodomethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane35 
 
O
B
O
I
1
2
3
 
 
A mixture of 4,4,5,5-tetramethyl-2-(phenylthiomethyl)-1,3,2-dioxaborolane (1.25 g, 
5 mmol), methyl iodide (3.55 ml, 50 mmol, 10 eq) and sodium iodide (1.125 g, 7.5 
mmol, 1.5 eq) in acetonitrile (25 ml) was stirred at rt for 48 hr. After which the 
reaction was quenched with sat ammonium chloride solution (25 ml) and the aqueous 
layer extracted with diethyl ether (3 x 25 ml). The organic fractions were dried over 
magnesium sulfate, reduced in vacuo and the resulting crude oil purified using flash 
column chromatography eluting with 5 % diethyl ether in hexane to give the title 
compound as a pale straw coloured oil (741 mg, 57 %). 
 
1
H-NMR (500 MHz, CDCl3)  2.17 (2H, s, H-1), 1.27 (12H, s, H-3). 
 
13
C NMR (126 MHz, CDCl3)  109.99 (1-CH2), 84.20 (2-C), 24.40 (3-CH3). 
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(2.6) 3-(Phenylthio)-1,2-oxaborolan-2-ol35 
S
O
B
OH
Ha
Hb Ha
Hb
1
2
3
4
5
6 7
8
9
 
 
To a solution of diisopropylamine (2.02 g, 2.80 ml, 19.98 mmol) in THF (2.6 ml) 
was added 1.6M 
n
BuLi (12.5 ml, 19.98 mmol) dropwise at 0 °C over 5 mins and 
allowed to stir for a further 5 mins giving a pale yellow solution. To this was added 
at 0 °C a solution of  4,4,5,5-tetramethyl-2-(phenylthiomethyl)-1,3,2-dioxaborolane 
(5 g, 4.72 ml, 19.98 mmol, 1 eq) in THF (2.6 ml) as drops over 5 mins which 
precipitated the lithium salt as a white solid. To this solution was slowly bubbled 
ethylene oxide at -5 ° C. The reaction mixture was then stirred at 0 °C for a further hr 
and allowed to warm to rt overnight whereupon the reaction mixture was quenched 
with 2M HCl (20 ml). The aqueous phase was extracted with diethyl ether (2 x 20 
ml) and the combined organic layers basified with 6N sodium hydroxide. The basic 
layer was then washed with diethyl ether and re-acidified using 2M HCL, extracted 
with diethyl ether, dried over magnesium sulfate and reduced in vacuo to give a 
crude mixture of the ring open and closed products. The crude reaction mixture was 
refluxed overnight with borax (3 g) sodium borate (3 g) in water (25 ml) and then 
purified using flash column chromatography which also helped to convert the ring 
open variant to the title compound isolated as a white solid (1.34 g, 35 %). 
 
H-NMR (500 MHz, CDCl3) δ 7.39 (2H, dd, J=8.1, 0.8, H-1 + H-5), 7.30 (2H, t, 
J=7.7, H-2 +H-5), 7.20 (1H, t, J=7.4, H-3), 4.85 (1H, s, OH), 4.22 (1H, ddd, J=9.2, 
7.4, 6.0, H-9
a
/H-9
b
), 4.07 (1H, dt, J=9.3, 6.8, H-9
b
/H-9
a
), 3.05 (1H, dd, J=7.8, 6.7, H-
7), 2.51 (1H, td, J=13.5, 7.2, H-8
a
/H-8
b
), 2.08 (1H, td, J=13.5, 6.4, H-8
b
/H-8
a
). 
 
13
C-NMR (126 MHz, CDCl3) δ 129.24, 128.93, 126.17, 67.36, 67.36, 33.85. 
 
IR (cm
-1
) 3337 (br), 1582, 1479, 1427, 1360, 1261, 1024, 738; 
 
HRMS (ESI+) calcd for C9H11BNaO2S m/z 217.0465 found 217.0467 
mp  104-106 °C. 
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See supporting information for crystal structure. 
 
(2.13) (3-Methoxypropyl)(phenyl)sulfide 
12
3
S O
4
5
6
7 8
10
9
 
 
A crude solution of azido(methoxy)(3-methoxy-1-(phenylthio)propyl)borane (50 mg) 
in deuterated DMSO was sealed into an NMR tube and heated to 140 °C for 48 hours 
or untill the starting material no longer remained, according to 
1
H-NMR. The 
reaction material was then diluted with water (5 ml) and extracted with ethyl acetate 
(3 x 5 ml). Following extraction the organic solvent was dried over magnesium 
sulfate, reduced in vacuo and purified using flash column chromatography to give the 
title compound as a pale straw coloured oil (30 mg, 12.8 % over 2 steps). 
 
1
H-NMR (500 MHz, CDCl3)  7.35 (2H, d, J=7.3, H-9 + H-5), 7.31-7.25 (2H, m, H-
8 + H-6), 7.17 (1H, t, J=7.3, H-7), 3.48 (2H, t, J=6.1, H-1/H-3), 3.33 (3H, s, H-10), 
3.01 (2H, t, J=7.2, H-3/H-1), 1.94-1.87 (2H, m, H-2). 
 
13
C NMR (126 MHz, CDCl3)  136.56, 129.07, 128.80, 70.91, 58.59, 30.32, 29.30. 
 
HRMS (ESI+) calcd for C10H14KOS
+
 m/z 221.0397 found 221.0607. 
 
LRMS: (EI) m/z 182 (C10H14OS). 
 
 
 
 
 
 
 
 
 
Novel strategies for the construction of cyclic boronate esters & acids                                  Experimental 
 
70 
(2.14) Azido(methoxy)(3-methoxy-1-(phenylthio)propyl)borane 
 
12
3
S B
O
MeO
N35
6
7
8
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3-(Phenylthio)-1,2-oxaborolan-2-ol (340 mg, 1.75 mmol) was dissolved in diethyl 
ether (34 ml) whereupon trimethyloxonium tetrafluoroborate (518 mg, 3.5 mmol, 2 
eq) was added in one portion and allowed to stir for two hours. The diethyl ether was 
then removed by rotary evaporation and replenished with acetonitrile (34 ml). To the 
stirring solution was added sodium azide (114 mg, 1.75 mmol, 1 eq) and heated to 
reflux for two hours. Saturated ammonium chloride was added (30 ml) and the 
organic layer separated, dried and reduced in vacuo to give a crude mixture which 
was then purified by crystallising from hexane and diethyl ether to give a crude 
brown/white solid (50 mg) which resembled the title compound and was hence 
tentatively assigned.  
 
1
H-NMR (500 MHz, CDCl3)  7.76 (2H, d, H-5 + H-9), 7.65 (3H, m, H-6 + H-7 + H-
8), 3.62-3.51 (1H, m, H-2
a
/H-2
b
), 3.21 (3H, d, J=10.6, H-11), 3.05 (3H, s, H-10), 
2.88 (1H, s, H-3), 1.83 (2H, s, H-1).  
 
13
C NMR (126 MHz, CDCl3)  1.33.59, 130.73, 130.02, 70.54, 58.28, 48.07, 29.03, 
27.85. 
 
HRMS (ESI+) calcd for C11H14BN3NaO2S
2+ 
m/z 287.0859 found 287.0855. 
 
HRMS (ESI+) calcd for C11H14BNaO2S
3+
 m/z 245.0997 found 245.0976. 
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(2.19) (E)-1-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)non-1-
en-3-yl 2,2,2-trichloroacetimidate 
 
1
2
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5
6
7
O
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O
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O
13
HN
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To a solution of (E)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)non-1-en-3-ol (1 
g, 3.7 mmol) in dry DCM (25 ml) was added DBU (685 mg, 4.5 mmol, 0.680 ml, 1.2 
eq) dropwise over 5 mins at rt. The resulting solution was then cooled to 0 °C where-
on trichloroacetonitrile was added dropwise over 15 minutes to a stirring solution. 
The reaction mixture was left to stir for 1 hour when, saturated ammonium chloride 
solution (25 ml) was added. The aqueous layer was separated and extracted with 
diethyl ether and the organic layers where then combined, dried over magnesium 
sulfate and reduced in vacuo. This gave the title compound as a crude brown oil 
(1.49 g, 97 %). 
 
1
H-NMR (500 MHz, CDCl3)  8.22 (1H, S, N-H), 6.20 (1H, dd, J=17.9, 5.3, H-8), 
5.73 (1H, d, J=17.9, H-9), 5.34 (1H, s, H-7), 3.95-3.88 (2H, m, H-12
a/b
 + H-13
a/b
), 
3.68 (2H, t, J=16.8, H-13
a/b
 + H-13
a/b
), 1.75 (2H, m, H-6), 1.49-1.38 (2H, m, H-5), 
1.36-1.22 (6H, m, H-4 + H-3 + H-2), 0.92-0.85 (3H, m, H-1). 
 
13
C NMR (126 MHz, CDCl3) 167.36 C=O, 167.31 C=O, 143.60 (8-C), 80.27 (7-
CH), 61.42 (11-CH2/12-CH2), 61.38 (12-CH2/11-CH2), 46.81 (14-CH3), 34.09 (6-
CH2), 31.64 (CH2), 28.94 (CH2), 24.99 (5-CH2), 22.52 (CH2), 14.01 (1-CH3), C-9 
(not seen due to boron α effect). 
 
IR (cm
-1
) 3409.25, 1655.25, 1023.03; 
 
HRMS: (ESI+) Ion could not be found. 
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(2.20) (E)-1-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)non-1-
en-3-ol 
1
2
3
4
5
6
7
OH
8
910
B
11
O
O
 
 
To a solution of methanol and dichloromethane (2:5 ratio, 350ml) and 1,2-ethanethiol 
(100 mg, 0.089 ml, 1.06 mmol, 0.2 eq) was added nickel(II)chloride hexahydrate 
(251 mg, 1.06 mmol, 0.2 mmol). The reaction mixture was then cooled to 0 °C and 
(E)-tert-butyldimethyl(1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)non-1-en-3-
yloxy)silane (2.1 g, 5.3 mmol) was added and allowed to stir overnight. The reaction 
mixture was worked up with ammonium chloride, separated and the aqueous layer 
extracted with diethyl ether and the organic fractions combined, dried over 
magnesium sulfate and reduced in vacuo to give a crude oil. The crude oil was 
purified using flash column chromatography to give the title compound as a 
colourless oil (1.177 g, 82 %). 
 
1
H-NMR (500 MHz, CDCl3) δ 6.63 (1H, dd, J=18.1, 5.3, H-8), 5.63 (1H, dd, J=18.1, 
1.4, H-9), 4.16 (1H, dd, J=11.3, 5.5, H-7), 1.51 (2H, dt, J=9.8, 5.2, H-6), 1.46-1.22 
(20H, m, H-11 + H-5 + H-4 + H-3 + H-2), 0.89 (3H, t, J=6.9, H-1). 
 
13
C NMR (126 MHz, CDCl3)  155.27 (8-CH), 83.27 (10-C x 2), 73.78 (7-CH), 
36.67 (6-CH2), 31.73 (CH2), 29.20 (CH2), 25.25 (CH2), 24.76 (11-CH3 x 2), 24.74 
(11-CH3 x 2), 22.58 (CH2), 14.03 (1-CH3), C-9 (not seen due to boron α effect). 
 
IR (cm
-1
) 3309.34, 2927.87, 2858.29, 2094.00, 1683.14; 
 
HRMS (ESI+) calcd for C15H29BNaO2
+
 m/z 291.2101 found 291.2098. 
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(2.21) (E)-tert-Butyldimethyl(1-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)non-1-en-3-yloxy)silane 
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To (E)-tert-butyldimethyl(1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)non-1-en-
3-yloxy)silane and pinacol borane (95.9 mmol, 12.27 g, 13.91 ml) was added 
zirconocene hydrochloride (0.1 eq) and triethylamine (9.59 mmol, 970 mg, 1.33 ml). 
This mixture was heated at 60 °C for 16 hours and then diluted with hexane. The 
precipitate was removed via a silica plug and washed with hexane. The resulting 
organic layer was reduced in vacuo to give the title compound as a colourless oil (34 
g, 92 %). 
 
1
H-NMR (500 MHz, CDCl3) dd, J=4.9, 18.0, H-11), 5.56 (1H, dd, J=1.3, 
18.0, H-10), 4.14 (1H, app.q, J=4.8, H-12), 1.52-1.42 (2H, m, H-14) 1.26 (22H, m, 
H-15,16,17,18,3,1,6,7) 0.96-0.81 (12H, m, H-19,24,25,26), 0.02 (6H, d, J=8.3, H-
21,22). 
 
13
C NMR (126 MHz, CDCl3)  83.13, 74.34, 37.55, 31.78, 29.35, 24.93, 
24.76, 24.54, 22.56, 18.19, 14.05, 24.93, 24.70, 24.54, 13.99, -4.40, -4.91. 
 
IR (cm
-1
) 2929.48, 2857.32, 1641.96, 1362.99; 
 
HRMS (ESI+) calcd for C21H43BO3SiNa
+
 m/z 405.2965740, found 405.2966. 
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(2.22) tert-Butyldimethyl(non-1-yn-3-yloxy)silane 
 
9
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O
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Non-1-yn-3-ol (133 mmol, 18.582 g), 4-dimethylaminopyridine (catalytic), 
triethylamine (266 mmol, 26.92 g, 37 ml) and dichloromethane (70 ml) were added 
to a 250 ml round bottomed flask under nitrogen and cooled to 0 °C. The tert-
butylchlorodimethylsilane in hexane 50 % w/w (146.3 mmol, 22 g) was then added 
dropwise and the reaction mixture was left overnight. The reaction mixture was 
worked up with ammonium chloride and the layers separated. The organic layer was 
washed with brine and reduced in vacuo to give a crude oil. This crude oil was then 
purified via flash column chromatography and eluted with hexane to give the title 
compound as a pale straw coloured oil (24.4 g, 72 %). 
 
1
H-NMR (500 MHz, CDCl3)  4.35 (1H, td, J=6.5, 1.8, H-7), 2.39-2.35 (1H, m, H-
9), 1.71-1.65 (2H, m, H-6), 1.43 (2H, m, H-5), 1.37-1.26 (6H, m, H-4 + H-3 + H-2), 
0.99-0.85 (12H, m, H-1 + H-12), 0.14 (6H, d, J=12.3, H-10). 
 
13
C-NMR (126 MHz, CDCl3) δ 85.77 (2-C), 71.76 (9-CH), 62.75 (7-CH), 38.57 (6-
CH2), 31.74 (CH2), 28.89 (CH2), 25.74 (12-CH x 3), 25.05 (CH2), 22.55 (CH2), 18.17 
(11-C), 14.00 (2-CH3), -4.61 (CH3), -5.11 (CH3).  
 
IR (cm
-1
) 2928.67, 2857.44, 1463.29, 1251.27; 
 
HRMS (ESI+) calcd for C15H30NaOSi
+
 m/z 277.1958, found 277.1953.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
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(2.23) Non-1-yn-3-ol 
 
1
2
3
4
5
6
7
OH
8
9  
 
1-(Trimethylsilyl)non-1-yn-3-ol (144 mmol, 30.7 g) was dissolved in methanol (225 
ml), dichloromethane (225 ml) and stirred under nitrogen. To this solution sodium 
methoxide (7.2 mmol) was added and allowed to undergo removal of the 
trimethylsilyl group catalytically over 24 hours. The reaction mixture was then 
washed with water and the organic layers dried over magnesium sulfate and reduced 
in vacuo to give the title compound as a pale straw coloured oil (18.582 g, 92 %). 
 
1
H-NMR (500 MHz, CDCl3)   4.33 (1H, td, J=6.6, 1.6, H-7), 2.68 (1H, s, OH), 2.42  
(1H, d, J=2.0, H-9) 1.74-1.62 (2H, m, H-6), 1.48-1.36 (2H, m, H-5), 1.34-1.20 (6H,  
m, H-4 + H-3 + H-2), 0.86 (3H, t, J=6.7, H-1). 
 
13
C NMR (126 MHz, CDCl3)  85.15 (8-C), 72.63(9-CH), 62.12 (7-CH), 37.58 (6-
CH2), 31.66 (CH2), 28.86 (CH2), 24.95 (5-CH2), 22.50 (CH2), 13.96 (1-CH3). 
 
IR (cm
-1
) 3403.01, 2256.91, 1658.80; 
 
HRMS: (ESI+) Ion could not be found. 
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76 
(2.24) 1-(Trimethylsilyl)non-1-yn-3-ol 
 
 
1
2
3
4
56
7
OH
8
9
Si
10
 
 
 
To a stirred solution of TMS acetylene (150 mmol, 14.73 g, 21 ml) in tetrahydrofuran 
(600 ml), 
n
BuLi (165 mmol) was added slowly at -78 °C. The resulting mixture was 
stirred for one hour before heptaldehyde (150 mmol, 17.1g, 20.96 ml) was added 
slowly. The mixture was then left to warm overnight. The reaction mixture was 
neutralised with 2M HCl and extracted with diethyl ether. The organic layers were 
then washed with saturated aqueous sodium hydrogen carbonate, brine and then 
dried over magnesium sulfate. The dried organic layers were then reduced in vacuo 
to give the title compound as a colourless oil (30.7 g, 96 %). 
 
1
H-NMR (500 MHz, CDCl3)  4.33 (1H, t, J=6.6, H-7), 1.67 (2H, m, H-6), 1.42 (2H, 
m, H-2), 1.29 (6H, m, H-5 + H-4 + H-3), 0.87 (3H, t, J=6.8, H-1), 0.15 (9H, s, H-10). 
 
13
C NMR (126 MHz, CDCl3)  107.29 (9-C), 12.13 (10-C), 37.66 (6-C), 31.61 (CH2) 
28.81 (CH2) 22.50 (CH2), 25.05 (2-C), 13.93 (1-C), -0.18 (10-C). 
 
HRMS (ESI+) calcd for C12H24NaOSi
+
 m/z 235.15 found 235.1489. 
 
 
IR (cm
-1
) 3329, 2957, 2929, 1249; 
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 (2.29) (E)-1-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)non-
1-en-3-yl acetate 
1
2
3
4
5
6
7
O
8
9
10
B
11 O 12
O
13
O
 
 
Acetyl chloride (30.44 mmol, 2.39 g, 2.15 ml, 1.5 eq) was added to a solution of (E)-
1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)non-1-en-3-ol (20.29 mmol, 5.444 g), 
triethylamine (22.32 mmol, 2.25 g, 3.1 ml), DMAP (2.02 mmol, 0.1 eq) in 
dichloromethane (100 ml). The reaction mixture was then allowed to warm to rt and 
left overnight. Water (100 ml) was then added and the organic layer separated, 
washed with brine (100 ml) and reduced in vacuo. The resulting crude yellow oil was 
purified by flash column chromatography eluting with 20 % Et2O in hexane to give 
the title compound as a colourless oil (4.024 g, 63 %). 
 
1
H-NMR (500 MHz, CDCl3) δ 6.49 (1H, dd, J=18.1, 5.0, H-8), 5.55 (1H, dd, J=18.2, 
1.3, H-9), 5.28 (1H, dt, J=11.7, 3.2, H-7), 2.05 (3H, s, H-13), 1.65-1.54 (2H, m, H-6), 
1.35-1.19 (20H, m, H-5 + H-4 + H-3 + H-2 + H-11), 0.86 (3H, t, H-1). 
 
13
C-NMR (126 MHz, CDCl3) δ 170.15 C=O, 150.27 (8-CH), 83.27 (10-C), 74.97 (7-
CH), 60.26 (9-CH), 33.83 (6-C), 31.59 (CH2), 28.97 (CH2), 24.97 (CH2), 24.76 
(CH2), 24.68 (CH3 x 4), 22.49 (CH2), 21.01 (22-CH3), 13.96 (1-CH3). 
 
HRMS (ESI+) calcd for C17H31BO4 m/z 310.2300, found 310.2308. 
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(2.31) Potassium (E)-(3-acetoxynon-1-enyl)trifluoroborate 
 
1
2
3
4
5
6
7
O
8
9
10
KF3B
11
O
 
 
(E)-1-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolane-2-yl)non-1-en-3-yl acetate (0.64 
mmol, 200 mg) was dissolved in acetonitrile (5 ml) and potassium difluoride (1.98 
mmol, 192 mg, 3.1 eq) was added at room temperature followed by the addition of 
water (5 ml) over the period of one hour. The reaction mixture was reduced in vacuo 
and washed with hexane (10 ml) and then dried under high vacuum to give the title 
compound as a white solid (182 mg, 98 %). 
  
1
H-NMR (500 MHz, d6-DMSO)  5.42 (2H, m, H-8 + H-9), 4.98 (1H, dd, J=10.6, 
6.2, H-7), 1.95 (3H, s, H-13), 1.47 (2H, td, J=14.3, 6.4, H-6), 1.29-1.15 (8H, m, H-5 
+ H-4 +H-3 + H-2), 0.85 (3H, t, J=6.8, H-1). 
 
13
C NMR (126 MHz, d6-DMSO)  170.05 C=O, 132.47 (8/9-CH), 132.43 (9/8-CH), 
77.20 (7-CH), 34.59 (6-CH2), 31.64 (CH2), 28.93 (CH2), 25.26 (CH2), 22.47 (13-
CH3), 14.36 (1-CH3).  
 
IR (cm
-1
) 3274.69, 2933.2, 1724.3, 1238.6, 734.92; 
 
HRMS (ESI+) calcd for C11H19BF3O2
-
 m/z 251.1436 found 251.1436. 
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(2.33) Potassium (E)-trifluoro(3-hydroxynon-1-enyl)borate 
 
1
2
3
4
5
6
7 8
9
HO
BF3K
 
 
(E)-1-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)non-1-en-3-ol (3.7 mmol, 1 g) 
was dissolved in acetonitrile (25 ml) and potassium difluoride (11.5 mmol, 1.12 g) 
added at room temperature, followed by the addition of water (25 ml) over the period 
of one hour. The reaction mixture was then reduced in vacuo, washed with hexane, 
dried over magnesium sulfate and reduced in vacuo to give the title compound as a 
white solid (900 mg, 98 %). 
 
1
H-NMR (500 MHz, d6-DMSO)  5.44(1H, dd, J=18.0, 6.1, H-8), 5.27 (1H, d, 
J=17.6, H-9), 4.04 (1H, d, J=4.4, OH), 3.71-3.61 (1H, m, H-7) 1.37-1.16 (10H, m, H-
2 + H-3 + H-4 + H-5 + H-6), 0.84 (3H, t, J=6.9, H-1). 
 
13
C NMR (126 MHz, d6-DMSO)  138.78 (CH), 138.75 (CH), 74.38 (7-CH), 38.08 
(CH2), 31.87 (CH2), 29.37 (CH2), 25.68 (CH2), 22.55 (CH2), 14.41 (1-CH3). 
 
IR (cm
-1
) 3287 (br), 2925, 1642, 995; 
 
HRMS (ESI+) calcd for C9H17BF3O
-
 m/z 209.1330 found 209.1330. 
 
m.p. decomposed above 270 °C.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
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(2.34) Potassium (E)-trifluoro(3-(2,2,2-trichloro-1-
iminoethoxy)non-1-enyl)borate 
 
1
2
3
4
5
6
7
8
9
O 10
BF3K
11
CCl3
NH
 
 
Potassium (E)-trifluoro(3-hydroxynon-1-enyl)borate (200 mg, 0.8 mmol) was 
partially dissolved in acetonitrile by gentle heating and then cooled to room 
temperature whereupon DBU (0.98 mmol, 146 mg, 0.145 ml, 1.2 eq) was added. The 
reaction mixture was then cooled further to 0 °C and trichloroacetonitrile (1.2 mmol, 
173 mg, 0.120 ml, 1.5 eq) was added dropwise over 15 minutes. The reaction 
mixture was allowed to stir for 1 hour at room temperature and then quenched with 
saturated ammonium chloride (5 ml). The aqueous solution was then washed with 
dichloromethane (20 ml) and reduced in vacuo to give a white solid most of which 
was ammonium chloride. The crude 
1
H-NMR for such, showed a positive correlation 
to that of the title compound however with numerous attempts to resynthesise 
unsuccessfull the 
1
H-NMR has been tentatively assigned. 
  
1
H-NMR (500 MHz, d6-DMSO)  6.37 (1H, dd, J=5.3, 17.9, H-8), 5.41 (1H, dd, 
J=18, 1.2, H-9), 4.64 (1H, s, NH), 3.88 (1H, dd, J=11.1, 5.6, H-7), 1.39-1.13 (10H, 
m, H-6 +H-5 + H-4 + H-3 + H-2), 0.84 (3H, t, J=6.6, H-1). 
 
13
C-NMR (126 MHz, d6-DMSO) δ 141.47, 138.83, 108.88, 74.32, 38.06, 31.86, 
29.35, 25.67, 22.54, 14.40, C-9 (not seen due to boron α-effect). 
 
HRMS: (ESI+) Ion could not be found. 
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(2.36) (E)-3-(tert-Butyldimethylsilyloxy)non-1-enylboronic acid 
 
B
HO OH
O
Si
1
2
3
4
5
6
7
8
9
10
11
12
 
 
To a solution of (E)-tert-butyldimethyl(1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)non-1-en-3-yloxy)silane (5.5 g, 14.38 mmol) in acetone (90 ml) and water (135 
ml) in a 2:1 ratio was added sodium metaperiodate (9.54 g, 44.58 mmol, 3.1 eq) and 
ammonium acetate (3.33 g, 43.15 mmol, 3 eq). The resultant cloudy solution was 
stirred at ambient temperatures for 48 hr. After this the recation mixture was placed 
under reduced pressure to remove the acetone, diluted with ethyl acetate (135 ml) 
and the phases separated. The aqueous phase was extracted with ethyl acetate (100 
ml) and the organic layers combined, washed with brine and reduced in vacuo to give 
the title compound as pale straw coloured oil (4 g, 92 %). 
  
1
H-NMR (500 MHz, CDCl3) δ 6.90 (1H, dd, J=17.5, 5.1, H-8), 5.69 (1H, d, J=17.4, 
H-9), 4.22 (1H, s, H-7), 1.67-1.42 (2H, m, H-6), 1.28 (10H, m, H-5 + H-4 + H-3 + 
H-2 + OH + OH), 0.99 -0.79 (12H, m, H-12 + H-1), 0.05 (6H, d, J=7.7, H-10). 
 
13
C-NMR (126 MHz, CDCl3) δ 159.43 (8-CH), 119.67 (9-CH), 74.29 (7-CH), 37.52 
(6-CH2), 31.78 (CH2), 29.31 (CH2), 25.90 (CH3), 24.99 (CH2), 22.59 (CH2), 18.27 
(11-C), -4.41 (CH3), -4.86 (CH3). 
 
IR (cm
-1
) 2928.68, 2857.14, 1463.10, 1251.13, 1086.36, 833.28; 
 
HRMS: (ESI+) Ion could not be found. 
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(2.37) (E)-2-(3-(tert-Butyldimethylsilyloxy)non-1-enyl)-6-
methyl-1,3,6,2-dioxazaborocane-4,8-dione 
 
B
O
O
O
O
N
O
1
2
3
4
5
6
7
8
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13
Si
15
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A 100ml flask was charged with (E)-3-(tert-butyldimethylsilyloxy)non-1-
enylboronic acid (3 g, 9.92 mmol, 1 eq), N-methyliminodiacetic acid (1.47 g, 9.92 
mmol, 1 eq), benzene (225 ml) and DMSO (25 ml) in a 9:1 ratio respectively. The 
resulting solution was heated to reflux with the addition of a Dean Stark trap and 
water cooled condenser for 16 hr. The reaction mixture was then reduced in vacuo 
and the resulting crude mixture was absorbed onto silica from ethyl acetate and 
eluted from the column using 100 % ethyl acetate to give a white semi-solid (2.43 g, 
59.5 %). 
 
1
H-NMR (500 MHz, CDCl3) δ 6.20 (1H, dd, J=17.7, 4.9, H-8), 5.56 (1H, dd, J=17.7, 
0.7, H-9), 4.16 (1H, dd, J=11.4, 5.6, H-7), 3.86 (2H, d, J=16.4, H11/12), 3.65 (2H, 
dd, J=16.3, 9.0, H12/11), 2.82 (3H, s, H-14), 1.49-1.43 (2H, m, H-6), 1.33-1.22 (8H, 
m, H-5 + H-4 + H-3 + H-2), 0.89 (12H, m, H-1 + H-17), 0.03 (6H, d, J=16.2, H-15). 
 
13
C-NMR (126 MHz, CDCl3) δ 167.75 C=O, 167.67 C=O, 150.26 (8-CH), 121.03 
(9-CH), 74.11 (7-CH), 61.40 (2 x CH2), 46.75 (14-CH3), 37.90 (6-CH2), 31.79 (CH2), 
29.29 (CH2), 25.88 (CH3 x 3), 25.11 (CH2), 22.58 (CH2), 18.24 (16-C), 14.03 (CH3), 
-4.30 (CH3), -4.75 (CH3). 
 
IR (cm
-1
) 2856.53, 2954.94, 2928.74, 1766.13, 1461.52; 
 
HRMS (ESI+) calcd for C20H38BNNaO5Si
+
 m/z 434.25 found 434.2505. 
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83 
(2.38) (E)-2-(3-Hydroxynon-1-enyl)-6-methyl-1,3,6,2-
dioxazaborocane-4,8-dione 
 
B
O
O
O
O
N
OH
1
2
3
4
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11
12
14
13
 
 
To a solution (E)-2-(3-(tert-butyldimethylsilyloxy)non-1-enyl)-6-methyl-1,3,6,2-
dioxazaborocane-4,8-dione (2.35 g, 5.7 mmol) dissolved and stirring in acetonitrile 
(50 ml) was added 40 % HF (0.72 ml, 0.28 mmol, 0.05 eq). This was allowed to stir 
for 8 hrs or until all the starting material had vanished (monitored using tlc). Water 
(0.5 ml) was then added followed by sodium hydrogen carbonate (2 g) and stirred for 
a further 10 mins after which time sodium hydrogen sulfate (4 g) was added and the 
reaction mixture filtered and reduced in vacuo. The resulting white solid was washed 
twice using hexane and dried to yield the allyl alcohol as a white solid (1.675 g, 98.8 
%). 
 
1
H-NMR (500 MHz, CDCl3) δ 6.20 (1H, dd, J=17.8, 5.1, H-8), 5.60 (1H, d, J=17.7, 
H-9), 4.12 (1H, dd, J=11.5, 5.7, H-7), 4.01 (2H, d, J=16.7, H11/12), 3.75 (2H, dd, 
J=16.7, 8.4, H-12/11), 2.85 (3H, s, H-14), 2.19 (1H, s, OH), 1.55-1.45 (2H, m, H-6), 
1.44-1.21 (8H, m, H-5 + H-4 + H-3 + H-2), 0.88 (3H, t, J=6.8, H-1). 
 
13
C-NMR (126 MHz, CDCl3) δ 168.25 C=O, 168.23 C=O, 149.52 (8-CH), 73.47 (7-
CH), 61.59 (CH2), 61.56 (CH2), 47.01 (14-CH3), 37.05 (6-CH2), 31.78 (CH2), 29.21 
(CH2), 25.49 (CH2), 22.59 (CH2), 14.04 (1-CH3).  
 
IR (cm
-1
) 3451.91, 2927.95, 2857.41, 1743.71, 1693.75; 
 
HRMS (ESI+) calcd for C14H24BNNaO5
+
 320.16 found 320.1640. 
 
m.p. 34-36 °C. 
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(2.39) (E)-1-(6-Methyl-4,8-dioxo-1,3,6,2-dioxazaborocan-2-
yl)non-1-en-3-yl 2,2,2-trichloroacetimidate 
 
B
O
O
O
O
N
O
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4
5
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7
8
9
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12
14
13 HN CCl3
15
16
 
To a solution of (E)-2-(3-hydroxynon-1-enyl)-6-methyl-1,3,6,2-dioxazaborocane-
4,8-dione (125 mg, 0.42 mmol) and  trichloroacetonitrile (173 mg, 1.2 mmol), in 
DCM (10 ml) was added DBU (15.2 mg, 0.1 mmol) slowly, dropwise at -78 °C. The 
reaction mixture was not allowed to warm higher than -60 °C. After 2 hours a further 
0.25 equiv of DBU was added in the same manner followed by an additional 0.5 
equiv an hour after that. Following this the reaction was worked up with sat aq 
ammonium chloride (10 ml) separated and the organic layer washed with water (2 x 
10 ml). The organic layer was then dried over magnesium sulfate and reduced in 
vacuo. This crude mixture was then purified using flash column chromatography 
eluting with 20 % acetonitrile in ethyl acetate to give the title compound as a white 
pale green semi-solid (60 mg, 32.4 %). 
 
1
H-NMR (500 MHz, CDCl3) δ 8.22 (1H, s, N-H), 6.20 (1H, dd, J=17.9, 5.3, H-8), 
5.73 (1H, d, J=17.9, H-9), 5.34 (1H, s, H-7), 3.95-3.88 (2H, m, H-12/H-11), 3.68 
(2H, t, J=16.8, H-11/H-12), 1.75 (2H, m, H-6), 1.49-1.38 (2H, m, H-5), 1.36-1.22 
(6H, m, H-4 + H-3 + H-2), 0.92-0.85 (3H, m, H-1). 
 
13
C-NMR (126 MHz, CDCl3) δ 167.36 C=O, 167.31 C=O, 143.60 (8-C), 110.78 (C), 
109.99 (C), 80.27 (7-CH), 61.42 (11-CH2/12-CH2), 61.38 (12-CH2/11-CH2), 46.81 
(14-CH2), 34.09 (6-CH2), 31.64 (CH2), 28.94 (CH2), 24.99 (5-CH2), 22.52 (CH2), 
14.01 (1-CH3), C-9 (not seen due to boron α-effect). 
 
IR (cm
-1
) 3409.25, 1655.25, 1023.03; 
 
LRMS m/z (EI) 156: H7C5NO4. 
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HRMS: (ESI+) Ion could not be found. 
 
(2.41) (E)-2-(3-Chloronon-1-enyl)-6-methyl-1,3,6,2-
dioxazaborocane-4,8-dione 
 
B
O
O
O
O
HN
Cl
1
2
3
4
5
6
7
8
9
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11
12
13
 
 
Palladium (II) acetate (10 mg, 0.045 mmol, 0.05 eq) was added to a stirring mixture 
of (E)-1-(6-methyl-4,8-dioxo-1,3,6,2-dioxazaborocan-2-yl)non-1-en-3-yl 2,2,2-
trichloroacetimidate (200 mg, 0.45 mmol) in toluene (5 ml) and refluxed overnight. 
Water (5 ml) was then added and the reaction mixture extracted with diethyl ether (3 
x 5 ml). The combined organic layers were dried over magnesium sulfate, filtered 
and reduced in vacuo. The crude product was then purified via flash column 
chromatography eluting with 20 % diethyl ether in hexane to give the title compound 
as a white solid (97 mg, 68.4 %). 
 
1
H-NMR (500 MHz, CDCl3) δ 6.20 (1H, dd, J=17.4, 7.7, H-8), 5.66 (1H, d, J=17.4, 
H-9), 4.39 (1H, q, J=7.0, H-7), 4.05 (2H, dd, J=16.8, 1.7, H-12), 3.74 (2H, dd, 
J=16.8, 1.2, H-11), 2.86 (3H, s, H-14), 1.81 (2H, dd, J=14.8, 7.3, H-6), 1.51-1.22 
(8H, m, H-5 + H-4 + H-2), 0.89 (3H, t, J=7.1, H-1). 
 
13
C-NMR (126 MHz, CDCl3) δ 168.02 C=O, 167.92 C=O, 146.06 (8-CH), 126.44 
(9-CH), 64.19 (7-CH), 61.64 (CH2), 61.63 (CH2), 47.13 (14-CH3), 38.00 (6-C), 31.62 
(CH2), 28.68 (CH2), 26.44 (CH2), 22.54 (CH2), 14.01 (1-CH2).  
 
IR (cm
-1
) 2926.78, 2857.37, 1749.01, 1643.64, 1456.75; 
 
HRMS (ESI+) calcd for C14H23BClNNaO4
+
 m/z 338.13 found 338.1301. 
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(2.42) (2-Bromo-allyl)-trimethyl-silane65 
 
 
                                                                        
 
Trichlorosilane (56 ml, 0.556 mol) was added drop wise to a solution of 2,3-
dibromopropene (101 g, 0.505 mol), triethylamine (70 ml, 0.505 mol) and cuprous 
chloride (5.0 g, 0.051 mol) in diethyl ether (300 ml) at -10 °C. the reaction mixture 
was warmed to room temperature where it was stirred for 3 hours before being 
filtered under an atmosphere of nitrogen. The solids were washed with dry diethyl 
ether (3 x 100 ml). The yellow filtrate was cooled to 0 °C where methyl magnesium 
bromide (555 ml, 1.668 mol, 3M in diethyl ether) was added dropwise maintaining 
the temperature below 0 °C. The reaction mixture was then allowed to warm to room 
temperature where it was stirred for 15 hr. the reaction was quenched by pouring it 
slowly onto a cooled solution of 2 M HCl (1 L). The phases were separated and the 
aqueous phase was extracted with diethyl ether (3 x 800 ml). The combined organic 
layers were washed with brine (300 ml) then dried over magnesium sulfate, filtered 
and concentrated under reduced pressure. The residue was distilled (41-43 °C, 17 
mbar) to afford the title compound as a colourless oil (74.0 g, 76 %).  
 
1
H-NMR (500 MHz, CDCl3) δ 5.31 (1H, s, H-1
a
/H-1
b
), 5.22 (1H, d, J=1.3 H-
1
b
/H-1
a
), 2.10 (2H, s, H-3), 0.11 (9H, s, H-4 x 3). 
 
13
C-NMR (126 MHz, CDCl3) δ 131.15 (2-C), 113.92 (1-CH2), 33.34 (3-CH2), 
1.56 (4-CH3 x 4). 
 
IR (cm
-1
) 2959, 2180, 1730, 1255, 843; 
 
LRMS: (EI) m/z 192, 73. 
 
HRMS: (ESI+) Ion could not be found. 
 
 
 
Si
Br
1
2
3 4Ha
Hb
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(2.58) (E)-5-methyl-2-(trimethylsilyl)hepta-1,5-dien-4-ol 
 
1
2 3
4
5 6
7
8
HO
Si
9  
 
t
BuLi was added to a solution of 2-bromo-3-(trimethylsilyl)propene in diethyl ether 
(30 ml) at -70 °C over 20 min. The solution was then allowed to warm to 0 °C and 
stirred for 1.5 hr then re-cooled to -70 °C. To this, a solution of zinc chloride (2.72 g, 
20 ml, 20 mmol, 1 eq) was added over 10 min and allowed to warm to 0 °C stirring 
for a further 2 hr and then re-cooled to -70 °C. To the resulting solution of 
organozinc reagent, trans-2-methyl-2-butenal was added over 5 mins dropwise and 
allowed to warm to rt and stirred for 48 hr. The reaction mixture was quenched with 
sat ammonium chloride solution (90 ml) and extracted with diethyl ether (3 x 30 ml). 
The combined organic layers were dried over magnesium sulfate, filtered and 
concentrated in vacuo. The crude oil was purified by distillation using a kugelrohl 
apparatus under vacuum (125 °C, 5.3 mbar) to give the title compound as a 
colourless oil (500 mg, 12.6 %). 
 
1
H-NMR (500 MHz, CDCl3)  5.72-5.67 (1H, m, H-8
a
/H-8
b
), 5.56-5.47 (2H, m, H-2 
+ H-8
b
/H-8
a
), 4.07 (1H, dd, J=9.5, 3.4, H-5), 2.46 (1H, dd, J=13.9, 3.0, H-6
a
/H-6
b
), 
2.29 (1H, dd, J=13.9, 9.5, H-6
b
/H-6
a
), 2.29 (1H, dd, J=13.9, 9.5, H-6
a
/H-6
b
), 1.67-
1.61 (6H, m, H-1 + H-4), 0.13 (9H, s, H-9). 
 
13
C NMR (126 MHz, CDCl3)  149.40 (7-C), 137.43 (3-C), 127.54 (8-CH2), 120.37 
(2-CH), 75.31 (5-CH), 42.96 (6-CH2), 13.00 (1-CH3), 11.44 (4-CH3), -1.33 (9-CH3 x 
3). 
 
IR (cm
-1
) 3388 (br), 2955, 1379, 1249, 834; 
 
HRMS: (ESI+) Ion could not be found. 
 
GCMS: (EI) m/z 183, 99, 85. 
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(2.61) (2E,4E,7E,9E)-3,9-dimethylundeca-2,4,7,9-tetraen-6-one 
 
1
2
3
4
5
6
7
8
10
11
12
13
O
9
 
 
t
BuLi (23.5 ml, 40 mmol) was added dropwise to a solution of 2-bromo-3-
(trimethylsilyl)propene in diethyl ether (30 ml) at -70 °C over 20 mins. The solution 
was allowed to warm to 0 °C and stirred for a further 1.5 hr then re-cooled to -70 °C. 
To this a solution of triisopropyl borate (4.615 ml, 20 mmol, 1 eq) in diethyl ether 
(20 ml) was added over 10 minutes and again allowed to warm to 0 °C, stirred for 2 
hr and re-cooled to -70 °C. To the resulting solution, trans-2-methyl-2-butenal (2.89 
ml, 30 mmol, 1.5 eq) was added over 5 minutes and left to stir overnight. The 
reaction mixture was quenched with ammonium chloride solution (90 ml) and 
extracted with diethyl ether (3 x 30 ml). The orange yellow solution was dried over 
magnesium sulfate, filtered, reduced in vacuo and purified using flash column 
chromatography eluting with 20 % diethyl ether in hexane to yield a bright 
yellow/orange solid (750 mg, 19.7 %). 
 
1
H-NMR (500 MHz, CDCl3) δ 7.29 (2H, d, J=15.6, H-5 + H-9), 6.33 (2H, d, J=15.6, 
H-6 + H-8), 6.04 (2H, q, J=6.9, H-2 + H-12), 1.81 (H12, m, H-1 + H-4 + H-11 + H-
13). 
 
13
C-NMR (126 MHz, CDCl3) δ 189.86 C=O, 147.50 (5+9-CH), 137.19 (2+12-CH), 
134.31 (3+10-C),  123.24 (6+8-CH), 14.68 (4+11-CH3), 11.85 (1+13-CH3).  
 
IR (cm
-1
) 2922.74, 1655, 1622, 1446; 
 
HRMS (ESI+) calcd for C13H18NaO
+
 m/z 213.12 Found: 213.1250. 
 
m.p. decomposed above 170 °C. 
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(2.68) (Z)-2,2,2-Trichloro-N-(1-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)non-2-enyl)acetamide 
 
1
2
3
4
5
6
7
8
9
11
B
O
N
HCl3C
O
O
12
10
13
 
 
To a solution of (E)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)non-1-en-3-ol 
(250 mg, 0.932 mmol) in DCM (10 ml) at 0 °C was added DBU (213 mg, 1.398 
mmol, 0.21 ml). To this was added trichloroacetonitrile (1.614 g, 11.184 mmol, 1.12 
ml) dropwise over 15 mins and then stirred for an hour at 0 °C and a further 3 hours 
after that at rt. The reaction mixture was quenched with saturated ammonium 
chloride solution (10 ml) and extracted with DCM (3 x 10 ml). The organic layers 
were combined, dried over magnesium sulfate and reduced in vacuo to give a crude 
brown oil. The crude mixture was purified using flash column chromatography 
eluting with 20 % Et2O in hexane to give the title compound as a colourless oil (120 
mg, 31 %). 
 
1
H-NMR (500 MHz, CDCl3) δ 5.71 (1H, dtd, J=7.8, 6.6, 1.2, H-7), 5.59 (1H, dd, 
J=15.2, 7.3, H-8), 4.08 (1H, s, NH), 4.00 (1H, d, J=7.0, H-9), 2.09-2.01 (2H, m, H-
6), 1.38 (2H, dq, J=14.6, 7.2, H-5), 1.34-1.20 (18H, m, H-13 X 4 + H-4 + H-3 + H-
2), 0.89 (3H, t, J=6.0, H-1). 
 
13
C-NMR (126 MHz, CDCl3) δ 131.39 (7-CH), 127.57 (8-CH), 110.78 (C), 109.98 
(C), 79.35 (C), 76.50 (C), 64.87 br (9-CH), 32.50 (6-CH2), 31.69 (CH2), 29.27 (CH2), 
28.90 (CH2), 25.55 (CH3), 25.24 (CH3), 24.54 (CH3), 22.58 (CH2), 21.13 (CH3), 
14.03 (1-CH3). 
 
IR (cm
-1
) 3200, 2931, 2858, 1726, 1459, 1392, 1150; 
 
LRMS (EI) 251: C15H28BO2
+
. 
 
HRMS: (ESI+) Ion could not be found. 
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5.1 The Chemistry of Penverne et al. 
This project aims to develop the work undertaken by Michael Annis on free radical 
cascade reactions involving furan rings. Annis expanded on initial work done by 
Penverne and Demircan. Penverne was investigating unwanted addition of radicals to 
furans and their subsequent fragmentation. He initially showed that cyclopentenes 
could be prepared from the alkenyl bromide 5.1 in a tandem radical 
addition/fragmentation sequence; see scheme 5.1
(68,69)
. 
 
O
R
OTBDMS
Br
O
R
OTBDMS
O
TBDMSO
R
TBDMSO
O
R
TBDMSO
O
R
AIBN, Bu3SnH
PhCH3
R = CH3, 27%
R = H, 12%
5.1 5.2
5.4 5.3
5.5
 
Scheme 5.1: Tandem radical addition/fragmentation sequence. 
 
The alkenyl bromide was treated with tributyltin hydride/AIBN creating a radical 
that then attacked the furan ring giving an intermediary spirocycle that then 
fragmented to form the resulting cyclopentene 5.5. 
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5.2 The chemistry of Demircan et al. 
Following on from Penvern’s work, Demircan utilised the furan fragmentation in his 
synthesis to construct the CD rings of the steriodal skeleton. He achieved this by 
replacing the TBDMSO moiety with a phenylthiol group that would subsequently 
eliminate to give a terminal alkene making up the last of three ready for [2+2+2] 
electrocyclisation creating the C ring
(70,71)
.  
 
 
O
R
THPO
Br
O
R
OTHP
SPh
AIBN, Bu3SnH
PhCH3,
SPh
O
PhS
THPOR
R
O OTHP
- SPh
electrocyclisation
+ aromatisation
R
O OTHP
R = C5H11, 51%
R = CH3, 58%
5.6 5.7
5.9 5.8
5.10
 
Scheme 5.2: Mechanistic pathway to 5.10 involving furan fragmentation. 
  
The alkenyl bromide was treated with tributyl tin hydride/AIBN to form a radical 
that attacks the furan 5-exo-trig passing through an intermediary spirocycle 5.8 that 
then fragments to lose a phenylthiol radical. The resulting unsaturated compound 5.9 
then undergoes [2+2+2] electrocylisation and aromatisation to give the bicycle 5.10 
in good yield.  
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5.3 The chemistry of Annis et al.  
Annis who was working on radical cascade reactions involving furan rings set out to 
create the ABCD rings of the steroidal core. Annis mediated the approach made by 
Demircan and Ueono and expanded it adding a further ring closing reaction to the 
cascade sequence
(72)
.  
 
 
PhO2S Br
O
OTHP
O PhO2S
O
OTHP
O
AIBN
Bu3SnH
PhCH3,
O
PhO2S
OTHP
O
O
PhO2S
OTHPO
O
OTHP
O
O
OTHPO
yield 11%
5-exo-dig
5-exo-trig
- SO2Ph
electrocylisation
+ aromatisation
5.11
5.12
5.14 5.13
5.15
5.16
 
 
Scheme 5.3: Mechanistic pathway of 5.16 involving a cascade sequence and furan 
fragmentation. 
 
This was achieved by extending the carbon chain by adding an ether moiety and a 
sulfone to act as the radical leaving group. The precursor was then treated with 
tributyltin hydride/AIBN creating a radical which underwent 5-exo-dig addition to 
create the new furan ring 5.13 followed by subsequent radical 5-exo-trig addition and 
fragmentation of furan with loss of the sulfonyl radical to give the intermediary 
compound 5.15. This then underwent [2+2+2] electrocylisation and aromatisation to 
give the tricycle 5.16 in 11 % yield. 
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With numerous studies and developments in the field of palladium chemistry 
specifically those concerned with palladium-catalysed oligocyclisations by 
carbopalladation ring formation there are a plethora of different papers to review, 
however I will focus on work done by Negishi and of those within the University of 
Sussex and its partners. Recent work is concerned with the influence of tether lengths 
on oligocyclsations of 2-bromoalk-1-ene-(n+1),(m+n+1)-diynes via palladium 
catalysis and looking at the associated effects of different terminal substituents. This 
work is an investigative study that also looks into possible mechanistic pathways. 
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5.4 The chemistry of Negishi et al.  
Negishi
(73)
 investigated selective carbopalladation routes to benzene derivatives with 
varying degrees of substitution. This work was developed from his previous work 
into the construction of benzene derivatives from a partially intramolecular reaction 
that gave highly regiocontrolled benzene derivatives. Negishi chose 5.17 and 5.19 as 
test substrates to achieve intramolecular formation of benzene derivative 5.18. Both 
substrates gave a reasonable yield with the stated reagents in scheme 5.4. 
 
E
E
O
Br
E
E
O
E
E
O
3% Pd(PPh
3)4, MeCN
2 eq. Et
3N, reflux 12 h
3%
Pd(
PPh 3
) 4,
MeC
N
5%
HOA
c, re
flux
12 h
85% (NMR)
67%
(NM
R)
E = COOEt
5.17
5.19
5.18
 
 
Scheme 5.4 
 
At the time of writing his paper Negishi was not certain of the mechanism, however 
it was presumed highly likely that the tetrakis(triphenylphosphine)palladium (0) 
formed in situ undergoes oxidative addition and subsequent 5-exo-dig 
carbopalladation followed by further 5-exo-dig carbopalladation to give an 
intermediary compound that either undergoes further carbopalladation or 
electrocyclic rearrangement to give the resulting bis annulated benzene derivative 
5.18. 
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5.5 The chemistry of Parsons, de Mejiere et al.  
In a summary of Parsons and de Mejieres
(74)
 work various tricyclic rings were 
produced with many different combinations of tether links between multiple bond 
fragments giving [5-6-5], [6-5-6], [6-6-6] and [5-6-6] tricyclic ring systems all with 
varying substituents at terminal non-brominated vinylic locations
(75)
. Tricyclic rings 
with a bridge-annulated cyclopropane moiety between rings A and B were also 
reported which provided insight into an alternative mechanistic pathway.  
R
R2
R1
Br
R
R2R1
BrPdL2
R
R2R1
BrPdL2
R
R2
R1
BrPdL2
R
R2
R1
L2PdBr
R
R2
R1
R
R2
R1
n-4
m-4 m-4
m-4
m-4
m-4
m-4
m-4
n-4
n-4 n-4
n-4
n-4
m-exo-dig
5-exo-trig
route D
[4 + 2]
cycloaddition
route A
6pi-electro-
cyclisation
route B or
6-endo-trig
route c
beta-hydride
elimination
3-exo-trig
beta-hydride
elimination
n-exo-dig
5.20
5.21
5.23
5.22
5.24
5.26
5.27
General Conditions
Pd(OAc)2 (10 mol-%),
PPh3 (25 mol-%),
Ag2CO3 (3 equiv.),
MeCN, 80 C
n-4
 
Scheme 5.6: Possible pathways for cascade oligocyclizations of 2-bromoalk-1-ene-
(n+1),(m+n+1)-diynes 5.20, n = 5 or 6, m = 5 or 6.  
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It was noted from previous work that it would be of benefit to develop access to core 
tricyclic ring structures of importance in organic synthesis. The ABC ring systems in 
steroids could be constructed from long chain 2-bromoalk-1-ene-alkyne chains with 
a terminal furan moiety. This could utilise the carbopalladation type reactions 
expanded on by Parsons and de Miejire and combining it with the attack and 
subsequent fragmentation of furans seen by that of Penverne, Annis and Demircan.  
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6. Results & Discussion 
 
 
 
 
 
Novel aspects of furan chemistry                                                                         Results and Discussion 
 
100 
6.1 Formation of oxygen containing tricycle 
6.1.1 Retrosynthesis of 6.1 
It was hypothesised the 2-bromoalkene precursor 6.2 of the bis annulated benzene 
derivative 6.1 could be prepared from the propargyl alcohol 6.3 which in turn could 
be generated from the alkyne 6.4 using 
n
BuLi and paraformaldehyde. The alkyne 6.4 
could be generated from the aldehyde 6.6 on treatment with ethynylmagnesium 
bromide and TBDMS protection. The furan aldehyde 6.6 would be synthesised using 
conditions developed by Hashmi
(76) 
reacting methyl furan with acrolein in the 
presence of a catalytic amount of gold chloride. 
 
O
O
TBDMSO
O
OTBDMS
O
Br
O
OTBDMS
OH
O
TBDMSO
O
HO
O
O
O
6.1 6.2
6.3
6.4 6.5
6.6 6.7  
 
Scheme 6.1: Retrosynthesis of 1-(8-(tert-butyldimethylsilyloxy)-3,6,7,8-tetrahydro-1H-
indeno[5,4-c]furan-5-yl)propan-2-one 6.1. 
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6.2 Synthetic approach to 6.1 
Hashmi found when treating allenyl ketones with gold (III) chloride they produced 
substituted furan derivatives
(76,77)
. Hashmi showed that although the allenyl ketone 
6.8 initially formed a substituted furan 6.11 that it would react further with an α,β-
unsaturated ketone to give the corresponding furan substituted at 2 and 5 positions 
6.10. Once the α,β-unsaturated ketone furan derivative 6.10 had formed it could then 
react further with the monosubstituted furan 6.11 to give the double addition product 
6.12 and enone saturation.  
 
•
R
O
O
R
O
R
O
R
O
R
O
R
2
R2
O
R1
O
R
R2 O
R1
1 mol% AuCl3/MeCN
+
1 mol% AuCl3,MeCN
+
1 mol%
AuCl3
MeCN6.8 6.9 6.10
6.11
6.12
6.10
 
 
Scheme 6.2: Hashmi furan synthesis and alkylation of furan with enones, catalysed by gold 
chloride. 
 
Scheme 6.2 depicts the various outcomes witnessed by Hashmi when treating the 
allene 6.8 and the enone 6.9 with a catalytic amount of gold chloride. The allene 6.8 
forms the 2-substituted furan 6.11 which can then add to the enone 6.9 to give the 
2,5-disubstitued furan 6.10. It is then possible for the mono-substituted furan 6.11 to 
add again to the 2,5-disubstituted furan 6.10 to give the di-furan product 6.12. The 
reaction is thought to proceed either by gold activation of the enone, which then 
forms the new C-C bond at the 5-position of the furan by electrophilic aromatic 
substitution or direct electrophilic attack of gold at the furan forming a furyl-gold 
species which subsequently attacks the α,β-unsaturated ketone 1,4. The gold enolate 
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then undergoes protonation from the freed proton during electrophilic aromatic 
substitution; see scheme 6.3. 
 
O
+
O AuLn
O
O
+ H
O
+
O
AuLn
O
+
O
Au2Cl3
H+-
Au2Cl3
O
O
AuLn
H+-
or
6.13
6.14
6.15
6.16
6.17
6.13
6.14
6.6
 
 
Scheme 6.3: Possible mechanistic routes to aldehyde 6.6. 
 
Synthesis of the 2-methylfuran-5-propanal 6.6 was achieved by adding dropwise a 
solution of acrolein in MeCN to methylfuran and gold (III) chloride in MeCN at  
-20 °C. The reaction was monitored using thin layer chromatography. 
 
O
O+
O
O
(a)
6.13 6.14 6.6  
 
Scheme 6.4: Reagents and Conditions (a) gold (III) chloride 1 mol%, MeCN, 0 °C,  
0.5 hr. 
 
The reaction seemed to work well on a small scale with a yield in excess of 80 %, 
when carried out on a small quantity (1 g) of the methylfuran. On a larger scale the 
reaction proved capricious and the best yield that could be achieved was around 35 
% when using 15 g of methylfuran. This was due to the increased formation of side 
products namely the di and tri-substituted furan as well as a large amount of a black, 
presumably polymeric substance. 
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6.2.1 Alkylation of 2-methylfuran-5-propanal 
The aldehyde was simply alkylated with 2 equivalents of ethynylmagnesium bromide 
in THF which gave the resulting alkynyl alcohol 6.5 in good yield. This was 
achieved by nucleophilic attack of the lone pair of the ethynyl anion at the 
electrophilic centre of the carbonyl and aided by stabilisation due to magnesium 
bromide thought to go through a six membered transition state. 
 
O
OH
(a)
O
O6.6 6.5  
Scheme 6.5: Reagents and Conditions: (a) ethynylmagnesium bromide (2 eq), THF,  
0 °C, 80 %. 
6.2.2 Protection of secondary alcohol using TBDMSCl 
TBDMSCl offered an easy protection of the secondary alcohol 6.5 and also added 
significant weight on taking the resulting product forward. Imidazole was used as a 
base along with a catalytic amount of DMAP to assist a fast reaction.  A catalytic 
amount of DMAP is used to activate the TBDMSCl as DMAP displaces the chloride 
ion making the resulting nitrogen-silicon bond more susceptible to nucleophilic 
attack from the hydroxyl due to the 4-dimethylaminopyridine moiety’s propensity to 
lose its positive charge. The reaction is then worked up with ammonium chloride and 
generally gave the protected alcohol 6.4 in good yields in the range 70-99 %. 
 
O
OH
(a)
O
OTBDMS6.5 6.4
 
 
Scheme 6.6: Reagents and Conditions: (a) TBDMSCl (1.1eq), imidazole (1.2eq), 
DMAP (0.1 eq), DCM, rt. 
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6.2.3 Preparation of propargyl alcohol moiety 
The alkyne 6.4 was deprotonated using 
n
BuLi at -78 °C and the resulting lithium salt 
added to dry paraformaldehyde in THF to give the resulting primary alcohol 6.3 in 
good yield (69 %). 
 
(a)
O
OTBDMS
O
OTBDMS
OH
6.4 6.3  
 
Scheme 6.7: Reagents and Conditions: (a) 
n
BuLi (1.1 eq), -78 °C, THF. (b)
 
paraformaldehyde (2 eq), THF, 0 °C. 
6.2.4 Preparation of oxygen tricycle precursor 
The primary alcohol 6.3 was deprotonated using NaH in THF at 0 °C and the 
resulting alkoxide attacked 2,3-dibromopropene to give the ether 6.2 in moderate 
yield (64 %). 
  
(a)
O
OTBDMS
OH
O
OTBDMS
O
Br
6.3 6.2  
 
Scheme 6.8: Reagents and Conditions: (a) NaH (1.1 eq), 2,3-dibromopropene (1 eq), 
THF, 0 °C. 
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6.2.5 Cyclisation of 6.1 precursor 
The open chain precursor 6.2 was treated under Heck conditions and heated at 80 °C 
for 5 hr in MeCN to give the resulting bis annulated benzene derivative 6.1 in 27 % 
yield. 
(a)
O
OTBDMS
O
Br
O
O
TBDMSO
6.2 6.1
 
 
Scheme 6.9: Reagents and Conditions: (a) Pd(OAc)2 (0.1 eq), PPh3 (0.3 eq), KCO3 (2 
eq), MeCN, 80 °C, 5 hr. 
 
The mechanism for this reaction is thought to start with oxidative addition of 
palladium (0) into the carbon-bromine bond and is thought to be followed by 5–exo-
dig carbopalladation mediated cyclisation to give the 3,4-substituted oxalone 
intermediate 6.20. This cyclises further by carbopalladation, 5-exo-dig onto the furan 
to give the intermediate spiro-cycle 6.21, with palladium then mediating a further 
cyclisation to create the tetracyclic compound 6.22 6-endo-trig. Palladium can then 
migrate opening the furan ring resulting in the ketone 6.23 followed by beta hydride 
elimination of the palladium species and aromatisation to give the bis annulated 
benzene product 6.1.  
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O
OTBDMS
O
Br
O
OTBDMS
Br(Ph3P)2Pd
O
O
OTBDMS
Br(Ph3P)2Pd
O
O
TBDMSO
Br(Ph3P)2Pd
O
H
O
TBDMSO
O
O
TBDMSO
O
O
OTBDMS
O
(Ph3P)2Pd
Br
O
TBDMSO
Br(Ph3P)2Pd
O
aromitisation
6.18 6.19
6.20
6.21
6.236.22
6.24
6.1
H
proton
transfer
H
 
 
Scheme 6.10: Proposed mechanistic pathway for the construction of 6.1. 
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6.3 Sulfur containing tricycle 
6.3.1 Retrosynthesis of 6.25 
It was hypothesised that the bis-annulated benzene sulfone derivative 6.25 could be 
synthesised from the previously made propargyl alcohol 6.3 by utilising Mitsunobu 
chemistry and displacing triphenylphosphine oxide formed on treatment with DEAD 
and triphenylphosphine with thioacetic acid to give the thio ester 6.29. The resulting 
ester could then be reduced using lithium aluminium hydride to give the thiol 6.28. 
 
O
OTBDMS
OH
S
O
O
O
TBDMSO
O
TBDMSO
S
Br
O
O
O
TBDMSO
S
Br
O
TBDMSO
HS
O
TBDMSO
S
O
6.25
6.26
6.27
6.28
6.29
6.3
 
 
Scheme 6.11: Retrosynthesis of target molecule bis-thiophenone cyclopentane benzene 
derivate 6.25. 
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The thiol can be alkylated using 2,3-dibromopropene and sodium hydride to give the 
2-bromo-ene moiety on the thiol 6.27. The last step before attempting cyclisation 
would be oxidation of the thiol to a sulfone perhaps using m-CPBA before cyclising 
using the same conditions developed in the previous cyclisation in chapter 6.2.5. 
6.4 Synthetic approach to 6.25 
6.4.1 Preparation of thioacetate using Mitsunobu conditions 
The propargyl alcohol 6.3 and thioacetic acid were added to a canary yellow solution 
of DEAD and triphenylphosphine under Mitsunobu conditions
(78)
. DEAD and 
triphenylphosphine form a phosphonium intermediate that then adds to the oxygen of 
the alcohol to give a triphenylphosphine moiety that is displaced by thioacetic acid to 
give the thioacetate compound 6.29 in a 74 % yield.  
 
O
OTBDMS
OH
O
TBDMSO
S
O
6.3 6.29
(a)
 
 
Scheme 6.12 Reagents and Conditions: (a) Thioacetic acid, DEAD, PPh3, THF, -20 °C. 
6.4.2 Reduction of the thioacetic moiety in 6.29 
The thioacetate 6.29 was treated with 4 eq of lithium aluminium hydride in an 
attempt to reduce the thioester moiety and monitored via thin layer chromatography. 
The reaction gave a major product that was not that of the thiol but an allene. It 
seemed the hydride had added 1,4 through the alkynyl triple bond to give an allene 
and turn the thioacetate moiety into a leaving group. 
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O
TBDMSO
S
O
O
TBDMSO
HS
(a)
6.29
6.28
x
 
Scheme 6.13: Reagents and Conditions: (a) LiAlH4, THF, 0 °C. 
 
Figure 6.1 demonstrates the possible mechanism of allene formation. Lithium 
aluminium hydride can add to the alkyne triple bond to form an allene displacing 
thioacetic acid stabilised by lithium.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
 
O
TBDMSO
S
O
Al
H
HH
HLi
 
 
Figure 6.1: Shows the proposed mechanism of allene 6.30 formation. 
 
Although the thiol was relatively easy to synthesise from 6.29 using sodium 
methoxide, isolation and hence purification proved difficult due to its propensity to 
decompose in air and during purification using flash column chromatography. 
 
O
TBDMSO
S
O
(a)
6.29
6.30
O
TBDMSO
•
 
 
Scheme 6.15: Reagents and Conditions: (a) LiAlH4 (4 eq), THF, 0 °C. 
 
To bypass the need for purification a one pot synthesis of the sulfur bis-annulated 
benzene precursor was proposed. In actual fact this proved to be by far a better 
solution giving an almost quantitative yield (99 %). So after treatment with sodium 
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methoxide in methanol, 2,3-dibromopropene was simply added dropwise at 0 °C and 
left to stir for an hour. The reaction mixture worked up with ammonium chloride and 
extracted with no need of further purification to give 6.27. 
 
O
TBDMSO
S
Br
O
TBDMSO
HS
O
TBDMSO
S
O
(a)
(b)6.29
6.28
6.27  
 
Scheme 6.16: Reagents and Conditions: (a) NaOMe, MeOH; (b) 2,3-dibromopropene, 
MeOH. 
6.4.3 Oxidation of thioether 6.27 to a sulfone 
Attempts to oxidise the thioether all failed, either the substrate decomposed or 
remained unchanged. Table 6.1 lists attempts including a mild solid-state oxidation 
using urea-hydrogen peroxide complex developed by Varma et al.
(79) 
to oxidise 6.27. 
 
O
OTBDMS
S
Br
O
TBDMSO
S
Br
O
O
6.27
6.26  
 
Scheme 6.16: Reagents and Conditions; See table on next page. 
 
 
 
 
 
Novel aspects of furan chemistry                                                                         Results and Discussion 
 
111 
 
Reagents and conditions 
    
Reagent Yield % Temperature 
5.2.4 UHP, neat, 24 hr 0  85 °C 
5.2.4 m-CPBA, DCM decomp rt 
5.2.4 H2O2, DCM decomp rt 
 
Table 6.1: Results for attempts at oxidation of thioether 6.27 to a sulfone. 
 
Only a small number of attempts were tried as it was thought more important to 
achieve the tricycle and then to see if subsequent oxidation could be achieved 
following cyclisation.  
6.4.4 Formation of spirocycle following Heck type conditions 
The thioether tricyclic precursor 6.27 was treated as before with triphenylphosphine, 
potassium carbonate and palladium acetate in acetonitrile at 80 °C for 12 hours this 
didn’t give the expected bis-annulated benzene-thiophane derivative 6.31 but gave 
instead the cyclopentadiene sulfone 6.32. 
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S
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TBDMSO
S
O
TBDMSO
O
O
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(b)
(b)
6.27
6.32
6.31
 
 
Scheme 6.17: Reagents and Conditions: (a) Pd(AcO)2 (0.1 eq), P(Ph)3 (0.3 eq), K2CO3 (2 
eq), MeCN; (b) Pd(AcO)2 (0.1 eq), dppe (0.3 eq), K2CO3 (2 eq), DMF. 
 
The reaction was then repeated substituting MeCN for DMF and triphenylphosphine 
for a more stable ligand at high temperatures 1,2-bis(diphenylphosphino)ethane and 
heated to a higher temperature of 120 °C for approximately 0.5 hr giving a more 
respectable 40 % yield in a much quicker period.  It was hoped using an elevated 
temperature, cyclopentadiene 6.32 would ring expand by one carbon to give the 
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desired [5,6,5] tricycle 6.31. However, the observed tricycle was again that of the 
cyclopentadiene 6.32, easily identifiable by its alpha beta unsaturated enone in the 
1
H-NMR signature. Subsequently a new proposed mechanism was formulated for its 
construction. As before the palladium inserts via oxidative addition into the carbon-
bromine bond which then inserts via carbopalladation undergoing cyclisation 5-exo-
dig, giving a thiolane intermediate 6.34. This intermediate undergoes further 
carbopalladation mediated cyclisation to create a spirocycle with the furan ring 5-
exo-trig 6.35. Palladium then instead of cyclising to the ethane 2 substituted thiolane 
moiety, migrates opening the furan ring to give 6.36. From here palladium adds onto 
the 2-methylene thiolane moiety in a further carbopalladation reaction 5-endo-trig, to 
give the resulting tricycle 6.37 that then undergoes beta hydride elimination to yield 
the bis annulated cylopentadiene 6.38. 
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Scheme 6.18: Proposed mechanistic pathway for the construction of cyclopentadiene 6.38. 
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Another surprising but welcome result was the oxidation of the sulfide to a sulfone 
reducing the need to oxidise before or even after cyclisation.  This was thought to 
occur via palladium mediated oxidation utilising acetate and DMF as an oxygen 
source. For the mechanism in Scheme 6.19 to work the assumption is made that the 
DMF used in this reaction is slightly wet. 
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Scheme 6.19: Proposed mechanistic pathway for the oxidation of thiol to sulfone 6.25. 
 
Sulfur is thought to attack palladium in an SN2 fashion displacing acetate to give the 
intermediary pallado-sulfur compound 6.39. DMF can then attack sulfur to form the 
more stable tetravalent sulfur intermediary 6.40, which can then undergo loss of 
palladium and oxidative addition to give the sulfoxide 6.41 as DMF reforms with the 
addition of water. Sulfur is then thought to attack palladium acetate again in an SN2 
fashion giving the pentavalent pallado-sulfur intermediary 6.43 which can then 
undergo a similar loss of palladium triggered by oxidative addition from DMF 
followed by loss of DMF through the addition of water 6.44. 
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6.5 Formation of nitrogen containing tricycle 
6.5.1 Retrosynthetic analysis of 6.45 
It was proposed that the nitrogen variant bis-annulated benzene pyrrolidine 
derivative 6.45 could also be synthesised much like the thiophane derivative 6.32, 
starting from the proparlgyl alcohol 6.3 and employing Mitsunobu chemistry to 
install the nitrogen via a phthalimide moiety 6.49. 
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Scheme 6.20: Retrosynthesis for target molecule pyrole cyclopentane-bis-annulated 
benzene derivative 6.45. 
 
The phthalimide 6.49 could be reduced to the free amine 6.48 and protected using 
Boc anhydride before alkylation to give the nitrogen tricycle precursor 6.47. 
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6.6 Synthetic approach of 6.45 
6.6.1 Mitsunobu coupling 
Treating the propargyl alcohol 6.3 with an intermediary phosphonium complex 
formed from DEAD and triphenylphosphine as described previously in chapter 6.4.1 
and forms a phosphonium-oxide moiety which is then displaced by phthalimide to 
give the propargyl phthalimide compound 6.49 in good yield (73 %). 
 
N
TBDMSO
O
O
O
TBDMSO
O
HO
(a)
6.3 6.49  
 
Scheme 6.21: Reagents and Conditions (a) DEAD (1.2 eq), PPh3 (1.2 eq), phthalimide 
(1.2 eq), THF, - 20°C. 
6.6.2 Phthalimide deprotection 
The phthalimide was successfully cleaved to the free amine with hydrazine in 
refluxing methanol in excellent yield (98 %). It follows a modification of the Gabriel 
synthesis
(80)
 first achieved by Ing and Manske
(81)
 and a procedure for this has been 
reported by Sen
(82)
. 
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Scheme 6.22: Reagents and Conditions (a) hydrazine hydrate, HCl, MeOH. 
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6.6.3 Free amine protection and alkylation 
The free amine 6.48 was quickly protected using Boc-anhydride in ethanol. Excess 
di-tert-butyl dicarbonate was found in the reaction mixture and after purification 
failed using flash column chromatography a method described by Hassner
(83) 
was 
employed. Any excess (BOC)2O was destroyed using one equivalent of TFE and a 
catalytic amount of DMAP. 
H2N
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6.46
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Scheme 6.23: Reagents and Conditions (a) (BOC)2O, MeOH, TFE, DMAP (b) see table 
below. 
 
Alkylating the now partially protected amine 6.47 however failed; table 6.2 lists 
various attempts. It is thought the bulky Boc protecting group sterically hindered 
attempts to deprotonate the amide.  
 
Reagents and conditions 
    
Reagent Yield % Temperature 
6.47 NaH (60% dispersion in mineral oil), THF 0  25 °C 
6.47 
nBuLi (1.1 eq), THF 0 0 °C 
6.47 CTAB, NaOH decomp 0 °C 
6.47 TBAI, NaH, DMF decomp 0 °C 
6.47 NaH (60% dispersion in mineral oil), Et2O 0 25 °C 
6.47 NaH, THF 0 25 °C 
6.47 K2CO3, MeCN, 48 hr 0 25 °C 
6.47 NaH (60%), THF  0 reflux 
6.47 K2CO3, MeCN 0 reflux 
 
Table 6.2: Results for attempts at alkylating the amide 6.47. 
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6.6.4 Alkylation followed by protection 
To reduce the hindrance around the amine moiety it was decided alkylation should be 
carried out first. Alkylation didn’t work as before with NaH acting as a base so 
potassium carbonate was used along with the alkylating agent 2,3-dibromopropene to 
give the 2-bromo-alkene amine 6.50 in a reasonable 60 % yield. The reaction was 
slow however and took 48 hours and was left for 72 hours with no extra visible effect 
(tlc). 
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Scheme 6.24: Reagents and Conditions (a) K2CO3 (1 eq), 2,3-dibromopropene (1 eq), 
THF, rt; (b) (BOC)2O (1.1 eq), TFE (1 eq), DMAP (0.1 eq), EtOH, rt. 
 
The alkylated amine 6.50 was then easily protected as before using Boc anhydride 
and subsequent TFE and DMAP to remove any excess Boc residue.  
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6.6.5 Formation of pyrole based bis-annulated benzene tricycle 
The tricyclic precursor 6.46 was treated with palladium acetate, dppe and potassium 
carbonate in DMF at 80 °C for 4 hr and gave the expected bis-annulated benzene 
derivative 6.45 in 35 % yield.   
 
BocN
Br
OTBDMS
O (a)
BocN
O
TBDMSO
6.46 6.45
 
 
Scheme 6.25: Reagents and Conditions (a) Pd(OAc)2 (0.1 eq), dppe (0.3 eq),  
K2CO3 (2 eq), DMF, 80 °C.  
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6.6.6 Proposed new mechanistic route to 6.45 
Due to the discovery that the sulfide based precursor 6.26 when treated with 
palladium acetate, dppe, potassium carbonate and refluxed in DMF gave the fused 
cyclopentadiene 6.25 it is now thought that all the oligocycles go through the 
cylopentadiene 6.51 system as described in scheme 6.26. It is therefore hypothesised 
that the cyclopentadiene ring 6.51 expands to give the [5,6,5] ring system 6.52 
through the help of Pd (II) which can act as a catalytic Lewis acid
(84)
 for this process. 
The bis annulated cyclohexene 6.52 can then undergo proton loss and aromatization 
in basic conditions to give the bis-annulated benzene tricyclic structure 6.45. 
 
Boc
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Scheme 6.26: Mechanistic pathway depicting ring expansion and continuation to 
mechanism shown in scheme 6.18 to give nitrogen containing tricycle 6.45. 
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6.7 Formation of an all carbon tricycle 
6.7.1 Retrosynthetic analysis of 6.53 
The hypothesised all carbon variant 6.53 would hopefully cyclise from its precursor 
6.54 using the same Heck conditions deployed in all previous cyclisations. The 
precursor could be made simply. Starting again with the propargyl alcohol 6.3 and  
using Mitsunobu chemistry to couple 6.3 with 2-bromo-alkenyl-dimethylmalonate 
6.55 which can be made from dimethyl malonate and 2,3-dibromopropene. 
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TBDMSO
O
TBDMSO
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MeO2C
MeO2C
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Scheme 6.27: Retrosynthesis for target molecule cyclopentane-bis-annulated benzene 
derivative 6.53. 
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6.8 Synthetic approach to 6.53 
6.8.1 Preparation of dimethyl 2-(2-bromoallyl)malonate 
It has been shown that that di-methyl 2-(2-bromoallyl)malonate 6.55 can be 
constructed by treating di-methyl malonate 6.57
(85)
 in THF with sodium hydride to 
give the corresponding sodium salt and adding to it, dropwise a solution of 2,3-
dibromopropene 6.56 in THF at 0 °C. The reaction mixture generally contained 
about a 3:1 ratio of the mono 6.55 (37 %) and di-substituted malonate derivative 
respectively. 
 
Br CO2Me
CO2Me
6.55
Br
Br CO2MeMeO2C
(a)
6.56 6.57  
 
Scheme 6.28: Reagents and Conditions (a) NaOMe, MeOH, 2,3-dibromopropane, 0 °C. 
6.8.2 Construction of carbon bis-annulated benzene precursor 
The precursor 6.54 was constructed by using Mitsunobu conditions and turning the 
malonate moiety into a nucleophile, and has been shown previously by Takacs
(86)
. 
The primary propargyl alcohol was treated with a phosphino complex created by 
triphenylphosphine and DEAD while 6.55 was treated with 
n
BuLi and added to the 
alcohol, displacing triphenyphosphine oxide to give 6.54 in good yield (57 %). 
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Scheme 6.29: Reagents and Conditions (a) DEAD, PPh3, THF, -20 °C. 
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6.8.3 Cyclisation of the carbon tricyle 6.53 
The cyclisation worked well under the previously established conditions and was 
monitored using thin layer chromatography until all notable starting material had 
been used up. This gave the tricycle 6.53 as a viscous, colourless oil in a reasonable 
yield (32 %). 
O
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Scheme 6.30: Reagents and Conditions (a) Pd(OAc)2 (0.1 eq), dppe (0.3 eq),  
K2CO3 (2 eq), DMF, 120 °C, 1 hr. 
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6.9 New target tricycle starting with furfuryl alcohol 
 
O
O
OTBS
TBSO
6.58  
Figure 6.2 
 
It was proposed the tricyclic structure 6.58 could be achieved starting with furfuryl 
alcohol. The alcohol could be protected first with TBDMSCl and then treated with 
acrolein in the presence of gold chloride under Hashmi conditions to give the 
aldehyde 6.61. This aldehyde would then be built upon following the same steps as 
laid out in chapter 6.1 to give the desired tricycle 6.58. 
 
O
HO
O
TBSO
O
TBSO O
6.59 6.60 6.61
(a) (b)
 
 
Scheme 6.31: Reagents and Conditions (a) TBDMSCl, imidazole, DMAP, rt; (b) acrolein, 
AuCl3, MeCN. 
 
 
The furfuryl alcohol was distilled and then protected with TBDMSCl using 
imidazole and a catalytic amount of DMAP in a good yield (90 %). However 
treatment with acrolein and gold chloride did not yield the aldehyde 6.61 and even 
under heating gave only the starting furan back. In an addition to gold catalysis a 
method by Borcherdt
(87)
 was tried.  Borcherdt reported that furans when heated in the 
presence of acrolein and glacial acetic acid give substituted furans but sadly this too 
failed.  It was unclear why the protected furfuryl alcohol 6.60 failed and so to check 
the possibility of the TBDMS group interfering with the reaction the unprotected 
furfuryl alcohol 6.59 was treated with acrolein under the same conditions, but this 
also failed to undergo addition to the enone and so an alternative target molecule was 
sought. 
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6.10 Formation of a [5:6:6] bis-annulated benzene tricycle 
6.10.1 Retrosynthetic analysis of 6.62 
The conditions established to construct [5,6,5] and [5,5,5] tricycles work on a variety 
of different substrates; but could the newly developed route to these tricycles work 
for [5,6,6] or even [5,5,6] tricycles. Below is a proposed retrosynthetic route to 
creating [5,6,6] ring systems that possibly go through a [5,5,6] mechanism. 
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TBDMSO
O
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O
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Scheme 6.32: Retrosynthesis for target molecule bis-annulated benzene derivative 6.62.       
 
The route starts with the aldehyde 6.6 already developed using gold chemistry. Using 
Wittig chemistry, the aldehyde can be homologated to the extended chain aldehyde 
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6.67 using methoxymethyltriphenylphosphonium chloride increasing the chain 
length by one and going through the enol ether 6.68 which is then hydrolysed to the 
corresponding aldehyde 6.67. Much like the previous synthesis it is simply building 
up the chain from here on. Alkylation of the aldehyde using ethynylmagnesium 
bromide followed by protection of the resulting alcohol 6.66 to 6.65. Then treatment 
of this alkyne with 
n
BuLi and paraformaldehyde should give the propargyl alcohol 
6.64 which can then be alkylated with 2,3-dibromopropene to give the [5,6,6] 
precursor 6.63. 
6.11 Synthetic approach to 6.62 
6.11.1 Formation of extended chain aldehyde 
The Wittig reagent (methoxymethyltriphosphonium chloride) was treated with n-
butyllithium at –20 °C and to this was added the aldehyde 6.6 to give the 
corresponding enol ether 6.68. 
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O
6.6 6.68
6.67
(a)
(b)
 
 
Scheme 6.33: Reagents and Conditions (a) MeOCH2PPh3Cl, 
n
BuLi, Et2O; (b) PPTS, H2O, 
MeCN, acetyl chloride, rt, 48 hr. 
 
The enol ether reaction mixture was then worked up with 2M HCl in an attempt to 
hydrolyse 6.68 in situ to its corresponding aldehyde emitting methanol. However a 
complex molecule of relatively high mass was isolated instead that has currently not 
been identified. The reaction was carried out again this time isolating the enol ether 
6.68 (82 %) and trying various hydrolysis methods to yield the desire aldehyde 6.67. 
Table 6.3 on the next page shows the hydrolysis attempts employed, it was found 
that only pyridinium para-toluene sulfonic acid would give the desired hydrolysis 
product. 
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Reagent Reagents and Conditions Yield % Temperature 
6.68 HCl (2M), THF 0  rt 
6.68 HCl (0.5 M), THF 0 0 °C 
6.68 pTSA 0 rt 
6.68 Amberlyst-15 0 rt 
6.68 iron (III) chloride 0 rt 
6.68 palladium acetate 0 rt 
6.68 oxalic acid 0 rt 
6.68 PPTS, THF 35 rt 
6.68 PPTS, acetyl 50 rt 
 
Table 6.3: Results for hydrolysis attempts on 6.68. 
 
PPTS gave a 50 % yield which was the best single reaction yield obtained. However 
the remaining starting material could be recovered and reacted again to give further 
product. This was carried out repeatedly to give a reasonable overall yield (~ 80 %).  
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6.11.2 Construction of extended chain precursor 
The remaining synthesis was then relatively straightforward, following the previous 
route discussed in the beginning of this chapter and with similar associated yields. 
The extended aldehyde was treated with ethynylmagnesium bromide to give the 
secondary alkynyl alcohol 6.66 (86.8 %). 
O
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6.67 6.66
6.656.64
6.63  
Scheme 6.34: Reagents and Conditions (a) ethynylmagnesium bromide, THF, -20 °C; 
(b) TBDMSCl, imidazole, DMAP, DCM, 0 °C, 8 hr; (c) 
n
BuLi, propargyl alcohol, -78 °C, 
THF; (d) NaH (60 %), 2,3-dibromopropene, MeCN, rt. 
 
This secondary alcohol 6.66 was then protected using TBDMSCl and the resulting 
alkynyl protected alcohol 6.65 (99 %) alkylated using 
n
BuLi and paraformaldehyde 
at -78 °C to give the propargyl alcohol 6.64 (90 %). This was followed by alkylation 
with 2,3-dibromopropene using sodium hydride as a base to give the extended chain 
precursor 6.63 (62 %). 
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6.11.3 Extended chain cyclisation 
The extended chain precursor 6.63 was initially subjected to the same Heck type 
conditions developed in the previous three cyclisations with palladium acetate, dppe 
and potassium carbonate in DMF, however no observed tricyclic product could be 
isolated. Numerous attempts to cyclise 6.63 were made and table 6.4 illustrates these. 
 
O
O
TBDMSO
O
OTBDMS
O
Br
6.63 6.62  
Scheme 6.35: Reagents and Conditions; See table below. 
 
Reagents and conditions 
    
Reagent Yield % Temperature 
6.63 Pd(OAc)2, dppe, K2CO3, DMF, 6hr 0 140 °C 
6.63 Pd(OAc)2, PPh3, K2CO3, DMF, 12hr 0 140 °C 
6.63 Pd(OAc)2, dppe, K2CO3, MeCN, 12hr 0 85 °C 
6.63 Pd(OAc)2, PPh3, K2CO3, MeCN, 24hr 0 85 °C 
 
Table 6.4: Results for attempts at extended chain cyclisation 6.63. 
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7. Future Work 
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7.1 Extending the range of examples for the new cyclisation 
7.1.1 Nitrogen heterocycle formation 
It would be of interest to extend the range of tricyclic compounds synthesised in this 
novel reaction and to test the versatility and scope of these cyclisations, probing their 
limitations in organic synthesis. Nitrogen functionality in the C cyclopentane ring 
beta to oxygen as seen in 7.2 & 7.4 could be investigated. The formation of a [5,6,6] 
ring system would also be worth investigating further following the failed cyclisation 
of 6.63 as well as optimisation of all the current cyclisations. A trial of microwave 
induced cyclisations on all the precursors could be of interest. The cyclisation 
reactions seem very dependent on temperature, with too long exposure at the 
required temperature they tend to decompose and it is therefore possible the differing 
conditions provided in a microwave with higher pressures over shorter time lengths 
may suit this reaction. 
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Scheme 7.1: Reagents and Conditions: Pd(OAc)2, K2CO3, dppe, DMF, 140 °C, 4 Bar,  
5 mins. 
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7.2 Synthetic application of tricyclic compounds 
Formation of these new tricyclic compounds gives a good method for constructing 
the backbone of pharmaceutically important molecules that contain three or more 
rings. One possible application could be lactonamycin 7.5 and its analogues 7.6 and 
7.7. 
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Figure 7.1 
 
If the tricycle 7.4 could be synthesised from its precursor 7.3 using the reagents 
and conditions previously described in scheme 7.1 it would also be feasible that 
7.4 when heated could perform a retro Diels-Alder reaction to give the diene 7.8. 
When 7.8 is heated in the presence of benzoquinone the [4+2] Diels-Alder 
product 7.10 could result providing an elegant synthesis into tetracycles and a 
possible means to construct the core of lactonamycin. 
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Scheme 7.1: Reagents and Conditions (a) Heat, Lewis acid. 
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8. Experimental 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Studies towards the construction of cyclised ring systems                                                   Experimental 
 
134 
8.1 General Procedure 
All reactions were carried out under an atmosphere of nitrogen unless otherwise 
stated, using oven dried glassware. Commercially available chemicals and reagents 
were used as supplied unless otherwise stated. 
Tetrahydrofuran and diethyl ether were distilled from sodium using benzophenone as 
an indicator. Dichloromethane and acetonitrile were distilled from calcium hydride.  
Dry alcohol solvents were distilled from magnesium turnings and stored over 4 Å 
molecular sieves.  Triethylamine and pyridine were distilled from calcium hydride 
and stored over potassium hydroxide. All solvents for high temperature reactions 
(>100 °C) were first deoxygenated by sparging for at least 1 hour with nitrogen or 
argon gas.  
Microwave reactions were carried out using a CEM Discover-S 300W microwave 
system with a pressure tolerance of up to 18bar. 
Reactions were monitored by crude NMR of the RM or by tlc using Merck glass 
backed tlc plates coated with a 0.25 mm layer of 60 F254 silica gel.  Visualisation was 
achieved using 254 nm UV radiation (where applicable) and potassium 
permanganate, phosphomolybdic acid or vanillin stains as deemed appropriate. 
Column chromatography was carried out using Merck Kieselgel 60. 
NMR spectroscopy was performed using either Varian NMR System-600 MHz (600 
MHz for 
1
H and 151 MHz for 
13
C), or Varian NMR System-500 MHz (500 MHz for 
1
H and 126 MHz for 
13
C). The solvent used for NMR samples was either deuterated 
chloroform or perdeuterated dimethylsulfoxide.   
Heteronuclear Single Quantum Coherence (HSQC), Heteronuclear Multiple Bond 
Coherence (HMBC), Correlation Spectroscopy (COSY) and Hydrogen-Deuterium 
exchange (H-D) experiments were also run where necessary to allow for the full 
elucidation of structures. 
Mass spectrometry was performed using a Fissons Instrument VG Autospec and a 
Bruker Daltonics Apex III.   
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Infrared spectra were recorded on a Perkin-Elmer 1710 Fourier transform instrument 
with an ATR attachment. 
Melting points were recorded using a Gallenkamp melting point apparatus and are 
uncorrected. 
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(6.1) 1-(8-(tert-Butyldimethylsilyloxy)-3,6,7,8-tetrahydro-1H-
indeno[4,5-c]furan-5-yl)propan-2-one 
 
O
O
O
Si
1 2
3
4
5
6
7
8
9
10
11
12 13
14
15
16
17
Hb
Ha
Hb
Ha
Ha
Hb
 
 
To a stirred solution of triphenylphosphine (178 mg, 0.68 mmol, 0.3 eq), potassium 
carbonate (625 mg, 4.52 mmol, 2 eq) and (6-(2-bromoallyloxy)-1-(5-methylfuran-2-
yl)hex-4-yn-3-yloxy)(tert-butyl)dimethylsilane (1 g, 2.26 mmol) in acetonitrile (20 
ml) was added palladium (II) acetate (50 mg, 0.226 mmol, 0.1 eq). The resulting 
mixture was heated at 80 °C for 5 hr and quenched with water (40 ml) and extracted 
with diethyl ether (3 x 50 ml). The combined organic fractions were then dried over 
magnesium sulfate, filtered and reduced in vacuo. The resulting crude brown oil was 
purified using flash column chromatography eluting with 10 % diethyl ether in 
hexane to yield the title compound as a orange/green viscous oil (226 mg, 28 %). 
 
1
H-NMR (500 MHz, CDCl3) δ 6.94 (1H, s, H-9), 5.35-5.25 (2H, m, H-1 + H-11
a
/H-
11
b
), 5.10-5.02 (3H, m, H-12 + H-11
b
/H-11
a
), 3.68 (2H, m, H-6), 2.90 (1H, ddd, 
J=15.7, 9.0, 2.0, H-3
a
/H-3
b
), 2.69-2.61 (1H, m, H-3
b
/H-3
a
), 2.52-2.46 (1H, m, H-
2
a
/H-2
b
), 2.16(3H, s, H-8), 1.93 (1H, dtd, J=12.6, 9.1, 7.6, H-2
b
/H-2
a
), 0.93 (9H, s, 
H-17), 0.16(6H, d, J=10.7, H-15). 
 
13
C-NMR (126 MHz, CDCl3) δ 205.71 (C=O), 140.79 (C), 139.01 (C), 134.56 (C), 
129.64 (C), 121.36 (9-CH), 76.41 (1-CH), 72.93 (11-CH2), 72.44 (12-CH2), 48.43 (6-
CH2), 36.39 (2-CH2), 29.34 (8-CH3), 28.54 (3-CH2), 25.83 (17-CH3 x 3), 17.96 (C), -
4.18 (CH3), -4.81 (CH3). 
 
IR (cm
-1
) 3403, 2928, 2854, 1709, 1412, 1358; 
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HRMS (ESI+) calcd for C20H30O3SiNa
+
 m/z 369.1862 found 369.1860. 
 
(6.2) (6-(2-Bromoallyloxy)-1-(5-methylfuran-2-yl)hex-4-yn-3-
yloxy)(tert-butyl)dimethylsilane 
 
1
2
3 4
5
6
7
8 9
10 11
12
O O
O
Si
1314
Br
15
16
17  
 
To a stirred suspension of NaH (284 mg, 7.1 mmol, 1.1 eq) in THF (25 ml) was 
added dropwise 4-(tert-butyldimethylsilyloxy)-6-(5-methylfuran-2-yl)hex-2-yn-1-ol 
(2 g, 6.5 mmol) at 0 °C. The solution was stirred for 1 hr, after this time 2,3-
dibromopropene was added dropwise over 5 min at 0 °C. The solution was allowed 
to warm to room temperature over 2 hr and then added to a stirring biphasic mixture 
of 10% aq potassium carbonate (20 ml) solution and diethyl ether (20 ml). The aq 
layer was separated and extracted with diethyl ether (3 x 20 ml). The combined 
organic fractions were dried over magnesium sulfate, filtered and reduced in vacuo to 
yield a crude pale yellow oil. This crude oil was then purified using flash column 
chromatography eluting with 10 % ethyl acetate in hexane to yield the title 
compound as a colourless oil (1.79 g, 64 %). 
 
1
H-NMR (500 MHz, CDCl3) δ 5.94 (1H, d, J=1.3, H-14
a
/H-14
b
), 5.87 (1H, d, J=2.9, 
H-4), 5.85 (1H, app s, H-3), 5.65 (1H, d, J=0.8, H-14
b
/H-14
a
), 4.45 (1H, t, J=6.3, H-
8), 4.24 (2H, d, J=1.5, H-11), 4.19 (2H, s, H-12), 2.75-2.70 (2H, m, H-6), 2.25 (3H, 
s, H-1), 2.03-1.97 (2H, m, H-7), 0.92 (9H, s, H-17), 0.13 (6H, d, J=12.3, H-15). 
 
13
C-NMR (126 MHz, CDCl3) δ 153.34 (5-C), 150.34 (2-C), 128.61 (13-C), 118.34 
(14-CH2), 105.78 (3-CH), 105.61 (4-CH), 88.47 (9-C), 79.36 (10-C), 73.15 (12-
CH2), 62.04 (8-CH), 57.40 (11-CH2), 36.89 (7-CH2), 25.77 (17-CH3 x 3), 23.78 (6-
CH2), 18.19 (16-C), 13.45 (1-CH3), -4.52 (CH3), -5.05 (CH3). 
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IR (cm
-1
) 2928, 2856, 1639, 1360; 
 
HRMS (ESI+) calcd for C20H31BrNaO3Si
+
 m/z 449.11 found 449.1118. 
 
(6.3) 4-(tert-Butyldimethylsilyloxy)-6-(5-methylfuran-2-yl)hex-
2-yn-1-ol 
1
2
3 4
5
6
7
8 9
10 11
12O O
OH
Si
13
14
 
 
To a solution of tert-butyldimethyl(5-(5-methylfuran-2-yl)pent-1-yn-3-yloxy)silane 
(12.25 g, 44 mmol) in THF (300 ml) was added 2.5M 
n
BuLi (19.4 ml, 48.4 mmol, 
1.1 eq) dropwise at -78 °C over 5 minutes. The reaction mixture was allowed to 
warm to -40 °C over 1 hour where-on it was re-cooled to -78 °C and para-
formaldehyde (2.65 g, 88 mmol, 2 eq) was added in one lot. The mixture was left to 
stir overnight and quenched with saturated aqueous ammonium chloride solution 
(300 ml). This mixture was then extracted with diethyl ether (3 x 200 ml) and the 
combined organic fractions washed with brine, dried over magnesium sulfate, 
filtered and reduced in vacuo. The resulting yellow oil was then purified using flash 
column chromatography eluting with 20 % diethyl ether in hexane to give the title 
compound as a colourless oil (9.44 g, 69 %). 
 
1
H-NMR (500 MHz, CDCl3) δ 5.87 (1H, d, J=3.0, H-3), 5.85 (1H, dd, J=2.9, 0.9, H-
4), 4.45 (1H, tt, J=6.4, 1.6, H-8), 4.29 (2H, dd, J=6.1, 1.6, H-11), 2.73 (2H, td, J=7.2, 
2.0, H-6), 2.26 (3H, s, H-1), 2.00 (2H, ddd, J=13.5, 7.1, 1.5, H-7), 1.63-1.53 (1H, m, 
OH), 0.92, (9H, s, H-14), 0.13 (6H, d, H-12). 
 
13
C-NMR (126 MHz, CDCl3) δ 153.41 (5-C), 150.33 (2-C), 105.77 (3-CH), 105.60 
(4-CH), 87.21 (9-C), 82.43 (10-C), 62.04 (8-CH), 51.17 (11-CH2), 36.83 (7-CH2), 
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25.80 (14-CH3 x 3), 23.74 (6-CH2), 18.20 (13-C), 13.45 (1-CH3), -4.48 (12-C), -5.04 
(12-C). 
 
IR (cm
-1
) 3374.04, 2929.63, 2857.03, 1681.00, 1567.58, 1463.02, 1360.91, 1252.29; 
 
HRMS (ESI+) calcd for C17H28NaO3Si
+
 m/z 331.17 found 331.17. 
 
(6.4) tert-Butyldimethyl(5-(5-methylfuran-2-yl)pent-1-yn-3-
yloxy)silane 
 
O
O
Si
1
2
3 4
5 6
7
8
9
10
11
1213
 
 
 
To a solution of 5-(5-methylfuran-2-yl)pent-1-yn-3-ol (10 g, 60.9 mmol) in DCM 
(150 ml) was added TBDMSCl (10.10 g, 67 mmol, 1.1 eq), imidazole (4.97 g, 73.08 
mmol, 1.2 eq), DMAP (744mg, 6.09 mmol, 0.1eq). The reaction mixture was stirred 
overnight and water added (150 ml) then extracted with diethyl ether (3 x 100 ml) 
and the combined organic fractions washed with brine, dried over magnesium sulfate 
and reduced in vacuo. The crude yellow oil was then purified using flash column 
chromatography eluting with 5 % diethyl ether in hexane yielding the title compound 
as a pale straw coloured oil (12.35 g, 73 %). 
 
1
H-NMR (500 MHz, CDCl3) δ 5.87 (1H, d, J=3.0, H-4), 5.84 (1H, dd, J=2.8, 0.9, H-
3), 4.40 (1H, td, J=6.4, 2.1, H-8), 2.74 (2H, dd, J=8.8, 6.9, H-6), 2.40 (1H, d, J=2.1, 
H-10), 2.25 (3H, s, H-1), 2.04-1.98 (2H, m, H-7), 0.92 (9H, s, H-13), 0.13 (6H, d, 
J=13.8, H-11). 
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13
C-NMR (126 MHz, CDCl3) δ 153.39 (5-C), 150.33 (2-C), 105.76 (3-CH), 105.58 
(4-CH), 85.20 (9-C), 72.28 (10-CH), 61.86 (8-CH), 36.89 (7-CH2), 25.76 (13-CH x 
3), 23.69 (6-CH2), 18.18 (12-C), 13.45 (1-CH3), -4.69 (CH3), -5.12 (CH3). 
 
IR (cm
-1
) 3309.96, 2954.28, 2929.08, 2857.47, 1570.96, 1251.87; 
 
HRMS (ESI+) calcd for C8H10NaO2
+
 m/z 161.06 found 161.05732. 
 
(6.5) 5-(5-Methylfuran-2-yl)pent-1-yn-3-ol 
 
9
10
O
OH
1
2
3
4
5
6
7
8
 
 
Ethynylmagnesium bromide (448 ml, 112 mmol, 2 eq) was added to a stirred 
solution of  3-(5-methylfuran-2-yl)propanal (15.5 g, 112 mmol) in THF (200 ml) 
dropwise at -60 °C over a period of 30 minutes. The resulting solution was allowed 
to warm to 0 °C and quenched with saturated aqueous ammonium chloride solution. 
The reaction mixture was then extracted with diethyl ether (3 x 50 ml) and the 
combined organic fractions washed with brine, dried over magnesium sulfate, 
filtered and reduced in vacuo to give a crude pale yellow oil. This oil was then 
purified using flash column chromatography eluting with 20 % diethyl ether in 
hexane to yield the title compound as a colourless oil (12.74 g, 69 %). 
 
1
H-NMR (500 MHz, CDCl3) δ 5.90 (1H, d, J=2.7, H-4), 5.85 (1H, app s, H-3), 4.43 
(1H, app s, H-8), 2.79 (2H, td, J=7.5, 3.2, H-6), 2.50 (1H, s, H-10), 2.26 (3H, s, H-1), 
2.05 (2H, ddd, J=9.1, 7.8, 2.1, H-7), 1.92 (1H, s, OH). 
 
13
C-NMR (126 MHz, CDCl3) δ 152.89 (5-C), 150.59 (2-C), 105.93 (3/4-CH), 105.85 
(4/3-CH), 84.42 (10-CH), 73.25 (9-C), 61.53 (2-CH), 35.99 (7-CH2), 23.67 (6-CH2), 
13.46 (1-CH3). 
 
IR (cm
-1
) 3400, 3287.50, 2924.11, 1712.93;  
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HRMS (ESI+) calcd for C10H12O2Na
+
 m/z 187.0735 found 187.0735. 
 
(6.6) 3-(5-Methylfuran-2-yl)propanal76 
 
O
O
1
2
3
4
5
6
7
8
 
 
To a stirred solution of 2-methylfuran (2.0 g, 2.44 mmol) and gold (III) chloride (37 
mg, 0.12 mmol, 0.05 eq) in acetonitrile (20 ml) was added acrolein (2.07 g, 3.7 
mmol, 1.5 eq) dropwise over 5 minutes at 0 °C. The reaction mixture was then 
allowed to stir for 1 hour over an ice bath at which point flash grade silica was added 
and the resulting crude mixture reduced in vacuo absorbing the crude resulting oil 
onto silica. It was then purified using column chromatography eluting with 5 % 
diethyl ether in hexane to yield the title compound as a straw coloured oil (2.35 g, 70 
%). 
 
1
H-NMR (500 MHz, CDCl3) δ 9.81 (1H, q, J=1.3, H-8), 5.88 (1H, d, J=3.0, H-4), 
5.84 (1H, dd, J=2.8, 0.7, H-3), 2.93 (2H, t, J=7.3, H-6), 2.78-2.74 (2H, m, H-7), 2.24 
(3H, s, H-1). 
 
13
C-NMR (126 MHz, CDCl3) δ 201.18 (8-CH), 151.93 (5-C), 150.81 (2-C), 106.09 
(4-CH), 105.94 (3-CH), 41.99 (7-CH2), 20.83 (6-CH2), 13.40 (1-CH3). 
 
IR (cm
-1
) 2923.11, 1723.09, 1617.13, 1570, 1217.96; 
 
HRMS (ESI+) calcd for C8H10O2Na
+
 m/z 161.06 found 161.0573. 
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(6.27) (6-(2-Bromoallylthio)-1-(5-methylfuran-2-yl)hex-4-yn-3-
yloxy)(tert-butyl)dimethylsilane 
 
1
2
3
4
5 6 7 8 9
10
11 12
14
O
S
Si
O
15
16
13 Br
HbHa 14
 
 
To a solution of S-4-(tert-butyldimethylsilyloxy)-6-(5-methylfuran-2-yl)hex-2-ynyl 
ethanethioate (3.3 g, 9 mmol) in methanol (75 ml) was added sodium methoxide (9.9 
mmol, 1.1 eq) at rt. The reaction mixture was allowed to stir for 30 minutes 
whereupon 2,3-dibromopropene (879 mg, 1.8 ml, 9 mmol 1 eq) was added and 
allowed to stir for a further hour. The reaction mixture was then quenched with water 
(75 ml) and extracted with diethyl ether (3 x 75 ml). The combined organic fractions 
were washed with brine, dried over magnesium sulfate, filtered and reduced in vacuo 
to yield the title compound as a colourless oil (3.939 g, 99 %).  
 
1
H-NMR (500 MHz, CDCl3) δ 5.88-5.82 (3H, m, H-3 + H-4 + H-14
b
), 5.57 (1H, d, 
J=1.6, H-14
a
), 4.43 (1H, tt, J=6.7, 1.7, H-8), 3.62 (2H, s, H-12), 3.28 (2H, d, J=1.8, 
H-11), 2.74-2.70 (2H, m, H-6), 2.25 (3H, s, H-1), 2.02-1.96 (2H, m, H-6), 2.25 (3H, 
s, H-1), 2.02-1.96 (2H, m, H-7), 0.92 (9H, s, H-17), 0.12 (6H, d, J=12.7, H-15). 
 
13
C-NMR (126 MHz, CDCl3) δ 153.38 (5-C), 150.32 (2-C), 128.61 (13-C), 119.34 
(14-CH2), 105.78 (3-CH), 105.58 (4-CH), 84.92 (9-C), 79.28 (10-C), 62.17 (8-CH), 
41.20 (12-CH2), 37.14 (7-CH2), 25.78 (17-CH3 x 3), 23.81 (6-CH2), 18.85 (11-CH2), 
18.18 (16-C), 13.45 (1-CH3), -4.49 (CH3), -5.05 (CH3). 
 
IR (cm
-1
) 2927, 2855, 1713, 1620, 1570, 1251, 1087; 
 
HRMS (ESI+) calcd for C20H31BrNaO2SSi
+
 m/z 465.09 found 465.089. 
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(6.29) S-4-(tert-Butyldimethylsilyloxy)-6-(5-methylfuran-2-
yl)hex-2-ynyl ethanethioate 
 
1
2
3
4
5 6 7 8 9
10
11 12 13
14
O
S
O
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O
15
16
 
 
A solution of DEAD (2.26 g, 2.05 ml, 13 mmol, 1 eq) in THF (30 ml) was added 
dropwise to a stirred solution of triphenylphosphine (3.4 g, 13 mmol, 1 eq) in THF 
(30 ml) at 0 °C. The resulting canary yellow solution was kept at 0 °C for 15 minutes 
and then a pre-cooled mixture of 4-(tert-butyldimethylsilyloxy)-6-(5-methylfuran-2-
yl)hex-2-yn-1-ol (4 g, 13 mmol) and thioacetic acid (989 mg, 0.924 ml, 13 mmol, 1 
eq) in THF (30 ml) was added in one portion. The mixture was stirred at room 
temperature for 4 hr and the solvent removed in vacuo. Purification was achieved 
using flash column chromatography eluting with 2-4 % diethyl ether in hexane to 
yield the title compound as a pale straw coloured oil (3.538 g, 74 %). 
 
1
H-NMR (500 MHz, CDCl3) δ 5.85 (1H, d, J-2.9, H-3), 5.83 (1H, d, J=2.8, H-4), 
4.38 (1H, t, J=6.4, H-8), 3.68 (2H, d, J=1.8, H-11), 2.71-2.66 (2H, m, H-6), 2.35 (3H, 
d, J=1.0, H-13), 2.25 (3H, s, H-1), 1.98-1.92 (2H, m, H-7), 0.90 (9H, s, H-16), 0.11 
(6H, d, J=12.4, H-14). 
 
13
C-NMR (126 MHz, CDCl3) δ 193.93 (12-C), 153.47 (5-C), 150.27 (2-C), 105.76 
(3-CH), 105.55 (4-CH), 84.21 (9-C), 78.85 (10-C), 62.09 (8-C), 36.85 (7-CH2), 30.07 
(13-CH3), 25.80 (16-CH3 x 3), 23.75 (6-CH2), 18.18 (15-C), 17.96 (11-CH2), 13.45 
(1-CH3), -4.49 (CH3), -5.06 (CH3). 
 
IR (cm
-1
) 2928, 2856, 1697, 1570, 1437, 1354; 
 
HRMS (ESI+) calcd for C19H30NaO3SSi
+
 m/z 389.16 found 389.1577. 
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(6.30) tert-Butyldimethyl(1-(5-methylfuran-2-yl)hexa-4,5-dien-
3-yloxy)silane 
14
1
2
3
4
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6
7
8
9
10
11
12
13O Si
•
O  
 
 
S-4-(tert-Butyldimethylsilyloxy)-6-(5-methylfuran-2-yl)hex-2-ynylethanethioate (3.3 
g, 9 mmol) in THF (100 ml) was added dropwise to a stirring suspension of LiAlH4 
(1.36 g, 36 mmol, 4 eq) at 0 °C in THF (80 ml). The resulting reaction mixture was 
allowed to stir at rt for 2 hr where-on it was re-cooled to 0 °C, quenched with ice 
(100 ml) and extracted with diethyl ether (3 x 50 ml). The combined organic layers 
were dried over magnesium sulfate, reduced in vacuo and purified using flash 
column chromatography eluting with diethyl ether in hexane to yield the title 
compound as an orange coloured oil (961 mg, 36.5 %). 
 
1
H-NMR (500 MHz, CDCl3) δ 5.86-5.83 (2H, m, H-3 + H-4), 5.14 (1H, dd, J=13.8, 
6.8, H-9), 4.81-4.73 (2H, m, H-11), 4.23 (1H, dt, J=7.1, 5.8, H-8), 2.74-2.58 (2H, m, 
H-6), 2.26 (3H, s, H-1), 1.96-1.82 (2H, m, H-7), 0.92 (9H, s, H-14), 0.08 (6H, d, 
J=1.6, H-12). 
 
13
C-NMR (126 MHz, CDCl3) δ 207.44 (10-C), 154.05 (5-C), 150.14 (2-C), 105.72 
(3-CH), 105.24 (4-CH), 94.58 (9-CH), 76.01 (11-CH2), 70.71 (8-CH), 36.83 (7-CH2), 
25.86 (14-CH3 X 3), 24.06 (6-CH2), 18.16 (13-C), 13.44 (1-CH3), -4.30 (CH3), -4.95 
(CH3). 
 
IR (cm
-1
) 2928, 2856, 1956, 1571; 
 
HRMS (ESI+) calcd for C17H28NaO2Si
+
 m/z 315.1751 found 315.1747. 
 
 
Novel aspects of furan chemistry                                                                                          Experimental 
 
145 
 (6.32) (E)-4-(4-(tert-Butyldimethylsilyloxy)-1,3,4,5,6,6a-
hexahydropentaleno[1,2-c]thiophen-6a-yl-1,1-dioxide)but-3-
en-2-one 
S
O
O
Si
12
34
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12 13
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O
O
 
 
To a solution of (6-(2-bromoallylthio)-1-(5-methylfuran-2-yl)hex-4-yn-3-yloxy)(tert-
butyl)dimethylsilane (1 g, 2.26 mmol), dppe (180 mg, 0.452 mmol, 0.2 eq), 
potassium carbonate (624 mg, 4.52 mmol, 2 eq) in DMF (40 ml) was added 
palladium (II) acetate (50 mg, 0.226 mmol, 0.1 eq). The reaction mixture was heated 
to 120 °C for 30 minutes and then diluted down with water (400 ml). The mixture 
was then extracted with diethyl ether (3 x 200 ml), dried over magnesium sulfate, 
filtered and reduced in vacuo to yield a crude brown oil. The oil was then purified 
using flash column chromatography eluting with diethyl ether in hexane to give the 
title compound as a bright yellow viscous oil (356 mg, 40 %). 
 
1
H-NMR (500 MHz, CDCl3) δ 7.23 (1H, d, J=16.1, H-4), 6.51 (1H, s, H-14), 6.10 
(1H, d, J=16.1, H-3), 4.97 (1H, dd, J=4.5, 2.7, H-12
a
/H-12
b
), 4.96-4.92 (1H, m, H-8), 
4.76 (1H, t, J=3.0, H-12
b
/H-12
a
), 4.10 (2H, t, J=2.8, H-11), 2.74-2.65 (1H, m, H-6), 
2.45-2.37 (1H, m, H-6), 2.37-2.29 (1H, m, H-7), 2.27 (3H, s, H-1), 1.85-177 (1H, m, 
H-7), 0.87 (9H, s, H-17), 0.03 (6H, d, H-15). 
 
13
C-NMR (126 MHz, CDCl3) δ 198.79 (2-C), 150.80 (10-CH2), 146.91 (5-C), 138.86 
(9-C), 137.85 (4-CH), 135.51 (14-CH), 131.32 (13-C), 129.34 (3-CH), 105.66 (12-
CH2), 79.07 (8-CH), 37.19 (11-CH3), 33.00 (7-CH2), 29.43 (6-CH2), 27.14 (1-CH3), 
25.77 (17-CH3 x 3), 18.12 (16-C), -4.81 (15-CH3), -4.84 (15-CH3). 
 
IR (cm
-1
) 3405, 2927, 2855, 1666, 1590, 1462, 1252; 
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HRMS (ESI+) calcd for C20H30NaO4SSi
+
 m/z 417.15 found 417.1548. 
 
(6.45) tert-Butyl 8-(tert-butyldimethylsilyloxy)-5-(2-oxopropyl)-
3,6,7,8-tetrahydrocyclopenta[e]isoindole-2(1H)-carboxylate 
 
1
2
3
4
5
6
78
9
10
11
12 13 14
15
16
17
18
19
20 N
O
O
O
Si
O
Ha
Hb
Ha
Hb
Ha
Hb
 
 
To a stirring solution of  tert-butyl 2-bromoallyl(4-(tert-butyldimethylsilyloxy)-6-(5-
methylfuran-2-yl)hex-2-ynyl)carbamate (500 mg, 0.95 mmol), dppe (75 mg, 0.19 
mmol, 0.2 eq), potassium carbonate (262 mg, 1.9 mmol, 2 eq) in DMF (25 ml) was 
added palladium (II) acetate (22 mg, 0.095 mmol, 0.1 eq) in one lot. The reaction 
mixture was heated to 87 °C for 4 hrs and diluted with water (250 ml) whereupon it 
was then extracted with diethyl ether (3 x 100 ml). The combined organic layers 
were dried over magnesium sulfate, filtered and reduced in vacuo to yield a crude 
brown oil. This oil was purified using flash column chromatography eluting with    
20 % diethyl ether in hexane to yield the title compound as a white solid (152 mg, 35 
%). 
 
1
H-NMR (500 MHz, CDCl3) δ 6.95 (1H, d, J=24.3, H-14), 5.34 (1H, t, J=7.3, H-8), 
4.84 (1H, dd, J=23.2, 15.1, H-11
a
/H-11
b
), 4.69-4.99 (3H, m, H-12 +H-11
a
/H-11
b
), 
3.67 (2H, d, J=2.7, H-3), 2.96-2.82 (1H, m, H-6
a
/H-6
b
), 2.69-2.58 (1H, m, H-6
b
/H-
6
a
), 2.55-2.43 (1H, m, H-7
a
/H-7
b
), 2.16 (3H, s, H-1), 1.93 (1H, ddt, J=17.4, 12.4, 8.8, 
H-7
b
/H-7
a
), 1.52 (9H, d, J=2.8, H-20), 0.95 (9H, d, J=9.4, H-17), 0.18(6H, d, J=21.6, 
H-15). 
 
13
C-NMR (126 MHz, CDCl3) δ 205.63 (2-C=O), 154.58 (18-C=O), 140.65 (C), 
139.96 (C), 136.68 (10-C), 132.90 (13-C), 129.79 (5-C), 123.18 (14-C), 79.45 (19-
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C), 76.60 (8-C), 51.31 (CH2), 51.26 (CH2), 48.43 (3-CH3), 36.43 (7-CH2), 29.34 (1-
CH3), 28.58 + 28.54 + 28.43 (20-CH3 X 3), 25.94 + 25.89 (17-CH3 x 3), 18.01 (16-
C), -4.10 (CH3), -4.95 (CH3). 
 
IR (cm
-1
) 2929, 2857, 1697, 1472, 1399; 
 
HRMS (ESI+) calcd for C25H39NNaO4Si
+
 m/z 468.25 found 468.2541. 
 
MP 112-115 °C. 
 
(6.46) tert-Butyl 2-bromoallyl(4-(tert-butyldimethylsilyloxy)-6-
(5-methylfuran-2-yl)hex-2-ynyl)carbamate 
 
1
2
3
4
5 6 7 8 9
10
11 12
17
O
Si
O
15
16
13 Br
14
N
O O
18
1920
 
 
To a solution of N-(2-bromoallyl)-4-(tert-butyldimethylsilyloxy)-6-(5-methylfuran-
2-yl)hex-2-yn-1-amine (460 mg, 1.08 mmol) in ethanol (15ml) was added di-tert-
butyl dicarbonate (259 mg, 1.18 mmol, 1.1 eq). The reaction mixture was allowed to 
stir for 2 hr when TFE (108 mg, 0.08 ml, 1.08 mmol, 1 eq) and DMAP (13 mg, 0.108 
mmol, 0.1 eq) were added in one lot. After 5 minutes the reaction mixture was 
quenched with water (20 ml) and extracted with diethyl ether (3 x 20 ml). The 
organic fractions were combined, dried over magnesium sulfate, filtered and reduced 
in vacuo to give a crude oil that was purified with flash column chromatography 
eluting with 20 % diethyl ether in hexane to give the title compound as a colourless 
oil (2.26 g, 91 %).  
 
1H-NMR (500 MHz, CDCl3) δ  5.86 (1H, d, J=2.9, H-4), 5.84 (1H, s, H-3), 5.76 (1H, 
d, J=12.6, H-14
a
/H-14
b
), 5.58 (1H, s, H-14
b
/H-14
b
), 4.41 (1H, t, J=6.3, H-8), 4.17 
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(3H, s, H-12 + H-11
a
/H-11
b
), 4.06 (1H, s, H-11
b
/H-11
a
), 2.73-2.69 (2H, m, H-6), 
2.25 (3H, s, H-1), 2.00-1.95 (2H, m, H-7), 1.48 (9H, s, H-17), 0.19 (9H, s, H-20), 
0.11 (6H, d, J=10.4, H-18). 
 
13
C-NMR (126 MHz, CDCl3) δ 153.39 (5-C), 150.32 (2-C), 129.08 (15-C), 117.52 
(14-CH2), 105.77 (3-CH), 105.57 (4-CH), 85.17 (9-C), 80.87 (16-C), 53.34 (12-
CH2), 36.95 (7-CH2), 35.5 (11-CH2), 28.25 (17-CH3 X 3), 25.78 (20-CH3 X 3), 23.78 
(6-CH2), 18.19 (19-C), 13.45 (1-CH3), -4.49 (CH3), -5.03 (CH3). 
 
IR (cm
-1
) 2930, 2856, 1701, 1402; 
 
HRMS (ESI+) calcd for C25H40BrNNaO4Si
+
 m/z 548.18 found 548.1802. 
 
(6.47) tert-butyl 4-(tert-butyldimethylsilyloxy)-6-(5-
methylfuran-2-yl)hex-2-ynylcarbamate 
 
1
2
3
4
5 6 7 8 9
10
11
14
O
Si
O
15
16
H
N O12 13
17
O
 
 
To a stirring solution of 4-(tert-butyldimethylsilyloxy)-6-(5-methylfuran-2-yl)hex-2-
yn-1-amine (1.29 g, 4.2 mmol), in ethanol (20 ml) was added di-tert-butyl 
dicarbonate (1.01 g, 4.62 mmol, 1.1 eq). After one hour TFE (420 mg, 4.20 mmol, 1 
eq) and DMAP (51 mg, 0.42 mmol, 0.1 eq) were added consecutively and allowed to 
stir for a further 5 minutes. Chloroform (50 ml) was then added and the mixture 
washed with 0.5 M HCl (50 ml), dried over magnesium sulfate, filtered, and purified 
using flash column chromatography eluting with 15 % diethyl ether in hexane to 
yield the title compound as a colourless oil (1.41 g, 82 %). 
 
1
H-NMR (500 MHz, CDCl3) δ 5.86 (1H, d, J=3.0, H-4), 5.84 (1H, dd, J=2.9, 0.8, H-
3), 4.63 (1H, s, NH), 4.41-4.38 (1H, m, H-8), 3.93 (2H, d, J=4.2, H-11), 2.70 (2H, 
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dd, J=9.2, 6.7, H-6), 2.25 (3H, s, H-1), 2.00-1.94 (2H, m, H-7), 1.46 (9H, s, H-14), 
0.91 (9H, s, H-17), 0.11 (6H, d, J=12.2, H-15). 
 
13
C-NMR (126 MHz, CDCl3) δ 153.44 (5-C), 150.29 (2-C), 105.77 (3-CH), 105.57 
(4-CH), 84.45 (9-C), 80.42 (10-C), 79.85 (12-C), 62.02 (8-CH), 36.85 (7-CH2), 30.68 
(11-CH2), 28.39 (13-C), 28.33 (14-CH3 x 3), 25.80 (17-CH3 X 3), 23.74 (6-CH2), 
18.19 (16-C), 13.45 (1-CH3), -4.47 (15-CH3), -5.05 (15-CH3). 
 
IR (cm
-1
) 3356, 2930, 2856, 1698; 
 
HRMS (ESI+) calcd for C22H37NNaO4Si
+
 m/z 430.24 found 430.2384. 
 
(6.48) 4-(tert-Butyldimethylsilyloxy)-6-(5-methylfuran-2-yl)hex-
2-yn-1-amine 
1
2
3
4
5 6 7 8 9
10
11
12
O
Si
O
13
14
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To 2-(4-(tert-butyldimethylsilyloxy)-6-(5-methylfuran-2-yl)hex-2-ynyl)isoindoline-
1,3-dione (1.4 g, 3.2 mmol) in THF (50 ml) was added hydrazine monohydrate (0.62 
ml, 12.8 mmol, 4 eq). This was then heated to reflux for 1 hr whereupon water (50 
ml) was added. The organic layer was then separated and washed with brine (50 ml), 
dried over magnesium sulfate, filtered and reduced in vacuo. To give the title 
compound as a colourless oil (970 mg, 98 %). 
 
1H-NMR (500 MHz, CDCl3) δ 5.86 (1H, d, J=2.9, H-4), 5.84 (1H, dd, J=2.8, 0.9, H-
3), 4.44-4.39 (1H, m, H-8), 3.44 (2H, d, H-11), 2.71 (2H, dd, J=9.0, 6.6, H-6), 2.25 
(3H, s, H-1), 2.00-1.95 (2H, m, H-7), 1.36 (2H, s, NH2), 0.92 (9h, s, H-14), 0.12 (6H, 
d, J=12.5, H-12).  
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13
C-NMR (126 MHz, CDCl3) δ 153.52 (5-C), 150.23 (2-C), 105.76 (3-CH), 105.49 
(4-CH), 85.04 (10-C), 83.65 (9-C), 62.14 (8-CH), 37.01 (7-CH2), 31.57 (11-C), 25.81 
(14-CH3 x 3), 23.80 (6-CH2), 18.20 (13-C), 13.43 (1-CH3), -4.45 (CH3), -5.01 (CH3). 
 
IR (cm
-1
) 2953, 2855, 1570, 1471, 1360; 
 
HRMS (ESI+) calcd for C17H29NNaO2Si
+
 m/z 330.19 found 330.1860. 
 
(6.49) 2-(4-(tert-Butyldimethylsilyloxy)-6-(5-methylfuran-2-
yl)hex-2-ynyl)isoindoline-1,3-dione 
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To a solution of triphenylphosphine (1.4 g, 5.3mmol, 1.2 eq) in THF (25 ml), DEAD 
(922 mg, 5.3 mmol, 1.2 eq) was added dropwise at 0 °C. When this solution turned 
canary yellow a mixture of 4-(tert-butyldimethylsilyloxy)-6-(5-methylfuran-2-
yl)hex-2-yn-1-ol (1.36 g, 4.4 mmol, 1 eq) and phthalimide (780 mg, 5.3 mmol, 1.2 
eq) in THF (25 ml) was added steadily and quickly. The resulting white suspension 
turned clear and was monitored by tlc and stirred at room temperature for 4 hr, then 
the solvent removed in vacuo. Purification was achieved using flash column 
chromatography eluting with diethyl ether in hexane to give the title compound as a 
pale straw coloured oil (1.7 g, 73 %). 
 
1H-NMR (500 MHz, CDCl3) δ 7.9-7.85 (2H, m, H-17+14), 7.76-7.71 (2H, m, H-
15+16), 5.84-5.80 (2H, m, H-3+4), 4.47 (2H, d, J=1.8, H-11), 4.39-4.35 (1H, m, H-
8), 2.68 (2H, td, J=7.4, 3.5, H-6), 2.22 (3H, s, H-1), 1.98-1.92 (2H, m, H-7), 0.86 
(9H, S, H-22), 0.07 (6H, d, J=8.5, H-20). 
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13
C-NMR (126 MHz, CDCl3) δ 166.92 (C), 153.38 (5-C), 150.24 (2-C), 134.07 (CH 
x 2), 132.07 (13+14-C), 123.43 (CH x 2), 105.75 (CH), 105.60 (CH), 84.46 (9-C), 
77.82 (10-C), 61.93 (8-C), 36.71 (7-C), 27.27 (11-CH2), 25.74 (22-CH3 x 3), 18.13 
(21-C), 13.43 (1-CH3), -4.60 (CH3), -5.11 (CH3). 
 
IR (cm
-1
) 2928, 2856, 1773, 1717, 1570; 
 
HRMS (ESI+) calcd for C25H31NaO4Si
+
 460.19 found: m/z 460.1915. 
 
(6.50) N-(2-Bromoallyl)-4-(tert-butyldimethylsilyloxy)-6-(5-
methylfuran-2-yl)hex-2-yn-1-amine 
 
1
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To a stirring solution of 4-(tert-butyldimethylsilyloxy)-6-(5-methylfuran-2-yl)hex-2-
yn-1-amine (3.362 g, 11 mmol) and potassium carbonate (1.5 g, 11 mmol, 1 eq) in 
THF (120 ml) was added 2,3-dibromopropene (1.075 ml, 11 mmol, 1 eq) in one 
portion. The reaction mixture was allowed to stir at room temperature for 48 hrs. To 
this water (120 ml) was added and then extracted with diethyl ether (3 x 100 ml). The 
combined organic layers were washed with brine, dried over magnesium sulfate, 
filtered and reduced in vacuo to give a crude pale yellow oil. This oil was then 
purified using flash column chromatography eluting with 20 % diethyl ether in 
hexane to yield the title compound as a colourless oil (2.052 g, 43 %). 
 
1
H-NMR (500 MHz, CDCl3) δ 5.86 (1H, d, J = 3.0, H-4), 5.84 (2H, m, H-3, H-14
a
), 
5.58 (1H, d, J=1.7, H-14
b
), 4.43 (1H, t, J=6.3, H-8), 3.55 (2H, d, J=0.4, H-12), 3.45 
(2H, d, J=1.7, H-11), 2.72 (2H, dd, J=8.7, 6.7, H-6), 2.25 (3H, s, H-1), 2.01-1.96 
(2H, m, H-7), 1.57 (1H, s, NH), 0.92 (9H, s, H-17), 0.12 (6H, d, J=12.2, H-15). 
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13
C-NMR (126 MHz, CDCl3) δ 153.49 (5-C), 150.30 (2-C), 132.11 (13-C), 118.25 
(14-CH2), 105.77 (3CH), 105.53 (4-CH), 85.12 (9-C), 81.58 (10-C), 62.15 (8-CH), 
56.07 (12-CH2), 37.09 (7-CH2), 36.68 (11-CH2), 25.80 (17-CH3 x 3), 23.83 (6-CH2), 
18.21 (16-C), 13.46 (1-CH3), -4.47 (C), -5.02 (C). 
 
IR (cm
-1
) 2928.53, 2856.70, 1716.84; 
 
HRMS (ESI+) calcd for C20H33BrNO2Si
+
 m/z 426.15 found 426.1458. 
 
(6.53) Dimethyl 8-(tert-butyldimethylsilyloxy)-5-(2-oxopropyl)-
3,6,7,8-tetrahydroas-indacene-2,2(1H)-dicarboxylate 
 
O
O
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Dimethyl 2-(2-bromoallyl)-2-(4-(tert-butyldimethylsilyloxy)-6-(5-methylfuran-2-
yl)hex-2-ynyl)malonate (400 mg, 0.74 mmol), DPPE (59.76 mg, 0.15 mmol, 0.2 eq), 
palladium (II) acetate (16.61 mg, 0.074 mmol, 0.1 eq), potassium carbonate (204 mg, 
1.48 mmol, 2 eq) was heated to 120 °C in DMF (50 ml) for 25 minutes. The reaction 
mixture was then diluted with water (500 ml) and extracted with diethyl ether (3 x 
250 ml), dried over magnesium sulfate, filtered and reduced in vacuo. The resulting 
brown oil was purified using flash column chromatography eluting with 40 % diethyl 
ether in hexane to yield the title compound as a colourless oil (112 mg, 32 %). 
 
1
H-NMR (500 MHz, CDCl3) δ 6.92 (1H, s, H-5), 5.34 (1H, t, J=6.7, H-12), 3.76 (7H, 
m, H-18 + H-17 + H-9
a
/H-9
b
), 3.67-3.45 (5H, m, H-9
b
/H-9
a
 + H-7
a
 + H-7
b 
+ H-3), 
2.88 (1H, ddd, J=15.6, 9.0, 3.2, H-14), 2.60 (1H, dt, J=15.9, 8.0, H-14), 2.48-2.39 
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(1H, m, H-13), 2.14 (3H, s, H-1), 1.93 (1H, dtd, J=12.9, 8.5, 6.5, H-13), 0.94 (9H, s, 
H-22), 0.18 (6H, d, J=21.8, H-20). 
 
13
C-NMR (126 MHz, CDCl3) δ 206.09 (2-C), 172.37 (19-C), 172.06 (16-C), 141.02 
(C), 140.88 (4-C), 139.69 (8-C), 135.57 (10-C), 129.20 (C), 124.80 (5-CH), 76.31 
(12-C), 60.53 (C), 52.91 (18-CH3), 52.81 (17-CH3), 48.60 (3-CH2), 40.08 (7-CH2), 
38.82 (9-CH2), 36.10 (15-C), 29.3 (1-CH3), 25.86 (22-CH3 x 3), 17.99 (21-C), -4.06 
(20-CH), -4.70 (CH3). 
 
IR (cm
-1
) 2954, 2856, 1734, 1472; 
 
HRMS (ESI+) calcd for C25H36NaO6Si
+
 m/z 483.2173 found 483.22. 
 
(6.54) Dimethyl 2-(2-bromoallyl)-2-(4-(tert-
butyldimethylsilyloxy)-6-(5-methylfuran-2-yl)hex-2-
ynyl)malonate 
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To a stirred solution of triphenylphosphine (420 mg, 1.62 mmol, 1 eq) in THF (5 ml), 
a solution of DEAD (280 mg, 0.25 ml, 1.62 mmol, 1 eq)) in THF (2 ml) was  added 
dropwise at 0 °C. To this a mixture of  4-(tert-butyldimethylsilyloxy)-6-(5-
methylfuran-2-yl)hex-2-yn-1-ol (500 mg, 1.62 mmol) and dimethyl 2-(2-
bromoallyl)malonate (410 mg, 1.62 mmol, 1 eq) in THF (2 ml) was added dropwise 
over 1 minute. The solution was allowed to warm to room temperature overnight. 
The solvent was then reduced in vacuo and the resulting oil was purified using 
column chromatography eluting with 20 % diethyl ether in hexane to yield the title 
compound as a colourless oil (3.72 g, 57 %).  
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1
H-NMR (500 MHz, CDCl3) δ 5.85 (1H, d, J=2.9, H-4), 5.84 (1H, app S, H-3), 5.82 
(1H, S, H-15
a
/15
b
), 5.62 (1H, d, J=1.5, H-15
b
/15
a
), 4.35 (1H, t, J=6.3, H-8), 3.75 (6H, 
s, H-21 + H-19), 3.29 (2H, s, H-13), 2.96 (2H, d, J=1.8, H-11), 2.68 (2H, t, J=7.7, H-
6), 2.25 (3H, s, H-1), 2.00-1.86 (2H, m, H-7), 0.89 (12H, S, H-17), 0.69 (6H, d, 
J=9.6, H-15). 
 
13
C-NMR (126 MHz, CDCl3) δ 169.51 (20+18 C=O), 153.45 (5-C), 150.32 (2-C), 
126.27 (14-C), 122.67 (15-CH2), 105.77 (2-C), 105.53 (5-C), 85.41 (10-C), 78.64 (9-
C), 62.07 (8-CH), 56.13 (12-C), 52.92 (21+19-CH3), 42.99 (13-CH2), 37.28 (7-CH2), 
25.74 (17-CH3 x 3), 23.74 (6-CH2), 22.52 (11-CH2), 18.15 (16-C), 13.45 (1-CH3), -
4.60 (15-CH3), -5.14 (15-CH3). 
 
IR (cm
-1
) 2954, 1742, 1435; 
 
HRMS (ESI+) calcd for C25H37BrNaO6Si
+
 m/z 563.14 found 563.1435. 
(6.55) Dimethyl 2-(2-bromoallyl)malonate85 
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To a stirred solution of NaH (15.14 mmol, 1 eq) in THF (75 ml) dimethyl malonate 
was added dropwise at 0 °C and left to stir for 1 hr. To this solution was added 2,3-
dibromopropene (3.03 g, 1.48 ml, 15.14 mmol, 1 eq) in THF (20 ml) dropwise and 
left stirring overnight. The reaction was quenched with water (100 ml) and extracted 
with diethyl ether (3 x 100 ml) washed with brine and dried over magnesium sulfate, 
the filtered solution was then reduced in vacuo to yield a crude oil containing the 
mono and di-substituted product in roughly a 3:1 ratio. This crude oil was purified 
using flash column chromatography eluting with 20 % EtOAc in hexane to give the 
title compound as a colourless oil (1.44 g, 37 %).  
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1H-NMR (500 MHz, CDCl3) δ 5.70-5.68 (1H, m, H-1
a
/H-1
b
), 5.48 (1H, d, J=1.8, H-
1
b
/H-1
a
), 3.82 (1H, t, J=7.5, H-4), 3.76 (6H, s, H-6 + H-8), 3.03 (2H, dd, J=7.5, 0.8, 
H-3). 
 
13
C-NMR (126 MHz, CDCl3) δ 168.46 (5+7-C=O), 129.21 (2-C), 119.80 (1-CH2), 
52.72 (6+8-CH3), 50.41 (4-CH), 40.47 (3-CH2).  
 
HRMS (ESI+) calcd for C8H11BrNaO4
+
 m/z 272.97 found 272.9733. 
 
IR (cm
-1
) 2924, 1736, 1435, 1151; 
 
(6.60) tert-Butyl(furan-2-ylmethoxy)dimethylsilane 
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To a solution of TBDMSCl (8.44 g, 56 mmol, 1.1 eq), imidazole (6.95 g, 102 mmol, 
2 eq), DMAP (305 mg, 2.5 mmol, 0.05 eq) in DCM (50 ml) was added furfuryl 
alcohol (5 g, 4.4 ml, 50.9 mmol) in one portion and stirred at rt for 2 hours. The 
reaction mixture was then diluted with 50ml of water extracted with diethyl ether (3 
x 50 ml) washed with brine, dried over magnesium sulfate, filtered and reduced in 
vacuo to yield the title compound as a colourless oil (10.65 g , 99 %). 
 
1H-NMR (500 MHz, CDCl3) δ 7.38 (1H, dd, J = 1.8, 0.8 H-1), 6.33 (1H, dd, J = 3.1, 
1.8, H-2), 6.34 (1H, dd, J = 3.2, 0.5, H-3), 4.65 (2H, s, H-5), 0.92 (9H, s, H-8), 0.10 
(6H, s, H-6). 
 
13
C-NMR (126 MHz, CDCl3) δ 154.32 (4-C), 141.97 (1-CH), 110.13 (2-CH), 107.14 
(3-CH), 58.15 (5-CH2), 25.87 (8-CH3 x 3), 18.40 (7-C), -5.28 (6-CH3 x 2). 
 
IR (cm
-1
) 2954, 2857, 1472, 1254; 
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HRMS (ESI+) calcd for C11H20NaO2Si
+
 235.11 found m/z 235.1125. 
 
(6.63) (1-(2-Bromoallyloxy)-7-(5-methylfuran-2-yl)hept-2-yn-4-
yloxy)(tert-butyl)dimethylsilane 
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To a stirred solution of 4-(tert-butyldimethylsilyloxy)-7-(5-methylfuran-2-yl)hept-2-
yn-1-ol (2.1 g, 6.52 mmol) in THF (25 ml) was added 60 % NaH (288 mg, 7.2 mmol, 
1.1 eq) at 0 °C and left for 1 hour. 2,3-dibromopropane (1.3 g, 6.52 mmol, 1 eq) was 
then added dropwise at 0 °C and the reaction mixture allowed to warm to room temp. 
After 2 hr the reaction mixture was added to a stirring biphasic mixture of 10 % 
potassium carbonate (25 ml) and diethyl ether (25 ml) followed by separation and 
extraction of the aqueous layer using diethyl ether. The combined organic layers 
were then dried over magnesium sulfate, reduced in vacuo and purified via flash 
column chromatography eluting with 20 % diethyl ether in hexane to give the title 
compound as a colourless oil (1.79 g, 62 %). 
 
1
H-NMR (500 MHz, CDCl3) δ 5.94 (1H, d, J=1.5, H-15
a
/H-15
b
), 5.86 (1H, d, J=2.9, 
H-4), 5.85 (1H, d, J=0.6, H-3), 5.65 (1H, s, H-15
b
/H-15
a
), 4.44 (1H, t, J=5.2, H-9), 
4.24 (2H, d, J=1.6, H-12), 4.20 (2H, s, H-13), 2.61 (2H, t, J=6.9, H-6), 2.26 (3H, s, 
H-1), 1.80-1.70 (4H, m, H-7 + H-8), 0.92 (9H, s, H-18), 0.13 (6H, d, J=10.9, H-16). 
 
13
C-NMR (126 MHz, CDCl3) δ 154.02 (5-C), 150.18 (2-C), 128.64 (14-C), 118.34 
(15-CH2), 105.74 (3-CH), 105.43 (4-CH), 88.74 (10-C), 79.14 (11-C), 73.12 (13-
CH2), 62.70 (9-CH), 57.41 (12-CH2), 37.93 (CH2), 27.62 (6-CH2), 25.78 (18-CH3 x 
3), 23.78 (CH2), 18.21 (17-C), 13.47 (1-CH3), -4.52 (CH3), -5.01 (CH3). 
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IR (cm
-1
) 2955, 2931, 2856, 1715, 1361, 1253, 1079; 
 
HRMS (ESI+) calcd for C21H33BrKO3Si
+
 m/z 479.1014 found 479.1014. 
 
(6.64) 4-(tert-Butyldimethylsilyloxy)-7-(5-methylfuran-2-
yl)hept-2-yn-1-ol 
1
2
3
4
5
6
7
8
9
10
11
12
O
O
Si
HO
13
14
15
 
 
To a stirred solution of tert-butyldimethyl(6-(5-methylfuran-2-yl)hex-1-yn-3-
yloxy)silane (3.22 g, 11 mmol) in THF (35 ml) at -78 °C was added dropwise 2.5M 
n
BuLi (4.85 ml, 12.12 mmol, 1.1 eq) over 5 minutes. The reaction mixture was 
allowed to warm to -40 °C over 1 hour before re-cooling to -78 °C whereupon para-
formaldehyde (700 mg, 22 mmol, 2 eq) was added all at once. It was then stirred 
overnight and allowed to reach room temperature. The reaction mixture was then 
quenched with aqueous ammonium chloride (50 ml) and extracted with diethyl ether 
(3 x 50 ml). The organic fractions were combined and washed with brine, dried over 
magnesium sulfate, filtered and reduced in vacuo to give a crude pale straw coloured 
oil. The oil was purified using flash column chromatography eluting with 20 % 
diethyl ether in hexane and gave the title compound as a colourless oil (3.213 g, 90 
%). 
 
1
H-NMR (500 MHz, CDCl3) δ 5.86 (1H, d, J=3.0, H-4), 5.85 – 5.84 (1H, m, H-3), 
4.44-4.40 (1H, m, H-9), 4.29 (2H, dd, J=6.1, 1.6, H-12), 2.61 (2H, t, J=7.0, H-6), 
2.26 (3H, s, H-1), 1.80-1.69 (4H, m, H-7 + H-8), 0.92 (9H, s, H-15), 0.13 (6H, d, 
J=11.2, H-13). 
 
13
C-NMR (126 MHz, CDCl3) δ 154.05 (5-C), 150.18 (2-C), 105.73 (3-CH), 105.42 
(4-CH), 87.50 (10-C), 82.20 (11-C), 62.69 (9-CH), 51.18 (12-CH2), 37.92 (8-CH2), 
Novel aspects of furan chemistry                                                                                          Experimental 
 
158 
27.62 (6-CH2), 25.80 (15-CH3), 23.76 (7-CH2), 18.21 (14-C), -4.48 (CH3), -5.01 
(CH3). 
 
IR (cm
-1
) 3344, 2928, 2857, 1576, 1466, 1388; 
 
HRMS (ESI+) calcd for C18H30NaO3Si
+
 m/z 345.19 found 345.1856. 
 
(6.65) tert-Butyldimethyl(6-(5-methylfuran-2-yl)hex-1-yn-3-
yloxy)silane 
O
O
Si
1
2
3
4
5
6
7
8
9
10
11
12
13
14
 
 
To 6-(5-methylfuran-2-yl)hex-1-yn-3-ol (2 g, 11.22 mmol) in DCM (50 ml) was 
added TBDMSCl (1.86 g, 12.34 mmol, 1.1 eq), imidazole (1.53 g, 22.44 mmol, 2 eq) 
and DMAP (68 mg, 0.05 eq) and stirred at room temperature for two hours. To this, 
water (50 ml) was added and the mixture extracted with diethyl ether (3 x 50 ml). 
The organic layers were then combined and washed with brine (50 ml), dried over 
magnesium sulfate, filtered and reduced in vacuo to yield a pale straw coloured oil  
(3.253 g, 99 %). 
 
1
H-NMR (500 MHz, CDCl3) δ 5.87 (1H, d, J=3.0, H-4), 5.85 (1H, dd, J=2.9, 0.8, H-
3), 4.38 (1H, td, J=6.1, 2.0, H-9), 2.61 (2H, t, J=7.0, H-6), 2.39 (1H, d, J=2.1, H-11), 
2.26 (3H, s, H-1), 1.85-1.70 (4H, m, H-7 + H-8), 0.92 (9H, s, H-14), 0.14 (6H, d, 
J=12.2, H-12). 
 
13
C-NMR (126 MHz, CDCl3) δ 154.06 (5-C), 150.16 (2-C), 105.72 (3-CH), 105.39 
(4-CH), 85.48 (10-C), 72.05 (11-CH), 62.50 (9-CH), 37.91 (CH2), 27.61 (6-CH2), 
25.76 (14-CH3 x 3), 23.65 (CH2), 18.19 (13-C), 13.46 (1-CH3), -4.59 (CH3), -5.09 
(CH3). 
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IR (cm
-1
) 3309, 2930, 2857, 1684, 1251; 
 
HRMS (ESI+) calcd for C17H28NaOSi
+
 m/z 315.18 found 315.1751. 
 
(6.66) 6-(5-Methylfuran-2-yl)hex-1-yn-3-ol  
 
O
HO
1
2
3
4
5
67
8
9
10
11  
 
To a stirred solution of 4-(5-methylfuran-2-yl)butanal (2.6 g, 17.08 mmol) in THF 
(50 ml)  at -20 °C was added 0.5M ethynylmagnesium bromide (37.6 ml, 18.8 mmol) 
dropwise over a period of 5 minutes. The solution was then allowed to warm to room 
temperature over a period of 2 hours. The reaction was then quenched with aqueous 
ammonium chloride solution (50 ml) and extracted with diethyl ether (3 x 50 ml) the 
combined organic layers were dried over magnesium sulfate, filtered and reduced in 
vacuo to give a crude pale straw coloured oil. This oil was then purified using flash 
column chromatography eluting with diethyl ether in hexane to yield the title 
compound as a colourless oil (2.17 g, 86.8 %). 
 
1
H-NMR (500 MHz, CDCl3) δ 5.88 (1H, d, J=2.9, H-4), 5.85-5.84 (1H, m, H-3), 
4.43-4.38 (1H, m, H-9), 2.63 (2H, t, J=6.9, H-6), 2.47 (1H, d, J=2.1, H-11), 2.26 (3H, 
s, H-1), 1.94 (1H, d, J=5.0, OH), 1.86-1.75 (4H, m, H-7 + H-8). 
 
13
C-NMR (126 MHz, CDCl3) δ 153.77 (5-C), 150.28 (2-C), 105.77 (4-CH), 105.56 
(3-CH), 84.77 (10-C), 73.02 (11-CH), 62.05 (9-CH), 37.00 (CH2), 27.57 (6-CH2), 
23.66 (CH2), 13.47 (1-C). 
 
IR (cm
-1
) 3287, 2945, 1711, 1375, 1032; 
 
HRMS (ESI+) calcd for C11H13O2
-
 m/z 177.0921 found 177.0910. 
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(6.67) 4-(5-Methylfuran-2-yl)butanal 
 
O
O
1
2
3
4
5
67
8
9
 
 
To a solution of (Z)-2-(4-methoxybut-3-enyl)-5-methylfuran (5 g, 30 mmol) in THF 
(50 ml) was added PPTS (1.885 g, 7.5 mmol, 0.25 eq.) and water (two drops). The 
reaction mixture was allowed to stir for 48 hours and monitored using tlc. To the 
reaction mixture was added acetyl chloride (0.1 eq) and allowed to stir for a further 
24 hours after which water was added (50 ml) and the aqueous layer extracted with 
diethyl ether (3 x 50 ml), dried over magnesium sulfate, filtered and reduced in 
vacuo. The straw like oil was then purified using flash column chromatography 
eluting with 20 % diethyl ether in hexane to yield the title aldehyde as a colourless 
oil (2.61 g, 57.2 %). The unreacted starting material was recovered and the process 
repeated to give a similar yield. 
 
1
H-NMR (500 MHz, CDCl3) δ 9.75 (1H, s, H-9), 5,87 (1H, d, J=2.9, H-4), 5.84 (1H, 
dd, J=2.9, 0.8, H-3), 2.63 (1H, t, J=7.3, H-6), 2.48 (2H, td, J=7.3, 1.4, H-8), 2.25 (3H, 
s, H-1), 1.96 (2H, dq, J=14.6, 7.3, H-7). 
 
13
C-NMR (126 MHz, CDCl3) δ 201.98 (9-CH), 152.94 (5-C), 150.56 (2-C), 106.11 
(4-CH), 105.82 (3-CH), 43.03 (8-CH2), 27.23 (6-CH2), 20.76 (7-CH2), 13.44 (1-
CH3). 
 
IR (cm
-1
) 2938, 1720, 1680, 1568, 1454; 
 
HRMS (ESI+) calcd for C9H12NaO2
+
 m/z 175.07 found 175.0730. 
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(6.68) (Z)-2-(4-Methoxybut-3-enyl)-5-methylfuran  
 
O
O
12
3
4
5
6
7
8
9
10
 
 
To a solution of (methoxymethyl)triphenylphosphonium chloride (24.68 g, 72 mmol, 
1.1 eq) in THF (350 ml) was added 2.5M 
n
BuLi (29 ml, 72 mmol 1.1 eq) dropwise 
over 1 hour at -20 °C. To the resulting brick red solution was added 3-(5-
methylfuran-2-yl)propanal (9 g, 65.2 mmol) over 5 mins at -20 °C. The reaction 
mixture was quenched with water (350 ml) and the organic layer separated and 
washed with brine, dried over magnesium sulfate and reduced in vacuo to give a 
crude yellow oil. This oil was then purified using flash column chromatography 
eluting with 5 % diethyl ether in hexane to give the title compound as a colourless oil 
(8.898 g, 82 %). 
 
1
H-NMR (500 MHz, CDCl3) δ 6.34 (1H, d, J=12.6, H-9), 5.87 (1H, s, H-4), 5.85 
(1H, s, H-3), 4.78 (1H, dt, 12.7, 7.3, H-8), 3.51 (3H, s, H-10), 2.63 (2H, t, J=7.6, H-
6), 2.30 – 2.21 (5H, m, H-1 + H-7). 
 
13
C-NMR (126 MHz, CDCl3) δ 153.86 (5-C), 150.15 (2-C), 147.63 (9-CH), 105.75 
(3-CH), 105.48 (4-CH), 101.93 (8-CH), 55.84 (10-CH3), 29.57 (6-CH2), 26.60 (7-
CH2), 13.45 (1-CH3). 
 
IR (cm
-1
) 2942, 1717, 1571, 1083; 
 
HRMS (ESI+) calcd for C10H14NaO2
+
 m/z 189.0886 found 189.0886. 
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Table 1.  Crystal data and structure refinement . 
Identification code  may708 
Empirical formula  C9 H11 B O2 S 
Formula weight  194.05 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/c  (No.14) 
Unit cell dimensions a = 19.8089(9) Å = 90°. 
 b = 7.9247(4) Å = 90.141(3)°. 
 c = 6.1422(3) Å  = 90°. 
Volume 964.20(8) Å3 
Z 4 
Density (calculated) 1.34 Mg/m3 
Absorption coefficient 0.30 mm-1 
F(000) 408 
Crystal size 0.4 x 0.3 x 0.05 mm3 
Theta range for data collection 4.02 to 26.72°. 
Index ranges -25<=h<=24, -9<=k<=9, -7<=l<=6 
Reflections collected 10453 
Independent reflections 2011 [R(int) = 0.072] 
Reflections with I>2sigma(I) 1684 
Completeness to theta = 26.72° 98.8 %  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2011 / 0 / 122 
Goodness-of-fit on F2 1.078 
Final R indices [I>2sigma(I)] R1 = 0.048, wR2 = 0.118 
R indices (all data) R1 = 0.059, wR2 = 0.126 
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Largest diff. peak and hole 0.44 and -0.38 e.Å-3 
The hydroxyl H atom was refined. 
 
Data collection KappaCCD , Program package WinGX , Abs correction not applied ,  
Refinement using SHELXL-97 , Drawing using ORTEP-3 for Windows  
 
Table 2.  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for may708.  U(eq) is defined as one third of the trace of the orthogonalized U ij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
S 2229(1) 5122(1) 5085(1) 36(1) 
O(1) 706(1) 3463(2) 5844(2) 36(1) 
O(2) 544(1) 5386(2) 2927(2) 31(1) 
C(1) 935(1) 6164(3) 1191(4) 48(1) 
C(2) 1581(1) 5201(3) 962(4) 37(1) 
C(3) 1674(1) 4192(2) 3085(3) 28(1) 
C(4) 3041(1) 5055(2) 3882(3) 30(1) 
C(5) 3540(1) 5993(3) 4934(4) 36(1) 
C(6) 4196(1) 5951(3) 4173(4) 44(1) 
C(7) 4359(1) 4989(3) 2355(4) 45(1) 
C(8) 3865(1) 4084(3) 1308(4) 44(1) 
C(9) 3203(1) 4105(3) 2056(4) 37(1) 
B 935(1) 4265(3) 4068(4) 27(1) 
________________________________________________________________________________ 
 
 
 
 
Table 3.   Bond lengths [Å] and angles [°] for may708. 
_____________________________________________________ 
S-C(4)  1.773(2) 
S-C(3)  1.804(2) 
O(1)-B  1.343(3) 
O(2)-B  1.371(3) 
O(2)-C(1)  1.456(3) 
C(1)-C(2)  1.498(3) 
C(2)-C(3)  1.540(3) 
C(3)-B  1.585(3) 
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C(4)-C(9)  1.389(3) 
C(4)-C(5)  1.393(3) 
C(5)-C(6)  1.384(3) 
C(6)-C(7)  1.391(4) 
C(7)-C(8)  1.372(4) 
C(8)-C(9)  1.392(3) 
C(4)-S-C(3) 104.85(9) 
B-O(2)-C(1) 110.30(16) 
O(2)-C(1)-C(2) 108.03(18) 
C(1)-C(2)-C(3) 106.58(17) 
C(2)-C(3)-B 101.25(16) 
C(2)-C(3)-S 115.82(15) 
B-C(3)-S 106.68(13) 
C(9)-C(4)-C(5) 119.95(19) 
C(9)-C(4)-S 124.33(16) 
C(5)-C(4)-S 115.69(16) 
C(6)-C(5)-C(4) 119.7(2) 
C(5)-C(6)-C(7) 120.3(2) 
C(8)-C(7)-C(6) 119.8(2) 
C(7)-C(8)-C(9) 120.7(2) 
C(4)-C(9)-C(8) 119.5(2) 
O(1)-B-O(2) 121.97(19) 
O(1)-B-C(3) 127.35(19) 
O(2)-B-C(3) 110.55(17) 
_____________________________________________________________ 
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